##ANALYSISTYPE=GERMLINE_SINGLESAMPLE
##SAMPLE=<ID=NA12878_03,Status=affected,Gender=n/a>
##DESCRIPTION=genotype=Genotype of variant in sample.
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - SNP quality (QUAL), depth (DP), allele frequency (AF), mean mapping quality of alternate allele (MQM), genotype, depth and allele frequency for child, mother and father (TRIO).
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, NM number, type, impact, exon number, HGVS.c, HGVS.p).
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in all populations of 1000g project.
##DESCRIPTION=ExAC=Allele frequency in all populations of ExAC project.
##DESCRIPTION=ExAC_hom=Homoyzgous counts for populations ALL, NFE and AFR of ExAC project.
##DESCRIPTION=Kaviar=Allele frequency in Kaviar database.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=Sift=Sift effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=MetaLR=MetaLR effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen2=PolyPhen2 (HVAR) effect prediction: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=FATHMM=FATHMM effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 15-20.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=ihdb_allsys_hom=Homozygous variant counts in NGSD independent of the processing system.
##DESCRIPTION=ihdb_allsys_het=Heterozygous variant counts in NGSD independent of the processing system.
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validated=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Comments from the NGSD. Comments of other samples are listed in brackets!
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, ExAC pLI score).
##FILTER=anno_high_impact=Variant annotated to have high impact by SnpEff.
##FILTER=anno_pathogenic_clinvar=Variant annotated to be pathogenic by ClinVar.
##FILTER=anno_pathogenic_hgmd=Variant annotated to be pathogenic by HGMD.
##FILTER=gene_blacklist=The gene(s) are contained on the blacklist of unreliable genes.
##FILTER=low_DP=Depth less than 20.
##FILTER=low_MQM=Mean mapping quality of alternate allele less than Q50.
##FILTER=low_QUAL=Variant quality less than Q30.
##FILTER=off-target=Variant outside the panel/exome target region.
##FILTER=pred_pathogenic=Variant predicted to be pathogenic by one or more tools (conservation or effect prediction).
#chr	start	end	ref	obs	genotype	filter	quality	gene	variant_type	coding_and_splicing	RepeatMasker	dbSNP	1000g	ExAC	ExAC_hom	Kaviar	phyloP	Sift	MetaLR	PolyPhen2	FATHMM	CADD	OMIM	ClinVar	HGMD	COSMIC	ihdb_allsys_hom	ihdb_allsys_het	classification	classification_comment	validated	comment	gene_info
chr1	27682481	27682481	G	A	het	off-target	QUAL=2181;DP=169;AF=0.51;MQM=60	MAP3K6	intron	MAP3K6:ENST00000357582:intron:MODIFIER:exon27/28:c.3711+36C>T:,MAP3K6:ENST00000486046:intron:MODIFIER:exon2/2:c.156+36C>T:,MAP3K6:ENST00000472410:intron:MODIFIER:exon19/19:c.2360-638C>T:,MAP3K6:ENST00000374040:intron:MODIFIER:exon26/27:c.3687+36C>T:,MAP3K6:ENST00000493901:intron:MODIFIER:exon28/29:c.3711+36C>T:,MAP3K6:ENST00000470890:intron:MODIFIER:exon3/4:n.765+36C>T:		rs12569127	0.1903	0.2656	4554/3529/231	0.2588											100	419					MAP3K6 (inh=n/a pLI=0.00)
chr1	27686063	27686063	G	C	hom	off-target	QUAL=6115;DP=198;AF=1.00;MQM=60	MAP3K6	intron	MAP3K6:ENST00000357582:intron:MODIFIER:exon17/28:c.2320-50C>G:,MAP3K6:ENST00000472410:intron:MODIFIER:exon13/19:c.1489-50C>G:,MAP3K6:ENST00000374040:intron:MODIFIER:exon16/27:c.2296-50C>G:,MAP3K6:ENST00000493901:intron:MODIFIER:exon18/29:c.2320-50C>G:		rs7521552	0.9880	0.9939	58800/32412/4752	0.9558											789	6					MAP3K6 (inh=n/a pLI=0.00)
chr1	27687466	27687466	G	T	het		QUAL=9743;DP=738;AF=0.52;MQM=60	MAP3K6	missense	MAP3K6:ENST00000357582:missense:MODERATE:exon14/29:c.1866C>A:p.Asn622Lys,MAP3K6:ENST00000472410:missense:MODERATE:exon10/20:c.1035C>A:p.Asn345Lys,MAP3K6:ENST00000374040:missense:MODERATE:exon13/28:c.1842C>A:p.Asn614Lys,MAP3K6:ENST00000493901:missense:MODERATE:exon15/30:c.1866C>A:p.Asn622Lys		rs35659744	0.1220	0.2622	3300/2798/11	0.2145	0.0290	T,T,T,T,.	T,T	B,B,.	T,T,T,.	10.76				COSM1559293, COSM1559292	196	815					MAP3K6 (inh=n/a pLI=0.00)
chr1	27690359	27690359	T	C	het	off-target	QUAL=1451;DP=111;AF=0.53;MQM=60	MAP3K6	intron	MAP3K6:ENST00000357582:intron:MODIFIER:exon5/28:c.864+49A>G:,MAP3K6:ENST00000472410:intron:MODIFIER:exon1/19:c.33+49A>G:,MAP3K6:ENST00000374040:intron:MODIFIER:exon4/27:c.840+49A>G:,MAP3K6:ENST00000493901:intron:MODIFIER:exon6/29:c.864+49A>G:	MIRb	rs4307592	0.2196	0.2976	1551/1146/215	0.2141											85	351					MAP3K6 (inh=n/a pLI=0.00)
chr1	27690644	27690644	A	G	het	off-target	QUAL=645;DP=89;AF=0.36;MQM=60	MAP3K6	intron	MAP3K6:ENST00000357582:intron:MODIFIER:exon4/28:c.695+51T>C:,MAP3K6:ENST00000374040:intron:MODIFIER:exon3/27:c.671+51T>C:,MAP3K6:ENST00000493901:intron:MODIFIER:exon5/29:c.695+51T>C:		rs12727507	0.3548	0.3309	7323/4186/2129	0.3215											126	440					MAP3K6 (inh=n/a pLI=0.00)
chr1	45796269	45796269	G	C	hom	off-target;low_DP	QUAL=264;DP=10;AF=1.00;MQM=60	MUTYH	intron	MUTYH:ENST00000450313:intron:MODIFIER:exon14/15:c.1477-40C>G:,MUTYH:ENST00000528332:intron:MODIFIER:exon5/6:c.520-40C>G:,MUTYH:ENST00000529984:intron:MODIFIER:exon5/6:c.478-40C>G:,MUTYH:ENST00000485271:intron:MODIFIER:exon1/3:c.88-40C>G:,MUTYH:ENST00000372104:intron:MODIFIER:exon15/16:c.1393-40C>G:,MUTYH:ENST00000448481:intron:MODIFIER:exon14/15:c.1426-40C>G:,MUTYH:ENST00000456914:intron:MODIFIER:exon14/15:c.1393-40C>G:,MUTYH:ENST00000354383:intron:MODIFIER:exon14/15:c.1396-40C>G:,MUTYH:ENST00000475516:intron:MODIFIER:exon14/15:c.*1206-40C>G:,MUTYH:ENST00000355498:intron:MODIFIER:exon14/15:c.1393-40C>G:,MUTYH:ENST00000372098:intron:MODIFIER:exon14/15:c.1468-40C>G:,MUTYH:ENST00000372110:intron:MODIFIER:exon14/15:c.1438-40C>G:,MUTYH:ENST00000481571:intron:MODIFIER:exon14/15:c.*1206-40C>G:,MUTYH:ENST00000372115:intron:MODIFIER:exon14/15:c.1435-40C>G:,MUTYH:ENST00000488731:intron:MODIFIER:exon5/6:c.478-40C>G:,MUTYH:ENST00000372100:intron:MODIFIER:exon14/15:c.1426-40C>G:,MUTYH:ENST00000531105:intron:MODIFIER:exon2/2:c.116-1160C>G:,MUTYH:ENST00000467459:intron:MODIFIER:exon6/7:c.*255-40C>G:,MUTYH:ENST00000482094:intron:MODIFIER:exon3/4:n.714-40C>G:,MUTYH:ENST00000529892:intron:MODIFIER:exon4/5:c.466-40C>G:,MUTYH:ENST00000533178:intron:MODIFIER:exon8/9:c.*722-40C>G:,MUTYH:ENST00000528013:intron:MODIFIER:exon14/15:c.1435-40C>G:		rs3219493	0.9353	0.9245	35987/19433/3346	0.8921							604933 [MUTYH (provisional) Adenomas,multiple colorectal,608456|Gastric cancer,somatic,613659|Colorectal adenomatous polyposis,autosomal recessive,with pilomatricomas,132600];				971	193					MUTYH (inh=AR pLI=0.00)
chr1	45797505	45797505	C	G	het		QUAL=3120;DP=233;AF=0.52;MQM=60	MUTYH	missense,3'UTR,intron,non_coding_transcript_exon	MUTYH:ENST00000450313:missense:MODERATE:exon12/16:c.1014G>C:p.Gln338His,MUTYH:ENST00000372104:missense:MODERATE:exon13/17:c.930G>C:p.Gln310His,MUTYH:ENST00000448481:missense:MODERATE:exon12/16:c.963G>C:p.Gln321His,MUTYH:ENST00000456914:missense:MODERATE:exon12/16:c.930G>C:p.Gln310His,MUTYH:ENST00000354383:missense:MODERATE:exon12/16:c.933G>C:p.Gln311His,MUTYH:ENST00000355498:missense:MODERATE:exon12/16:c.930G>C:p.Gln310His,MUTYH:ENST00000372098:missense:MODERATE:exon12/16:c.1005G>C:p.Gln335His,MUTYH:ENST00000372110:missense:MODERATE:exon12/16:c.975G>C:p.Gln325His,MUTYH:ENST00000372115:missense:MODERATE:exon12/16:c.972G>C:p.Gln324His,MUTYH:ENST00000372100:missense:MODERATE:exon12/16:c.963G>C:p.Gln321His,MUTYH:ENST00000467459:missense:MODERATE:exon4/8:c.347G>C:p.Ser116Thr,MUTYH:ENST00000528013:missense:MODERATE:exon12/16:c.972G>C:p.Gln324His,MUTYH:ENST00000412971:missense:MODERATE:exon7/7:c.546G>C:p.Gln182His,MUTYH:ENST00000475516:3'UTR:MODIFIER:exon12/16:c.*743G>C:,MUTYH:ENST00000481571:3'UTR:MODIFIER:exon12/16:c.*743G>C:,MUTYH:ENST00000533178:3'UTR:MODIFIER:exon6/10:c.*259G>C:,MUTYH:ENST00000528332:intron:MODIFIER:exon3/6:c.230-277G>C:,MUTYH:ENST00000529984:intron:MODIFIER:exon3/6:c.188-277G>C:,MUTYH:ENST00000488731:intron:MODIFIER:exon3/6:c.188-277G>C:,MUTYH:ENST00000531105:intron:MODIFIER:exon2/2:c.116-2396G>C:,MUTYH:ENST00000529892:intron:MODIFIER:exon2/5:c.175+190G>C:,MUTYH:ENST00000482094:non_coding_transcript_exon:MODIFIER:exon1/5:n.251G>C:,MUTYH:ENST00000462388:non_coding_transcript_exon:MODIFIER:exon5/5:n.794G>C:,MUTYH:ENST00000466231:non_coding_transcript_exon:MODIFIER:exon3/3:n.295G>C:		rs3219489	0.3135	0.2967	4266/1586/319	0.2680	0.0510	T,T,T,T,T,T,T,T,T,T,T,T	T	B,B,B,B,B,B,B	T,T,T,T,T,T,T,T,T,T,T	6.04	604933 [MUTYH (provisional) Adenomas,multiple colorectal,608456|Gastric cancer,somatic,613659|Colorectal adenomatous polyposis,autosomal recessive,with pilomatricomas,132600];	RCV000034684.1 [benign]; RCV000079500.6 [benign]; RCV000131427.2 [benign]; RCV000144634.1 [benign]; RCV000299432.1 [benign]; 	CM083726 [CLASS=DFP MUT=ALT PHEN="Reduced activity" GENE=MUTYH]; 	COSM3751252	218	1286	1	[1] Ilnaz Sepahi 29-03-2016 batch import			MUTYH (inh=AR pLI=0.00)
chr1	45798555	45798555	T	C	hom	off-target	QUAL=5837;DP=190;AF=1.00;MQM=60	MUTYH	intron,non_coding_transcript_exon	MUTYH:ENST00000450313:intron:MODIFIER:exon6/15:c.504+35A>G:,MUTYH:ENST00000528332:intron:MODIFIER:exon2/6:c.158-49A>G:,MUTYH:ENST00000529984:intron:MODIFIER:exon2/6:c.116-49A>G:,MUTYH:ENST00000372104:intron:MODIFIER:exon7/16:c.420+35A>G:,MUTYH:ENST00000448481:intron:MODIFIER:exon6/15:c.453+35A>G:,MUTYH:ENST00000456914:intron:MODIFIER:exon6/15:c.420+35A>G:,MUTYH:ENST00000354383:intron:MODIFIER:exon6/15:c.423+35A>G:,MUTYH:ENST00000475516:intron:MODIFIER:exon6/15:c.*233+35A>G:,MUTYH:ENST00000355498:intron:MODIFIER:exon6/15:c.420+35A>G:,MUTYH:ENST00000372098:intron:MODIFIER:exon6/15:c.495+35A>G:,MUTYH:ENST00000372110:intron:MODIFIER:exon6/15:c.465+35A>G:,MUTYH:ENST00000481571:intron:MODIFIER:exon6/15:c.*233+35A>G:,MUTYH:ENST00000372115:intron:MODIFIER:exon6/15:c.462+35A>G:,MUTYH:ENST00000488731:intron:MODIFIER:exon2/6:c.116-49A>G:,MUTYH:ENST00000372100:intron:MODIFIER:exon6/15:c.453+35A>G:,MUTYH:ENST00000531105:intron:MODIFIER:exon2/2:c.115+1508A>G:,MUTYH:ENST00000533178:intron:MODIFIER:exon1/9:c.122-196A>G:,MUTYH:ENST00000528013:intron:MODIFIER:exon6/15:c.462+35A>G:,MUTYH:ENST00000412971:intron:MODIFIER:exon1/6:c.37-49A>G:,MUTYH:ENST00000470256:intron:MODIFIER:exon4/8:c.308-49A>G:,MUTYH:ENST00000461495:intron:MODIFIER:exon5/9:c.*159+35A>G:,MUTYH:ENST00000435155:intron:MODIFIER:exon6/9:c.453+35A>G:,MUTYH:ENST00000467940:intron:MODIFIER:exon6/9:c.*343+35A>G:,MUTYH:ENST00000478796:intron:MODIFIER:exon1/4:n.407+35A>G:,MUTYH:ENST00000525160:intron:MODIFIER:exon4/6:c.*71+35A>G:,MUTYH:ENST00000485484:intron:MODIFIER:exon4/4:n.721+35A>G:,MUTYH:ENST00000462388:non_coding_transcript_exon:MODIFIER:exon1/5:n.63A>G:,MUTYH:ENST00000479746:non_coding_transcript_exon:MODIFIER:exon5/5:n.655A>G:,MUTYH:ENST00000492494:non_coding_transcript_exon:MODIFIER:exon4/5:n.769A>G:,MUTYH:ENST00000483642:non_coding_transcript_exon:MODIFIER:exon4/5:n.887A>G:,MUTYH:ENST00000481139:non_coding_transcript_exon:MODIFIER:exon4/4:n.845A>G:,MUTYH:ENST00000476789:non_coding_transcript_exon:MODIFIER:exon5/5:n.812A>G:,MUTYH:ENST00000462387:non_coding_transcript_exon:MODIFIER:exon3/3:n.777A>G:		rs3219487	0.9371	0.9255	52022/27990/4842	0.9134							604933 [MUTYH (provisional) Adenomas,multiple colorectal,608456|Gastric cancer,somatic,613659|Colorectal adenomatous polyposis,autosomal recessive,with pilomatricomas,132600];	RCV000254257.1 [benign]; 			1016	197					MUTYH (inh=AR pLI=0.00)
chr1	62713224	62713224	C	G	hom		QUAL=1165;DP=37;AF=1.00;MQM=60	KANK4	missense	KANK4:ENST00000371153:missense:MODERATE:exon9/10:c.2803G>C:p.Val935Leu,KANK4:ENST00000317477:missense:MODERATE:exon3/4:c.217G>C:p.Val73Leu,KANK4:ENST00000371150:missense:MODERATE:exon6/7:c.871G>C:p.Val291Leu,KANK4:ENST00000354381:missense:MODERATE:exon8/9:c.919G>C:p.Val307Leu		rs2941679	0.9862	0.9744	57571/31015/5111	0.9516	0.6980	T,T,T,T	T	B,B	T,T,T,T	15.02					2357	183					KANK4 (inh=n/a pLI=0.00)
chr1	62713246	62713246	G	A	het		QUAL=1311;DP=117;AF=0.44;MQM=60	KANK4	synonymous	KANK4:ENST00000371153:synonymous:LOW:exon9/10:c.2781C>T:p.His927His,KANK4:ENST00000317477:synonymous:LOW:exon3/4:c.195C>T:p.His65His,KANK4:ENST00000371150:synonymous:LOW:exon6/7:c.849C>T:p.His283His,KANK4:ENST00000354381:synonymous:LOW:exon8/9:c.897C>T:p.His299His		rs10889315	0.3189	0.3896	9671/6170/528	0.3831										COSM426544	460	1252					KANK4 (inh=n/a pLI=0.00)
chr1	62728784	62728784	A	G	hom	pred_pathogenic	QUAL=38237;DP=1208;AF=1.00;MQM=60	KANK4	missense,5'UTR	KANK4:ENST00000371153:missense:MODERATE:exon7/10:c.2519T>C:p.Val840Ala,KANK4:ENST00000371150:missense:MODERATE:exon4/7:c.587T>C:p.Val196Ala,KANK4:ENST00000354381:missense:MODERATE:exon6/9:c.635T>C:p.Val212Ala,KANK4:ENST00000317477:5'UTR:MODIFIER:exon1/4:c.-68T>C:		rs2666472	0.7159	0.7444	33236/17884/1580	0.7324	2.8390	T,T,T	T	B,B	T,T,T	8.63				COSM4144131	1379	963					KANK4 (inh=n/a pLI=0.00)
chr1	62728838	62728838	T	C	hom	pred_pathogenic	QUAL=35339;DP=1140;AF=1.00;MQM=60	KANK4	missense,5'UTR	KANK4:ENST00000371153:missense:MODERATE:exon7/10:c.2465A>G:p.His822Arg,KANK4:ENST00000371150:missense:MODERATE:exon4/7:c.533A>G:p.His178Arg,KANK4:ENST00000354381:missense:MODERATE:exon6/9:c.581A>G:p.His194Arg,KANK4:ENST00000317477:5'UTR:MODIFIER:exon1/4:c.-122A>G:		rs2258470	0.7163	0.7426	33613/18068/1595	0.7337	3.3070	T,T,T	T	B,B	T,T,T	5.14					1379	964					KANK4 (inh=n/a pLI=0.00)
chr1	62728861	62728861	T	C	hom		QUAL=35802;DP=1143;AF=1.00;MQM=60	KANK4	synonymous,5'UTR	KANK4:ENST00000371153:synonymous:LOW:exon7/10:c.2442A>G:p.Lys814Lys,KANK4:ENST00000371150:synonymous:LOW:exon4/7:c.510A>G:p.Lys170Lys,KANK4:ENST00000354381:synonymous:LOW:exon6/9:c.558A>G:p.Lys186Lys,KANK4:ENST00000317477:5'UTR:MODIFIER:exon1/4:c.-145A>G:		rs2260581	0.7163	0.7426	33625/18069/1593	0.7336											1379	965					KANK4 (inh=n/a pLI=0.00)
chr1	62728918	62728918	G	A	hom		QUAL=5593;DP=187;AF=1.00;MQM=60	KANK4	synonymous,5'UTR_premature_start_codon_gain,5'UTR	KANK4:ENST00000371153:synonymous:LOW:exon7/10:c.2385C>T:p.Pro795Pro,KANK4:ENST00000371150:synonymous:LOW:exon4/7:c.453C>T:p.Pro151Pro,KANK4:ENST00000354381:synonymous:LOW:exon6/9:c.501C>T:p.Pro167Pro,KANK4:ENST00000317477:5'UTR_premature_start_codon_gain:LOW:exon1/4:c.-202C>T:,KANK4:ENST00000317477:5'UTR:MODIFIER:exon1/4:c.-202C>T:		rs2262110	0.7161	0.7437	33830/18192/1608	0.7345											1381	966					KANK4 (inh=n/a pLI=0.00)
chr1	62729015	62729015	G	A	hom	off-target	QUAL=7385;DP=225;AF=1.00;MQM=60	KANK4	5'UTR,intron	KANK4:ENST00000317477:5'UTR:MODIFIER:exon1/4:c.-299C>T:,KANK4:ENST00000371153:intron:MODIFIER:exon6/9:c.2320-32C>T:,KANK4:ENST00000371150:intron:MODIFIER:exon3/6:c.388-32C>T:,KANK4:ENST00000354381:intron:MODIFIER:exon5/8:c.436-32C>T:		rs2262106	0.7095	0.7535	25643/13969/1095	0.7083											545	370					KANK4 (inh=n/a pLI=0.00)
chr1	62732421	62732421	T	C	het	pred_pathogenic	QUAL=11256;DP=891;AF=0.52;MQM=60	KANK4	missense	KANK4:ENST00000371153:missense:MODERATE:exon6/10:c.2302A>G:p.Thr768Ala,KANK4:ENST00000371150:missense:MODERATE:exon3/7:c.370A>G:p.Thr124Ala,KANK4:ENST00000354381:missense:MODERATE:exon5/9:c.418A>G:p.Thr140Ala		rs11207949	0.3055	0.2850	6079/2111/253	0.2813	2.3800	T,T,T	T	B,B	T,T,T	9.25					122	893					KANK4 (inh=n/a pLI=0.00)
chr1	62733939	62733939	G	A	het	off-target	QUAL=1676;DP=152;AF=0.46;MQM=60	KANK4	splice_region&intron	KANK4:ENST00000371153:splice_region&intron:LOW:exon5/9:c.2231+20C>T:,KANK4:ENST00000371150:splice_region&intron:LOW:exon2/6:c.299+20C>T:,KANK4:ENST00000354381:splice_region&intron:LOW:exon4/8:c.347+20C>T:		rs11207950	0.4669	0.4324	11564/5648/1676	0.4145											283	669					KANK4 (inh=n/a pLI=0.00)
chr1	62738904	62738904	T	C	hom		QUAL=2015;DP=76;AF=0.99;MQM=60	KANK4	synonymous,intron	KANK4:ENST00000371153:synonymous:LOW:exon3/10:c.1872A>G:p.Pro624Pro,KANK4:ENST00000354381:intron:MODIFIER:exon2/8:c.17-1643A>G:		rs7516290	0.8005	0.7470	30811/15109/3422	0.7022											1246	1046					KANK4 (inh=n/a pLI=0.00)
chr1	62739198	62739198	G	A	het		QUAL=1755;DP=140;AF=0.49;MQM=60	KANK4	synonymous,intron	KANK4:ENST00000371153:synonymous:LOW:exon3/10:c.1578C>T:p.Ser526Ser,KANK4:ENST00000354381:intron:MODIFIER:exon2/8:c.17-1937C>T:		rs17855078	0.2506	0.3085	6308/3987/186	0.3023											307	1167					KANK4 (inh=n/a pLI=0.00)
chr1	62740065	62740065	A	G	het		QUAL=1450;DP=128;AF=0.48;MQM=60	KANK4	synonymous,intron	KANK4:ENST00000371153:synonymous:LOW:exon3/10:c.711T>C:p.Gly237Gly,KANK4:ENST00000354381:intron:MODIFIER:exon2/8:c.17-2804T>C:		rs12127930	0.4822	0.4515	12895/6511/1987	0.4422										COSM4144132	552	1274					KANK4 (inh=n/a pLI=0.00)
chr1	62740446	62740446	T	C	hom		QUAL=7384;DP=239;AF=1.00;MQM=60	KANK4	synonymous,intron	KANK4:ENST00000371153:synonymous:LOW:exon3/10:c.330A>G:p.Pro110Pro,KANK4:ENST00000354381:intron:MODIFIER:exon2/8:c.17-3185A>G:		rs2666506	0.8045	0.7448	33966/15906/3719	0.7091											1247	1046					KANK4 (inh=n/a pLI=0.00)
chr1	62740449	62740449	T	C	hom		QUAL=7384;DP=239;AF=1.00;MQM=60	KANK4	synonymous,intron	KANK4:ENST00000371153:synonymous:LOW:exon3/10:c.327A>G:p.Ser109Ser,KANK4:ENST00000354381:intron:MODIFIER:exon2/8:c.17-3188A>G:		rs2666507	0.7810	0.7374	33241/15890/3051	0.7198											1245	1047					KANK4 (inh=n/a pLI=0.00)
chr1	62740781	62740781	A	-	het	off-target	QUAL=265;DP=121;AF=0.20;MQM=60	KANK4	intron	KANK4:ENST00000371153:intron:MODIFIER:exon2/9:c.17-22delT:,KANK4:ENST00000354381:intron:MODIFIER:exon2/8:c.17-3520delT:		rs761923018	0.0000	0.1967	0/0/0	0.1312											0	15					KANK4 (inh=n/a pLI=0.00)
chr1	78578177	78578177	T	C	het		QUAL=4972;DP=413;AF=0.46;MQM=60	GIPC2	intron	GIPC2:ENST00000370759:intron:MODIFIER:exon3/5:c.608-6900T>C:		rs6666954	0.4489	0.3224	6753/2474/1523	0.3067											167	699					GIPC2 (inh=n/a pLI=0.00)
chr1	120458004	120458004	A	T	het		QUAL=1768;DP=133;AF=0.55;MQM=60	NOTCH2	synonymous	NOTCH2:ENST00000256646:synonymous:LOW:exon34/34:c.7341T>A:p.Gly2447Gly		rs6685892	0.1925	0.1293	1431/359/637	0.1249							600275 [NOTCH2 (provisional) Alagille syndrome 2,610205|Hajdu-Cheney syndrome,102500];	RCV000251156.2 [benign]; 			32	536					NOTCH2 (inh=AD pLI=1.00)
chr1	120471857	120471857	C	T	het	off-target	QUAL=525;DP=29;AF=0.69;MQM=60	NOTCH2	intron	NOTCH2:ENST00000256646:intron:MODIFIER:exon22/33:c.3656-22G>A:		rs2493392	0.1925	0.1290	1405/346/625	0.1247							600275 [NOTCH2 (provisional) Alagille syndrome 2,610205|Hajdu-Cheney syndrome,102500];				20	233					NOTCH2 (inh=AD pLI=1.00)
chr1	120477998	120477998	C	A	het	off-target;low_DP	QUAL=286;DP=19;AF=0.63;MQM=60	NOTCH2	intron,non_coding_transcript_exon	NOTCH2:ENST00000256646:intron:MODIFIER:exon22/33:c.3655+97G>T:,NOTCH2:ENST00000478864:non_coding_transcript_exon:MODIFIER:exon2/2:n.412G>T:		rs2453056	0.3013	0.1872	2978/490/1358	0.1774							600275 [NOTCH2 (provisional) Alagille syndrome 2,610205|Hajdu-Cheney syndrome,102500];				27	226					NOTCH2 (inh=AD pLI=1.00)
chr1	120478285	120478285	T	C	het	off-target	QUAL=11662;DP=892;AF=0.51;MQM=60	NOTCH2	intron	NOTCH2:ENST00000256646:intron:MODIFIER:exon21/33:c.3523-58A>G:,NOTCH2:ENST00000478864:intron:MODIFIER:exon1/1:n.183-58A>G:		rs5025718	0.6044	0.0000	0/0/0	0.1451							600275 [NOTCH2 (provisional) Alagille syndrome 2,610205|Hajdu-Cheney syndrome,102500];				718	248					NOTCH2 (inh=AD pLI=1.00)
chr1	120484421	120484421	G	A	het	off-target	QUAL=762;DP=65;AF=0.49;MQM=60	NOTCH2	intron	NOTCH2:ENST00000256646:intron:MODIFIER:exon17/33:c.2753-44C>T:		rs2493420	0.2714	0.1844	2345/431/880	0.1685							600275 [NOTCH2 (provisional) Alagille syndrome 2,610205|Hajdu-Cheney syndrome,102500];				30	292					NOTCH2 (inh=AD pLI=1.00)
chr1	120496119	120496119	A	T	het	off-target	QUAL=7154;DP=639;AF=0.45;MQM=60	NOTCH2	intron	NOTCH2:ENST00000256646:intron:MODIFIER:exon14/33:c.2365+47T>A:,NOTCH2:ENST00000479412:intron:MODIFIER:exon13/13:n.2503+47T>A:		rs7534585	0.1923	0.1284	1418/354/631	0.1236							600275 [NOTCH2 (provisional) Alagille syndrome 2,610205|Hajdu-Cheney syndrome,102500];				17	200					NOTCH2 (inh=AD pLI=1.00)
chr1	120496127	120496127	A	C	het	off-target	QUAL=7123;DP=638;AF=0.45;MQM=60	NOTCH2	intron	NOTCH2:ENST00000256646:intron:MODIFIER:exon14/33:c.2365+39T>G:,NOTCH2:ENST00000479412:intron:MODIFIER:exon13/13:n.2503+39T>G:		rs7534586	0.1923	0.1283	1417/353/631	0.1236							600275 [NOTCH2 (provisional) Alagille syndrome 2,610205|Hajdu-Cheney syndrome,102500];				17	200					NOTCH2 (inh=AD pLI=1.00)
chr1	120512104	120512104	T	C	hom	off-target	QUAL=18002;DP=571;AF=1.00;MQM=60	NOTCH2	intron	NOTCH2:ENST00000256646:intron:MODIFIER:exon6/33:c.1108+30A>G:,NOTCH2:ENST00000479412:intron:MODIFIER:exon5/13:n.1246+30A>G:		rs2493409	0.9786	0.9929	54659/30854/4055	0.9472							600275 [NOTCH2 (provisional) Alagille syndrome 2,610205|Hajdu-Cheney syndrome,102500];				1001	3					NOTCH2 (inh=AD pLI=1.00)
chr1	120529750	120529750	A	C	het	off-target	QUAL=11339;DP=925;AF=0.48;MQM=60	NOTCH2	intron	NOTCH2:ENST00000256646:intron:MODIFIER:exon4/33:c.752-45T>G:,NOTCH2:ENST00000479412:intron:MODIFIER:exon3/13:n.890-45T>G:		rs2453040	0.1907	0.1274	1359/328/608	0.1222							600275 [NOTCH2 (provisional) Alagille syndrome 2,610205|Hajdu-Cheney syndrome,102500];				17	200					NOTCH2 (inh=AD pLI=1.00)
chr1	120539331	120539331	C	T	het	low_MQM	QUAL=25003;DP=1918;AF=0.52;MQM=49	NOTCH2	missense,intron	NOTCH2:ENST00000602566:missense:MODERATE:exon6/6:c.673G>A:p.Gly225Arg,NOTCH2:ENST00000256646:intron:MODIFIER:exon4/33:c.751+289G>A:,NOTCH2:ENST00000479412:intron:MODIFIER:exon3/13:n.889+289G>A:		rs2124109	0.0000	0.4411	0/0/0	0.0101							600275 [NOTCH2 (provisional) Alagille syndrome 2,610205|Hajdu-Cheney syndrome,102500];			COSM248829	0	2090					NOTCH2 (inh=AD pLI=1.00)
chr1	120611496	120611496	C	A	het	low_MQM	QUAL=276;DP=41;AF=0.49;MQM=47	NOTCH2	intron	NOTCH2:ENST00000256646:intron:MODIFIER:exon1/33:c.73+452G>T:,NOTCH2:ENST00000479412:intron:MODIFIER:exon1/13:n.293+452G>T:		rs2794164	0.0000	0.0662	12/1/1	0.0088							600275 [NOTCH2 (provisional) Alagille syndrome 2,610205|Hajdu-Cheney syndrome,102500];				43	812					NOTCH2 (inh=AD pLI=1.00)
chr1	120611960	120611960	C	T	het	low_MQM;pred_pathogenic	QUAL=4582;DP=1978;AF=0.21;MQM=47	NOTCH2	missense,non_coding_transcript_exon	NOTCH2:ENST00000256646:missense:MODERATE:exon1/34:c.61G>A:p.Ala21Thr,NOTCH2:ENST00000479412:non_coding_transcript_exon:MODIFIER:exon1/14:n.281G>A:		rs2603926	0.0000	0.3634	0/0/0	0.0029	0.4330	T	T	B,B	T	22.40	600275 [NOTCH2 (provisional) Alagille syndrome 2,610205|Hajdu-Cheney syndrome,102500];			COSM1600651	0	877					NOTCH2 (inh=AD pLI=1.00)
chr1	120611964	120611964	G	C	het		QUAL=16640;DP=1978;AF=0.38;MQM=59	NOTCH2	missense,non_coding_transcript_exon	NOTCH2:ENST00000256646:missense:MODERATE:exon1/34:c.57C>G:p.Cys19Trp,NOTCH2:ENST00000479412:non_coding_transcript_exon:MODIFIER:exon1/14:n.277C>G:		rs11810554	0.0000	0.4493	3/1/2	0.0210	0.7660	.,T	T,T	.,B,B	.,T	17.56	600275 [NOTCH2 (provisional) Alagille syndrome 2,610205|Hajdu-Cheney syndrome,102500];			COSM132738	6	2722					NOTCH2 (inh=AD pLI=1.00)
chr1	120612003	120612004	GG	-	het	low_MQM;anno_high_impact	QUAL=3950;DP=2047;AF=0.20;MQM=48	NOTCH2	frameshift,non_coding_transcript_exon	NOTCH2:ENST00000256646:frameshift:HIGH:exon1/34:c.17_18delCC:p.Pro6fs,NOTCH2:ENST00000479412:non_coding_transcript_exon:MODIFIER:exon1/14:n.237_238delCC:		rs864309621	0.0000	0.4057	0/0/0	0.0088							600275 [NOTCH2 (provisional) Alagille syndrome 2,610205|Hajdu-Cheney syndrome,102500];	RCV000202675.2 [benign]; 		COSM132830	0	1079	2	[3] old entry - no details available [2] ahdoeha1 12.08.2016		n/a (wahrscheinlich durch Pseudogen)	NOTCH2 (inh=AD pLI=1.00)
chr1	120612006	120612006	G	A	het		QUAL=18646;DP=2048;AF=0.39;MQM=58	NOTCH2	synonymous,non_coding_transcript_exon	NOTCH2:ENST00000256646:synonymous:LOW:exon1/34:c.15C>T:p.Arg5Arg,NOTCH2:ENST00000479412:non_coding_transcript_exon:MODIFIER:exon1/14:n.235C>T:		rs4021006	0.3940	0.4638	259/151/10	0.0257	1.0740					8.96	600275 [NOTCH2 (provisional) Alagille syndrome 2,610205|Hajdu-Cheney syndrome,102500];	RCV000173523.1 [uncertain significance]; 		COSM1320072	7	2717					NOTCH2 (inh=AD pLI=1.00)
chr1	120612034	120612034	T	G	het	low_MQM	QUAL=3544;DP=2047;AF=0.20;MQM=47	NOTCH2	5'UTR,non_coding_transcript_exon	NOTCH2:ENST00000256646:5'UTR:MODIFIER:exon1/34:c.-14A>C:,NOTCH2:ENST00000479412:non_coding_transcript_exon:MODIFIER:exon1/14:n.207A>C:	(CGC)n	rs201668322	0.0000	0.2585	0/0/0	0.0010							600275 [NOTCH2 (provisional) Alagille syndrome 2,610205|Hajdu-Cheney syndrome,102500];				0	680					NOTCH2 (inh=AD pLI=1.00)
chr2	17941423	17941423	T	G	hom	off-target	QUAL=1007;DP=33;AF=1.00;MQM=60	GEN1,SMC6	intron	GEN1:ENST00000317402:intron:MODIFIER:exon2/13:c.161+52T>G:,SMC6:ENST00000402989:intron:MODIFIER:exon4/29:c.-5-14205A>C:,SMC6:ENST00000428868:intron:MODIFIER:exon3/4:c.-5-14205A>C:,GEN1:ENST00000524465:intron:MODIFIER:exon2/3:c.161+52T>G:,GEN1:ENST00000381254:intron:MODIFIER:exon2/13:c.161+52T>G:,GEN1:ENST00000532257:intron:MODIFIER:exon2/2:c.161+52T>G:		rs2555072	0.7089	0.6821	28034/12149/1142	0.6596											405	453					GEN1 (inh=n/a pLI=0.00), SMC6 (inh=n/a pLI=0.46)
chr2	17942775	17942775	T	A	hom		QUAL=3038;DP=92;AF=1.00;MQM=60	GEN1,SMC6	missense,intron,non_coding_transcript_exon	GEN1:ENST00000317402:missense:MODERATE:exon3/14:c.274T>A:p.Ser92Thr,GEN1:ENST00000524465:missense:MODERATE:exon3/4:c.274T>A:p.Ser92Thr,GEN1:ENST00000381254:missense:MODERATE:exon3/14:c.274T>A:p.Ser92Thr,GEN1:ENST00000532257:missense:MODERATE:exon3/3:c.274T>A:p.Ser92Thr,SMC6:ENST00000402989:intron:MODIFIER:exon4/29:c.-5-15557A>T:,SMC6:ENST00000428868:intron:MODIFIER:exon3/4:c.-5-15557A>T:,GEN1:ENST00000534669:non_coding_transcript_exon:MODIFIER:exon1/2:n.113T>A:		rs1812152	0.8137	0.7138	31946/12878/3045	0.6928	0.5670	T,T,T,T	T	B	T,T,T,T	3.42					1043	1169					GEN1 (inh=n/a pLI=0.00), SMC6 (inh=n/a pLI=0.46)
chr2	17954027	17954027	G	A	hom		QUAL=972;DP=30;AF=1.00;MQM=60	GEN1,SMC6	missense,intron,non_coding_transcript_exon	GEN1:ENST00000317402:missense:MODERATE:exon8/14:c.929G>A:p.Ser310Asn,GEN1:ENST00000381254:missense:MODERATE:exon8/14:c.929G>A:p.Ser310Asn,GEN1:ENST00000528873:missense:MODERATE:exon3/9:c.242G>A:p.Ser81Asn,SMC6:ENST00000402989:intron:MODIFIER:exon4/29:c.-6+15055C>T:,SMC6:ENST00000428868:intron:MODIFIER:exon3/4:c.-6+15055C>T:,GEN1:ENST00000534451:non_coding_transcript_exon:MODIFIER:exon1/4:n.113G>A:		rs300175	0.9770	0.9932	59666/33260/4705	0.9644	-2.1950	T,T,T	T	B	T,T,T	0.01					2535	10					GEN1 (inh=n/a pLI=0.00), SMC6 (inh=n/a pLI=0.46)
chr2	17954421	17954421	C	G	hom	off-target	QUAL=3002;DP=93;AF=1.00;MQM=60	GEN1,SMC6	intron	GEN1:ENST00000317402:intron:MODIFIER:exon9/13:c.990+22C>G:,SMC6:ENST00000402989:intron:MODIFIER:exon4/29:c.-6+14661G>C:,SMC6:ENST00000428868:intron:MODIFIER:exon3/4:c.-6+14661G>C:,GEN1:ENST00000381254:intron:MODIFIER:exon9/13:c.990+22C>G:,GEN1:ENST00000528873:intron:MODIFIER:exon4/8:c.303+22C>G:,GEN1:ENST00000534451:intron:MODIFIER:exon2/3:n.174+22C>G:		rs300177	0.8115	0.7165	31145/12559/2772	0.6891											504	518					GEN1 (inh=n/a pLI=0.00), SMC6 (inh=n/a pLI=0.46)
chr2	17962450	17962450	A	G	hom		QUAL=3083;DP=96;AF=1.00;MQM=60	GEN1,SMC6	synonymous,intron	GEN1:ENST00000317402:synonymous:LOW:exon14/14:c.1971A>G:p.Glu657Glu,GEN1:ENST00000381254:synonymous:LOW:exon14/14:c.1971A>G:p.Glu657Glu,SMC6:ENST00000402989:intron:MODIFIER:exon4/29:c.-6+6632T>C:,SMC6:ENST00000428868:intron:MODIFIER:exon3/4:c.-6+6632T>C:		rs300168	0.5739	0.5758	22044/8822/268	0.5699											701	1288					GEN1 (inh=n/a pLI=0.00), SMC6 (inh=n/a pLI=0.46)
chr2	17962518	17962518	C	T	hom		QUAL=3598;DP=112;AF=1.00;MQM=60	GEN1,SMC6	missense,intron	GEN1:ENST00000317402:missense:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile,GEN1:ENST00000381254:missense:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile,SMC6:ENST00000402989:intron:MODIFIER:exon4/29:c.-6+6564G>A:,SMC6:ENST00000428868:intron:MODIFIER:exon3/4:c.-6+6564G>A:		rs300169	0.7580	0.6981	30600/12834/1870	0.6714	0.1800	T,T,T	T	B	T,T	1.94					1043	1164					GEN1 (inh=n/a pLI=0.00), SMC6 (inh=n/a pLI=0.46)
chr2	47601106	47601106	T	C	het		QUAL=747;DP=42;AF=0.71;MQM=60	EPCAM	missense,sequence_feature,non_coding_transcript_exon	EPCAM:ENST00000405271:missense:MODERATE:exon4/10:c.428T>C:p.Met143Thr,EPCAM:ENST00000456133:missense:MODERATE:exon4/11:c.428T>C:p.Met143Thr,EPCAM:ENST00000263735:missense:MODERATE:exon3/9:c.344T>C:p.Met115Thr,EPCAM:ENST00000419334:missense:MODERATE:exon3/3:c.572T>C:p.Met191Thr,EPCAM:ENST00000263735:sequence_feature:LOW:exon3/9:c.344T>C:,EPCAM:ENST00000474691:non_coding_transcript_exon:MODIFIER:exon2/3:n.612T>C:,EPCAM:ENST00000490733:non_coding_transcript_exon:MODIFIER:exon1/6:n.193T>C:		rs1126497	0.6661	0.5198	17704/6502/3641	0.5132	0.0400	T,T,T	T	B,B	T,T,T	0.24	185535 [EPCAM (confirmed) Diarrhea 5,with tufting enteropathy,congenital,613217|Colorectal cancer,hereditary nonpolyposis,type 8,613244];	RCV000162369.1 [benign]; RCV000244202.1 [benign]; RCV000298863.1 [likely benign]; 	CM1110060 [CLASS=DP MUT=REF PHEN="Breast cancer increased risk association with" GENE=EPCAM]; 	COSM3927762	603	1454	1	[1] Ilnaz Sepahi 29-03-2016 batch import			EPCAM (inh=AR pLI=0.00)
chr2	47635523	47635523	-	T	het	off-target;low_QUAL	QUAL=28;DP=20;AF=0.30;MQM=60	MSH2	splice_region&intron	MSH2:ENST00000233146:splice_region&intron:LOW:exon1/15:c.212-4dupT:,MSH2:ENST00000454849:splice_region&intron:LOW:exon2/3:c.14-4dupT:,MSH2:ENST00000543555:splice_region&intron:LOW:exon2/16:c.14-4dupT:,MSH2:ENST00000406134:splice_region&intron:LOW:exon1/15:c.212-4dupT:		rs757515274	0.0000	0.1446	0/0/0	0.0955							609309 [MSH2 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 1,120435|Muir-Torre syndrome,158320|Mismatch repair cancer syndrome,276300];				0	21					MSH2 (inh=AR+AD pLI=0.87)
chr2	48010488	48010488	G	A	het	low_DP;pred_pathogenic	QUAL=143;DP=14;AF=0.50;MQM=60	MSH6	missense,intron,non_coding_transcript_exon	MSH6:ENST00000234420:missense:MODERATE:exon1/10:c.116G>A:p.Gly39Glu,MSH6:ENST00000445503:missense:MODERATE:exon1/9:c.116G>A:p.Gly39Glu,MSH6:ENST00000456246:missense:MODERATE:exon1/3:c.116G>A:p.Gly39Glu,MSH6:ENST00000540021:missense:MODERATE:exon1/8:c.116G>A:p.Gly39Glu,MSH6:ENST00000606499:intron:MODIFIER:exon3/3:c.-37-7578G>A:,MSH6:ENST00000493177:non_coding_transcript_exon:MODIFIER:exon1/2:n.180G>A:		rs1042821	0.2009	0.2141	1894/1004/189	0.1731	1.7010	T,D,T	T	B,B,B	D,D	0.28	600678 [MSH6 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 5,614350|Endometrial cancer,familial,608089|Mismatch repair cancer syndrome,276300];	RCV000030258.4 [benign]; RCV000034489.1 [benign]; RCV000035318.9 [benign]; RCV000132091.3 [benign]; RCV000144626.1 [benign]; 	CM092149 [CLASS=DP MUT=ALT PHEN="Colorectal cancer association with" GENE=MSH6]; 	COSM3749667	161	1005	2	[2] old entry - no details available			MSH6 (inh=AD pLI=n/a)
chr2	48018030	48018030	A	G	het	off-target	QUAL=10785;DP=929;AF=0.46;MQM=60	MSH6,FBXO11	intron	MSH6:ENST00000234420:intron:MODIFIER:exon1/9:c.261-36A>G:,MSH6:ENST00000606499:intron:MODIFIER:exon3/3:c.-37-36A>G:,MSH6:ENST00000445503:intron:MODIFIER:exon1/8:c.261-36A>G:,MSH6:ENST00000456246:intron:MODIFIER:exon1/2:c.261-5003A>G:,MSH6:ENST00000540021:intron:MODIFIER:exon1/7:c.237+7421A>G:,MSH6:ENST00000455383:intron:MODIFIER:exon1/3:c.-37-36A>G:,MSH6:ENST00000420813:intron:MODIFIER:exon1/2:c.-37-36A>G:,MSH6:ENST00000538136:intron:MODIFIER:exon1/9:c.-642-36A>G:,MSH6:ENST00000411819:intron:MODIFIER:exon1/3:c.-37-36A>G:,FBXO11:ENST00000434234:intron:MODIFIER:exon3/3:c.*125-1451T>C:,FBXO11:ENST00000405808:intron:MODIFIER:exon3/3:c.170-1451T>C:		rs1800931	0.0220	0.0373	107/87/0	0.0375							600678 [MSH6 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 5,614350|Endometrial cancer,familial,608089|Mismatch repair cancer syndrome,276300];	RCV000074766.2 [benign]; 			6	89					MSH6 (inh=AD pLI=n/a), FBXO11 (inh=n/a pLI=1.00)
chr2	48022981	48022981	G	T	het	off-target	QUAL=281;DP=26;AF=0.46;MQM=60	MSH6,FBXO11	intron	MSH6:ENST00000234420:intron:MODIFIER:exon2/9:c.458-52G>T:,MSH6:ENST00000445503:intron:MODIFIER:exon2/8:c.458-2769G>T:,MSH6:ENST00000456246:intron:MODIFIER:exon1/2:c.261-52G>T:,MSH6:ENST00000540021:intron:MODIFIER:exon1/7:c.238-2769G>T:,MSH6:ENST00000455383:intron:MODIFIER:exon2/3:c.161-52G>T:,MSH6:ENST00000420813:intron:MODIFIER:exon2/2:c.161-52G>T:,MSH6:ENST00000538136:intron:MODIFIER:exon2/9:c.-445-52G>T:,MSH6:ENST00000411819:intron:MODIFIER:exon2/3:c.161-52G>T:,FBXO11:ENST00000434234:intron:MODIFIER:exon3/3:c.*125-6402C>A:,FBXO11:ENST00000405808:intron:MODIFIER:exon3/3:c.170-6402C>A:	FLAM_C	rs1800934	0.2244	0.0000	0/0/0	0.0354							600678 [MSH6 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 5,614350|Endometrial cancer,familial,608089|Mismatch repair cancer syndrome,276300];	RCV000075001.2 [benign]; 			56	340					MSH6 (inh=AD pLI=n/a), FBXO11 (inh=n/a pLI=1.00)
chr2	48030692	48030692	T	A	het	low_DP	QUAL=247;DP=17;AF=0.65;MQM=60	MSH6,FBXO11	synonymous,3'UTR,intron	MSH6:ENST00000234420:synonymous:LOW:exon5/10:c.3306T>A:p.Thr1102Thr,MSH6:ENST00000540021:synonymous:LOW:exon3/8:c.2916T>A:p.Thr972Thr,MSH6:ENST00000538136:synonymous:LOW:exon5/10:c.2400T>A:p.Thr800Thr,MSH6:ENST00000445503:3'UTR:MODIFIER:exon4/9:c.*2653T>A:,FBXO11:ENST00000434234:intron:MODIFIER:exon3/3:c.*124+4441A>T:,FBXO11:ENST00000405808:intron:MODIFIER:exon3/3:c.169+4642A>T:		rs2020910	0.0493	0.0204	196/0/0	0.0227							600678 [MSH6 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 5,614350|Endometrial cancer,familial,608089|Mismatch repair cancer syndrome,276300];	RCV000030267.4 [benign]; RCV000078313.6 [benign]; RCV000162391.1 [benign]; 			2	35	1	[1] Ilnaz Sepahi 29-03-2016 batch import			MSH6 (inh=AD pLI=n/a), FBXO11 (inh=n/a pLI=1.00)
chr2	48030838	48030838	A	T	het	off-target	QUAL=2490;DP=238;AF=0.49;MQM=60	MSH6,FBXO11	splice_region&intron,intron	MSH6:ENST00000234420:splice_region&intron:LOW:exon5/9:c.3438+14A>T:,MSH6:ENST00000445503:splice_region&intron:LOW:exon4/8:c.*2785+14A>T:,MSH6:ENST00000540021:splice_region&intron:LOW:exon3/7:c.3048+14A>T:,MSH6:ENST00000538136:splice_region&intron:LOW:exon5/9:c.2532+14A>T:,FBXO11:ENST00000434234:intron:MODIFIER:exon3/3:c.*124+4295T>A:,FBXO11:ENST00000405808:intron:MODIFIER:exon3/3:c.169+4496T>A:		rs2020911	0.4010	0.4043	10612/4778/173	0.3966							600678 [MSH6 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 5,614350|Endometrial cancer,familial,608089|Mismatch repair cancer syndrome,276300];	RCV000035324.9 [benign]; RCV000074853.3 [benign]; RCV000410944.1 [benign]; 			260	776					MSH6 (inh=AD pLI=n/a), FBXO11 (inh=n/a pLI=1.00)
chr2	48032875	48032878	CTAT	-	het	off-target	QUAL=603;DP=44;AF=0.59;MQM=60	MSH6,FBXO11	intron	MSH6:ENST00000234420:intron:MODIFIER:exon7/9:c.3646+35_3646+38delATCT:,MSH6:ENST00000445503:intron:MODIFIER:exon6/8:c.*2993+35_*2993+38delATCT:,MSH6:ENST00000540021:intron:MODIFIER:exon5/7:c.3256+35_3256+38delATCT:,MSH6:ENST00000538136:intron:MODIFIER:exon7/9:c.2740+35_2740+38delATCT:,FBXO11:ENST00000434234:intron:MODIFIER:exon3/3:c.*124+2255_*124+2258delATAG:,FBXO11:ENST00000405808:intron:MODIFIER:exon3/3:c.169+2456_169+2459delATAG:		rs2234731;rs3136358;rs606231384	0.7622	0.6925	29410/15213/3345	0.6503							600678 [MSH6 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 5,614350|Endometrial cancer,familial,608089|Mismatch repair cancer syndrome,276300];	RCV000074897.2 [benign]; RCV000078317.4,RCV000074897.2 [benign,benign]; RCV000078317.4,RCV000074897.2 [benign,benign]; RCV000078317.4 [benign]; 			547	511					MSH6 (inh=AD pLI=n/a), FBXO11 (inh=n/a pLI=1.00)
chr2	48033551	48033551	C	G	hom	off-target	QUAL=1514;DP=48;AF=1.00;MQM=60	MSH6,FBXO11	intron	MSH6:ENST00000234420:intron:MODIFIER:exon8/9:c.3802-40C>G:,MSH6:ENST00000445503:intron:MODIFIER:exon7/8:c.*3149-40C>G:,MSH6:ENST00000540021:intron:MODIFIER:exon6/7:c.3412-40C>G:,MSH6:ENST00000538136:intron:MODIFIER:exon8/9:c.2896-40C>G:,FBXO11:ENST00000434234:intron:MODIFIER:exon3/3:c.*124+1582G>C:,FBXO11:ENST00000405808:intron:MODIFIER:exon3/3:c.169+1783G>C:		rs3136367	0.8091	0.7426	33739/17563/4350	0.7296							600678 [MSH6 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 5,614350|Endometrial cancer,familial,608089|Mismatch repair cancer syndrome,276300];	RCV000030272.3 [benign]; RCV000202099.1 [benign]; 			628	459					MSH6 (inh=AD pLI=n/a), FBXO11 (inh=n/a pLI=1.00)
chr2	48033891	48033891	T	-	het	off-target	QUAL=298;DP=38;AF=0.45;MQM=60	MSH6,FBXO11	splice_region&intron,splice_region&non_coding_transcript_exon,intron	MSH6:ENST00000234420:splice_region&intron:LOW:exon9/9:c.4002-10delT:,MSH6:ENST00000445503:splice_region&intron:LOW:exon8/8:c.*3349-10delT:,MSH6:ENST00000540021:splice_region&intron:LOW:exon7/7:c.3612-10delT:,MSH6:ENST00000538136:splice_region&intron:LOW:exon9/9:c.3096-10delT:,FBXO11:ENST00000465204:splice_region&non_coding_transcript_exon:LOW:exon5/5:n.3158delA:,FBXO11:ENST00000434234:intron:MODIFIER:exon3/3:c.*124+1242delA:,FBXO11:ENST00000405808:intron:MODIFIER:exon3/3:c.169+1443delA:	(T)n	rs267608137;rs775865491	0.0000	0.4245	82/55/7	0.2520							600678 [MSH6 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 5,614350|Endometrial cancer,familial,608089|Mismatch repair cancer syndrome,276300];	RCV000074976.2 [likely benign]; 			187	286					MSH6 (inh=AD pLI=n/a), FBXO11 (inh=n/a pLI=1.00)
chr2	147596973	147596973	A	G	het		QUAL=10825;DP=818;AF=0.51;MQM=60	AC103881.1	intron	AC103881.1:ENST00000450667:intron:MODIFIER:exon2/5:n.229+1200A>G:		rs4411641	0.5090	0.4661	11314/4775/1636	0.4172											322	821					AC103881.1 (inh=n/a pLI=n/a)
chr2	190670539	190670539	-	A	het	off-target;anno_high_impact	QUAL=45;DP=44;AF=0.20;MQM=60	PMS1	frameshift,intron	PMS1:ENST00000409985:frameshift:HIGH:exon4/4:c.488dupA:p.Leu164fs,PMS1:ENST00000441310:intron:MODIFIER:exon4/12:c.418+70dupA:,PMS1:ENST00000342075:intron:MODIFIER:exon3/11:c.315+9873dupA:,PMS1:ENST00000418224:intron:MODIFIER:exon3/11:c.-111+9873dupA:,PMS1:ENST00000409823:intron:MODIFIER:exon4/11:c.418+70dupA:,PMS1:ENST00000374826:intron:MODIFIER:exon4/4:c.418+70dupA:,PMS1:ENST00000450931:intron:MODIFIER:exon5/12:c.418+70dupA:,PMS1:ENST00000421722:intron:MODIFIER:exon4/9:n.504+70dupA:,PMS1:ENST00000424766:intron:MODIFIER:exon4/4:c.418+70dupA:,PMS1:ENST00000447232:intron:MODIFIER:exon4/11:c.418+70dupA:,PMS1:ENST00000447734:intron:MODIFIER:exon2/4:c.133-12193dupA:,PMS1:ENST00000432292:intron:MODIFIER:exon2/10:c.-110-12193dupA:,PMS1:ENST00000424307:intron:MODIFIER:exon2/7:c.235+70dupA:,PMS1:ENST00000424059:intron:MODIFIER:exon3/8:n.418+70dupA:		rs3214425;rs397751218;rs555414470	0.2153	0.2434	527/220/112	0.1498											52	373	1	[1] ahstaea1 29.03.2017: ExAC: 0,24; 1000g: 0,21; Kaviar: 0,15			PMS1 (inh=n/a pLI=0.00)
chr2	215595164	215595164	G	A	het	pred_pathogenic	QUAL=261;DP=27;AF=0.44;MQM=60	BARD1	missense,3'UTR,non_coding_transcript_exon	BARD1:ENST00000260947:missense:MODERATE:exon10/11:c.1972C>T:p.Arg658Cys,BARD1:ENST00000432456:missense:MODERATE:exon2/3:c.85C>T:p.Arg29Cys,BARD1:ENST00000449967:missense:MODERATE:exon9/10:c.1540C>T:p.Arg514Cys,BARD1:ENST00000421162:missense:MODERATE:exon6/6:c.619C>T:p.Arg207Cys,BARD1:ENST00000455743:3'UTR:MODIFIER:exon9/10:c.*1592C>T:,BARD1:ENST00000471590:non_coding_transcript_exon:MODIFIER:exon1/3:n.71C>T:		rs3738888	0.0054	0.0079	4/2/0	0.0077	5.1650	D,D,D,D	T	B,B	T,T,T,T	27.20	601593 [BARD1 (confirmed) Breast cancer,susceptibility to,114480];	RCV000130975.5 [benign]; RCV000205691.1 [other]; RCV000212141.1 [benign]; RCV000269802.1 [likely benign]; 	CM067650 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=BARD1]; 	COSM3782110, COSM3782109	0	37	2	[2] Ilnaz Sepahi 29-03-2016 batch import	n/a (1xTP, 0xFP)		BARD1 (inh=n/a pLI=0.00)
chr2	215610638	215610638	A	G	het	off-target	QUAL=3825;DP=272;AF=0.51;MQM=60	BARD1	intron	BARD1:ENST00000260947:intron:MODIFIER:exon7/10:c.1678-60T>C:,BARD1:ENST00000449967:intron:MODIFIER:exon6/9:c.1246-60T>C:,BARD1:ENST00000455743:intron:MODIFIER:exon6/9:c.*1298-60T>C:,BARD1:ENST00000421162:intron:MODIFIER:exon3/5:c.325-60T>C:,BARD1:ENST00000465841:intron:MODIFIER:exon1/1:n.33-60T>C:		rs4986842	0.0030	0.0000	0/0/0	0.0013							601593 [BARD1 (confirmed) Breast cancer,susceptibility to,114480];				0	8					BARD1 (inh=n/a pLI=0.00)
chr2	215632155	215632155	T	C	het	off-target	QUAL=1539;DP=109;AF=0.57;MQM=60	BARD1	intron	BARD1:ENST00000260947:intron:MODIFIER:exon6/10:c.1568+51A>G:,BARD1:ENST00000449967:intron:MODIFIER:exon5/9:c.1136+51A>G:,BARD1:ENST00000455743:intron:MODIFIER:exon5/9:c.*1188+51A>G:,BARD1:ENST00000421162:intron:MODIFIER:exon2/5:c.216-14876A>G:		rs5031009	0.3662	0.3737	8118/4428/670	0.3614							601593 [BARD1 (confirmed) Breast cancer,susceptibility to,114480];				139	499					BARD1 (inh=n/a pLI=0.00)
chr2	215632192	215632192	G	A	het	off-target	QUAL=1787;DP=114;AF=0.57;MQM=60	BARD1	splice_region&intron,intron	BARD1:ENST00000260947:splice_region&intron:LOW:exon6/10:c.1568+14C>T:,BARD1:ENST00000449967:splice_region&intron:LOW:exon5/9:c.1136+14C>T:,BARD1:ENST00000455743:splice_region&intron:LOW:exon5/9:c.*1188+14C>T:,BARD1:ENST00000421162:intron:MODIFIER:exon2/5:c.216-14913C>T:		rs5031011	0.3522	0.3614	8067/4322/639	0.3527							601593 [BARD1 (confirmed) Breast cancer,susceptibility to,114480];	RCV000242028.1 [benign]; RCV000295207.1 [likely benign]; 			207	782					BARD1 (inh=n/a pLI=0.00)
chr2	215632255	215632255	C	T	het		QUAL=3044;DP=110;AF=0.55;MQM=60	BARD1	missense,sequence_feature,3'UTR,intron	BARD1:ENST00000260947:missense:MODERATE:exon6/11:c.1519G>A:p.Val507Met,BARD1:ENST00000449967:missense:MODERATE:exon5/10:c.1087G>A:p.Val363Met,BARD1:ENST00000260947:sequence_feature:LOW:exon6/11:c.1519G>A:,BARD1:ENST00000455743:3'UTR:MODIFIER:exon5/10:c.*1139G>A:,BARD1:ENST00000421162:intron:MODIFIER:exon2/5:c.216-14976G>A:		rs2070094	0.3662	0.3783	8892/4897/739	0.3305	-5.2640	T,T	T	B,B	T,T	4.77	601593 [BARD1 (confirmed) Breast cancer,susceptibility to,114480];	RCV000128872.3 [benign]; RCV000250250.1 [benign]; RCV000336172.1 [likely benign]; 	CM034384 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=BARD1]; 	COSM3757929, COSM3757930	450	1618	1	[1] Ilnaz Sepahi 29-03-2016 batch import			BARD1 (inh=n/a pLI=0.00)
chr2	215632256	215632256	A	G	hom		QUAL=3044;DP=110;AF=0.55;MQM=60	BARD1	synonymous,3'UTR,intron	BARD1:ENST00000260947:synonymous:LOW:exon6/11:c.1518T>C:p.His506His,BARD1:ENST00000449967:synonymous:LOW:exon5/10:c.1086T>C:p.His362His,BARD1:ENST00000455743:3'UTR:MODIFIER:exon5/10:c.*1138T>C:,BARD1:ENST00000421162:intron:MODIFIER:exon2/5:c.216-14977T>C:		rs2070093	0.7706	0.8134	40550/21983/1885	0.7319							601593 [BARD1 (confirmed) Breast cancer,susceptibility to,114480];	RCV000162380.1 [benign]; RCV000245092.1 [benign]; RCV000399697.1 [likely benign]; 			2158	1084	1	[1] Ilnaz Sepahi 29-03-2016 batch import			BARD1 (inh=n/a pLI=0.00)
chr2	215634055	215634055	C	T	het	off-target	QUAL=2564;DP=270;AF=0.47;MQM=60	BARD1	splice_region&intron,intron	BARD1:ENST00000260947:splice_region&intron:LOW:exon4/10:c.1315-19G>A:,BARD1:ENST00000449967:splice_region&intron:LOW:exon3/9:c.883-19G>A:,BARD1:ENST00000455743:splice_region&intron:LOW:exon3/9:c.*935-19G>A:,BARD1:ENST00000421162:intron:MODIFIER:exon2/5:c.216-16776G>A:		rs6704780	0.3652	0.3818	8670/4748/730	0.3699							601593 [BARD1 (confirmed) Breast cancer,susceptibility to,114480];	RCV000253290.1 [benign]; 			234	831					BARD1 (inh=n/a pLI=0.00)
chr2	215645464	215645464	C	G	het		QUAL=1090;DP=79;AF=0.53;MQM=60	BARD1	missense,3'UTR,intron	BARD1:ENST00000260947:missense:MODERATE:exon4/11:c.1134G>C:p.Arg378Ser,BARD1:ENST00000449967:missense:MODERATE:exon3/10:c.702G>C:p.Arg234Ser,BARD1:ENST00000455743:3'UTR:MODIFIER:exon3/10:c.*754G>C:,BARD1:ENST00000421162:intron:MODIFIER:exon2/5:c.215+16321G>C:		rs2229571	0.4593	0.5487	19001/12920/845	0.5442	-0.6010	T,T	T	B,B	T,T	8.65	601593 [BARD1 (confirmed) Breast cancer,susceptibility to,114480];	RCV000132162.3 [benign]; RCV000248120.1 [benign]; RCV000390287.1 [likely benign]; 	CM076014 [CLASS=DP MUT=ALT PHEN="Breast cancer reduced risk association with" GENE=BARD1]; 	COSM3757932, COSM3757931	1175	1658	1	[1] Ilnaz Sepahi 29-03-2016 batch import			BARD1 (inh=n/a pLI=0.00)
chr2	215674090	215674090	T	G	hom	off-target	QUAL=3891;DP=122;AF=1.00;MQM=60	BARD1	intron	BARD1:ENST00000260947:intron:MODIFIER:exon1/10:c.158+46A>C:,BARD1:ENST00000449967:intron:MODIFIER:exon1/9:c.-126+46A>C:,BARD1:ENST00000455743:intron:MODIFIER:exon1/9:c.158+46A>C:,BARD1:ENST00000421162:intron:MODIFIER:exon1/5:c.158+46A>C:,BARD1:ENST00000471787:intron:MODIFIER:exon1/1:n.259+46A>C:,BARD1:ENST00000479904:intron:MODIFIER:exon1/1:n.249+46A>C:		rs35933323	0.7448	0.7387	28663/14756/2178	0.6932							601593 [BARD1 (confirmed) Breast cancer,susceptibility to,114480];				599	486					BARD1 (inh=n/a pLI=0.00)
chr2	215674224	215674224	G	A	het	pred_pathogenic	QUAL=8572;DP=821;AF=0.50;MQM=60	BARD1	missense,5'UTR,non_coding_transcript_exon	BARD1:ENST00000260947:missense:MODERATE:exon1/11:c.70C>T:p.Pro24Ser,BARD1:ENST00000455743:missense:MODERATE:exon1/10:c.70C>T:p.Pro24Ser,BARD1:ENST00000421162:missense:MODERATE:exon1/6:c.70C>T:p.Pro24Ser,BARD1:ENST00000449967:5'UTR:MODIFIER:exon1/10:c.-214C>T:,BARD1:ENST00000471787:non_coding_transcript_exon:MODIFIER:exon1/2:n.171C>T:,BARD1:ENST00000479904:non_coding_transcript_exon:MODIFIER:exon1/2:n.161C>T:		rs1048108	0.3313	0.4377	7357/4010/154	0.3459	0.9680	T,D	T	B	T,D	11.97	601593 [BARD1 (confirmed) Breast cancer,susceptibility to,114480];	RCV000162363.2 [benign]; RCV000245618.1 [benign]; RCV000372881.1 [likely benign]; 	CM076015 [CLASS=DP MUT=ALT PHEN="Breast cancer reduced risk association with" GENE=BARD1]; 	COSM442275, COSM1482743	460	1654	1	[1] Ilnaz Sepahi 29-03-2016 batch import			BARD1 (inh=n/a pLI=0.00)
chr2	215674323	215674323	C	G	hom	off-target	QUAL=3254;DP=107;AF=1.00;MQM=60	BARD1	5'UTR,non_coding_transcript_exon	BARD1:ENST00000260947:5'UTR:MODIFIER:exon1/11:c.-30G>C:,BARD1:ENST00000449967:5'UTR:MODIFIER:exon1/10:c.-313G>C:,BARD1:ENST00000455743:5'UTR:MODIFIER:exon1/10:c.-30G>C:,BARD1:ENST00000421162:5'UTR:MODIFIER:exon1/6:c.-30G>C:,BARD1:ENST00000471787:non_coding_transcript_exon:MODIFIER:exon1/2:n.72G>C:,BARD1:ENST00000479904:non_coding_transcript_exon:MODIFIER:exon1/2:n.62G>C:		rs1129804	0.7446	0.7072	3938/1466/266	0.4951							601593 [BARD1 (confirmed) Breast cancer,susceptibility to,114480];	RCV000319630.1 [likely benign]; 			565	450					BARD1 (inh=n/a pLI=0.00)
chr2	215674341	215674341	A	G	hom	off-target	QUAL=3159;DP=106;AF=1.00;MQM=60	BARD1	5'UTR,non_coding_transcript_exon	BARD1:ENST00000260947:5'UTR:MODIFIER:exon1/11:c.-48T>C:,BARD1:ENST00000449967:5'UTR:MODIFIER:exon1/10:c.-331T>C:,BARD1:ENST00000455743:5'UTR:MODIFIER:exon1/10:c.-48T>C:,BARD1:ENST00000421162:5'UTR:MODIFIER:exon1/6:c.-48T>C:,BARD1:ENST00000471787:non_coding_transcript_exon:MODIFIER:exon1/2:n.54T>C:,BARD1:ENST00000479904:non_coding_transcript_exon:MODIFIER:exon1/2:n.44T>C:		rs17489363	0.7450	0.6895	3139/1035/182	0.4398							601593 [BARD1 (confirmed) Breast cancer,susceptibility to,114480];	RCV000374186.1 [likely benign]; 			564	449					BARD1 (inh=n/a pLI=0.00)
chr2	220415596	220415597	GA	-	hom	off-target	QUAL=4914;DP=162;AF=0.99;MQM=60	OBSL1	splice_region&intron,intron,non_coding_transcript_exon	OBSL1:ENST00000489804:splice_region&intron:LOW:exon3/3:n.555-7_555-6delTC:,OBSL1:ENST00000404537:intron:MODIFIER:exon20/20:c.5684-33_5684-32delTC:,OBSL1:ENST00000462534:intron:MODIFIER:exon2/2:n.549-33_549-32delTC:,OBSL1:ENST00000265318:intron:MODIFIER:exon19/19:c.*1078-33_*1078-32delTC:,OBSL1:ENST00000373876:intron:MODIFIER:exon19/19:c.5408-33_5408-32delTC:,OBSL1:ENST00000465149:non_coding_transcript_exon:MODIFIER:exon16/16:n.5234_5235delTC:		rs869062633	0.3840	0.4172	8518/5164/579	0.3859							610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];				228	554					OBSL1 (inh=AR pLI=0.00)
chr2	220416570	220416570	C	T	hom	off-target;low_DP	QUAL=341;DP=13;AF=1.00;MQM=60	OBSL1	intron	OBSL1:ENST00000404537:intron:MODIFIER:exon19/20:c.5414-50G>A:,OBSL1:ENST00000462534:intron:MODIFIER:exon1/2:n.279-50G>A:,OBSL1:ENST00000489804:intron:MODIFIER:exon2/3:n.285-50G>A:,OBSL1:ENST00000465149:intron:MODIFIER:exon15/15:n.4311-50G>A:,OBSL1:ENST00000265318:intron:MODIFIER:exon18/19:c.*808-50G>A:,OBSL1:ENST00000373876:intron:MODIFIER:exon18/19:c.5138-50G>A:		rs4672931	0.9287	0.9787	44431/26796/1921	0.8666							610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];				1131	12					OBSL1 (inh=AR pLI=0.00)
chr2	220416803	220416803	A	T	hom	off-target	QUAL=37811;DP=1170;AF=1.00;MQM=60	OBSL1	intron	OBSL1:ENST00000404537:intron:MODIFIER:exon19/20:c.5413+31T>A:,OBSL1:ENST00000462534:intron:MODIFIER:exon1/2:n.278+31T>A:,OBSL1:ENST00000489804:intron:MODIFIER:exon2/3:n.284+31T>A:,OBSL1:ENST00000465149:intron:MODIFIER:exon15/15:n.4310+31T>A:,OBSL1:ENST00000265318:intron:MODIFIER:exon18/19:c.*807+31T>A:,OBSL1:ENST00000373876:intron:MODIFIER:exon18/19:c.5137+31T>A:		rs4672933	0.9782	0.9943	30079/17103/2024	0.9093							610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];				1142	2					OBSL1 (inh=AR pLI=0.00)
chr2	220416942	220416942	G	C	hom		QUAL=1045;DP=34;AF=1.00;MQM=60	OBSL1	splice_region&intron,non_coding_transcript_exon	OBSL1:ENST00000404537:splice_region&intron:LOW:exon18/20:c.5309-4C>G:,OBSL1:ENST00000489804:splice_region&intron:LOW:exon1/3:n.180-4C>G:,OBSL1:ENST00000465149:splice_region&intron:LOW:exon14/15:n.4206-4C>G:,OBSL1:ENST00000265318:splice_region&intron:LOW:exon17/19:c.*703-4C>G:,OBSL1:ENST00000373876:splice_region&intron:LOW:exon17/19:c.5033-4C>G:,OBSL1:ENST00000462534:non_coding_transcript_exon:MODIFIER:exon1/3:n.170C>G:		rs34490902	0.3876	0.4668	7360/4539/456	0.3865							610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];	RCV000175465.1 [benign]; RCV000393467.1 [benign]; 			536	1430					OBSL1 (inh=AR pLI=0.00)
chr2	220417228	220417228	G	T	hom	off-target	QUAL=2391;DP=80;AF=1.00;MQM=60	OBSL1	intron	OBSL1:ENST00000404537:intron:MODIFIER:exon18/20:c.5308+30C>A:,OBSL1:ENST00000489804:intron:MODIFIER:exon1/3:n.179+30C>A:,OBSL1:ENST00000465149:intron:MODIFIER:exon14/15:n.4205+30C>A:,OBSL1:ENST00000265318:intron:MODIFIER:exon17/19:c.*702+30C>A:,OBSL1:ENST00000373876:intron:MODIFIER:exon17/19:c.5032+30C>A:		rs60549465	0.3391	0.4657	7246/4585/138	0.3556							610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];				197	473					OBSL1 (inh=AR pLI=0.00)
chr2	220417266	220417266	C	T	hom	pred_pathogenic	QUAL=4448;DP=147;AF=1.00;MQM=60	OBSL1	missense,3'UTR,non_coding_transcript_exon	OBSL1:ENST00000404537:missense:MODERATE:exon18/21:c.5300G>A:p.Arg1767Gln,OBSL1:ENST00000373876:missense:MODERATE:exon17/20:c.5024G>A:p.Arg1675Gln,OBSL1:ENST00000265318:3'UTR:MODIFIER:exon17/20:c.*694G>A:,OBSL1:ENST00000489804:non_coding_transcript_exon:MODIFIER:exon1/4:n.171G>A:,OBSL1:ENST00000465149:non_coding_transcript_exon:MODIFIER:exon14/16:n.4197G>A:		rs59332477	0.3766	0.4683	9523/5689/497	0.3862	3.5850	D,T	T	D	T,T	35.00	610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];	RCV000294940.1 [benign]; RCV000378784.1 [benign]; 		COSM3757971	527	1425					OBSL1 (inh=AR pLI=0.00)
chr2	220419236	220419236	T	C	hom		QUAL=14236;DP=471;AF=1.00;MQM=60	OBSL1	synonymous,3'UTR,intron,non_coding_transcript_exon	OBSL1:ENST00000404537:synonymous:LOW:exon15/21:c.4836A>G:p.Thr1612Thr,OBSL1:ENST00000373876:synonymous:LOW:exon14/20:c.4560A>G:p.Thr1520Thr,OBSL1:ENST00000265318:3'UTR:MODIFIER:exon14/20:c.*230A>G:,OBSL1:ENST00000465149:intron:MODIFIER:exon13/15:n.3717-1490A>G:,OBSL1:ENST00000596474:non_coding_transcript_exon:MODIFIER:exon1/1:n.259A>G:		rs10932813	0.9852	0.9961	59432/32960/4475	0.9293							610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];	RCV000297604.1 [benign]; 			2952	5					OBSL1 (inh=AR pLI=0.00)
chr2	220419339	220419339	T	C	hom		QUAL=21638;DP=704;AF=1.00;MQM=60	OBSL1	missense,3'UTR,intron,non_coding_transcript_exon	OBSL1:ENST00000404537:missense:MODERATE:exon15/21:c.4733A>G:p.Gln1578Arg,OBSL1:ENST00000373876:missense:MODERATE:exon14/20:c.4457A>G:p.Gln1486Arg,OBSL1:ENST00000265318:3'UTR:MODIFIER:exon14/20:c.*127A>G:,OBSL1:ENST00000465149:intron:MODIFIER:exon13/15:n.3716+1403A>G:,OBSL1:ENST00000596474:non_coding_transcript_exon:MODIFIER:exon1/1:n.156A>G:		rs10932814	0.9611	0.9859	57479/32224/3674	0.9502	0.1950	T,T	T	B	T,T	7.19	610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];	RCV000303609.1 [benign]; 			2938	18					OBSL1 (inh=AR pLI=0.00)
chr2	220420956	220420956	A	G	hom	pred_pathogenic	QUAL=1398;DP=55;AF=1.00;MQM=60	OBSL1	missense,synonymous,non_coding_transcript_exon	OBSL1:ENST00000265318:missense:MODERATE:exon13/20:c.3995T>C:p.Met1332Thr,OBSL1:ENST00000404537:synonymous:LOW:exon14/21:c.4395T>C:p.Asp1465Asp,OBSL1:ENST00000373876:synonymous:LOW:exon13/20:c.4119T>C:p.Asp1373Asp,OBSL1:ENST00000265317:synonymous:LOW:exon5/5:c.1092T>C:p.Asp364Asp,OBSL1:ENST00000603926:synonymous:LOW:exon14/14:c.4395T>C:p.Asp1465Asp,OBSL1:ENST00000604031:synonymous:LOW:exon5/5:c.999T>C:p.Asp333Asp,OBSL1:ENST00000456147:synonymous:LOW:exon5/5:c.1098T>C:p.Asp366Asp,OBSL1:ENST00000465149:non_coding_transcript_exon:MODIFIER:exon13/16:n.3502T>C:		rs10932816	0.9637	0.9901	56732/32015/3610	0.9212	-3.7700	D,.	T		T	0.26	610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];	RCV000388829.1 [benign]; 		COSM4133493	2959	6					OBSL1 (inh=AR pLI=0.00)
chr2	220421417	220421417	C	G	hom	pred_pathogenic	QUAL=23488;DP=738;AF=1.00;MQM=60	OBSL1	missense,non_coding_transcript_exon	OBSL1:ENST00000404537:missense:MODERATE:exon13/21:c.4095G>C:p.Glu1365Asp,OBSL1:ENST00000265318:missense:MODERATE:exon12/20:c.3819G>C:p.Glu1273Asp,OBSL1:ENST00000373876:missense:MODERATE:exon12/20:c.3819G>C:p.Glu1273Asp,OBSL1:ENST00000265317:missense:MODERATE:exon4/5:c.792G>C:p.Glu264Asp,OBSL1:ENST00000603926:missense:MODERATE:exon13/14:c.4095G>C:p.Glu1365Asp,OBSL1:ENST00000604031:missense:MODERATE:exon4/5:c.699G>C:p.Glu233Asp,OBSL1:ENST00000456147:missense:MODERATE:exon4/5:c.798G>C:p.Glu266Asp,OBSL1:ENST00000465149:non_coding_transcript_exon:MODIFIER:exon12/16:n.3326G>C:,OBSL1:ENST00000472388:non_coding_transcript_exon:MODIFIER:exon1/2:n.333G>C:		rs1983210	0.7246	0.7461	32983/18089/1813	0.7293	0.9020	T,T,T,T,.	T,T	B,P,B,.	T,T,T,T,.	24.50	610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];	RCV000402769.1 [benign]; 		COSM442368	1722	1094					OBSL1 (inh=AR pLI=0.00)
chr2	220421456	220421456	C	A	hom	off-target	QUAL=22655;DP=688;AF=1.00;MQM=60	OBSL1	splice_region&intron,non_coding_transcript_exon	OBSL1:ENST00000404537:splice_region&intron:LOW:exon12/20:c.4067-11G>T:,OBSL1:ENST00000465149:splice_region&intron:LOW:exon11/15:n.3298-11G>T:,OBSL1:ENST00000265318:splice_region&intron:LOW:exon11/19:c.3791-11G>T:,OBSL1:ENST00000373876:splice_region&intron:LOW:exon11/19:c.3791-11G>T:,OBSL1:ENST00000265317:splice_region&intron:LOW:exon3/4:c.764-11G>T:,OBSL1:ENST00000603926:splice_region&intron:LOW:exon12/13:c.4067-11G>T:,OBSL1:ENST00000604031:splice_region&intron:LOW:exon3/4:c.671-11G>T:,OBSL1:ENST00000456147:splice_region&intron:LOW:exon3/4:c.770-11G>T:,OBSL1:ENST00000472388:non_coding_transcript_exon:MODIFIER:exon1/2:n.294G>T:		rs1983211	0.1170	0.1859	1511/912/3	0.1576							610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];	RCV000309259.1 [benign]; RCV000366185.1 [likely benign]; 			55	383					OBSL1 (inh=AR pLI=0.00)
chr2	220422029	220422029	G	A	hom	off-target	QUAL=4770;DP=167;AF=1.00;MQM=60	OBSL1	intron	OBSL1:ENST00000404537:intron:MODIFIER:exon12/20:c.4066+36C>T:,OBSL1:ENST00000465149:intron:MODIFIER:exon11/15:n.3297+36C>T:,OBSL1:ENST00000265318:intron:MODIFIER:exon11/19:c.3790+36C>T:,OBSL1:ENST00000373876:intron:MODIFIER:exon11/19:c.3790+516C>T:,OBSL1:ENST00000265317:intron:MODIFIER:exon3/4:c.763+516C>T:,OBSL1:ENST00000603926:intron:MODIFIER:exon12/13:c.4066+36C>T:,OBSL1:ENST00000604031:intron:MODIFIER:exon3/4:c.670+516C>T:,OBSL1:ENST00000456147:intron:MODIFIER:exon3/4:c.769+516C>T:		rs55873563	0.1188	0.1828	158/124/3	0.0863							610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];				49	321					OBSL1 (inh=AR pLI=0.00)
chr2	220422400	220422400	C	G	hom	off-target	QUAL=10434;DP=387;AF=1.00;MQM=60	OBSL1	intron	OBSL1:ENST00000404537:intron:MODIFIER:exon11/20:c.3791-60G>C:,OBSL1:ENST00000465149:intron:MODIFIER:exon10/15:n.3022-60G>C:,OBSL1:ENST00000265318:intron:MODIFIER:exon10/19:c.3515-60G>C:,OBSL1:ENST00000373876:intron:MODIFIER:exon11/19:c.3790+145G>C:,OBSL1:ENST00000265317:intron:MODIFIER:exon3/4:c.763+145G>C:,OBSL1:ENST00000603926:intron:MODIFIER:exon11/13:c.3791-60G>C:,OBSL1:ENST00000604031:intron:MODIFIER:exon3/4:c.670+145G>C:,OBSL1:ENST00000456147:intron:MODIFIER:exon3/4:c.769+145G>C:		rs2278200	0.4087	0.0000	0/0/0	0.0836							610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];				179	478					OBSL1 (inh=AR pLI=0.00)
chr2	220422686	220422686	C	T	het	pred_pathogenic	QUAL=539;DP=64;AF=0.44;MQM=60	OBSL1	missense,non_coding_transcript_exon	OBSL1:ENST00000404537:missense:MODERATE:exon11/21:c.3649G>A:p.Glu1217Lys,OBSL1:ENST00000265318:missense:MODERATE:exon10/20:c.3373G>A:p.Glu1125Lys,OBSL1:ENST00000373876:missense:MODERATE:exon11/20:c.3649G>A:p.Glu1217Lys,OBSL1:ENST00000265317:missense:MODERATE:exon3/5:c.622G>A:p.Glu208Lys,OBSL1:ENST00000603926:missense:MODERATE:exon11/14:c.3649G>A:p.Glu1217Lys,OBSL1:ENST00000604031:missense:MODERATE:exon3/5:c.529G>A:p.Glu177Lys,OBSL1:ENST00000456147:missense:MODERATE:exon3/5:c.628G>A:p.Glu210Lys,OBSL1:ENST00000465149:non_coding_transcript_exon:MODIFIER:exon10/16:n.2880G>A:		rs72957510	0.0070	0.0061	1/1/0	0.0053	0.5010	T,D,T,T	T	P,B,P,B	T,T,T,T	16.43	610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];	RCV000174131.1 [benign]; RCV000379523.1 [uncertain significance]; 			2	46					OBSL1 (inh=AR pLI=0.00)
chr2	220422774	220422774	A	G	hom		QUAL=24045;DP=760;AF=1.00;MQM=60	OBSL1	synonymous,non_coding_transcript_exon	OBSL1:ENST00000404537:synonymous:LOW:exon11/21:c.3561T>C:p.Pro1187Pro,OBSL1:ENST00000265318:synonymous:LOW:exon10/20:c.3285T>C:p.Pro1095Pro,OBSL1:ENST00000373876:synonymous:LOW:exon11/20:c.3561T>C:p.Pro1187Pro,OBSL1:ENST00000265317:synonymous:LOW:exon3/5:c.534T>C:p.Pro178Pro,OBSL1:ENST00000603926:synonymous:LOW:exon11/14:c.3561T>C:p.Pro1187Pro,OBSL1:ENST00000604031:synonymous:LOW:exon3/5:c.441T>C:p.Pro147Pro,OBSL1:ENST00000456147:synonymous:LOW:exon3/5:c.540T>C:p.Pro180Pro,OBSL1:ENST00000465149:non_coding_transcript_exon:MODIFIER:exon10/16:n.2792T>C:		rs2278201	0.4191	0.4303	11375/6202/1290	0.4221	-4.6180		T			0.01	610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];	RCV000282793.1 [benign]; 		COSM3757974	489	1444					OBSL1 (inh=AR pLI=0.00)
chr2	220428381	220428381	A	T	het	off-target	QUAL=3406;DP=282;AF=0.45;MQM=60	OBSL1	intron	OBSL1:ENST00000404537:intron:MODIFIER:exon6/20:c.2408-32T>A:,OBSL1:ENST00000465149:intron:MODIFIER:exon6/15:n.1915-32T>A:,OBSL1:ENST00000265318:intron:MODIFIER:exon6/19:c.2408-32T>A:,OBSL1:ENST00000373876:intron:MODIFIER:exon6/19:c.2408-32T>A:,OBSL1:ENST00000603926:intron:MODIFIER:exon6/13:c.2408-32T>A:,OBSL1:ENST00000373873:intron:MODIFIER:exon6/8:c.2408-32T>A:,OBSL1:ENST00000289656:intron:MODIFIER:exon6/8:c.1169-32T>A:,OBSL1:ENST00000462385:intron:MODIFIER:exon1/1:n.139-32T>A:		rs2303543	0.5567	0.6462	25389/15212/464	0.6306							610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];				532	493					OBSL1 (inh=AR pLI=0.00)
chr2	220430203	220430203	C	T	hom		QUAL=23697;DP=741;AF=1.00;MQM=60	OBSL1	missense,non_coding_transcript_exon	OBSL1:ENST00000404537:missense:MODERATE:exon6/21:c.2168G>A:p.Arg723Lys,OBSL1:ENST00000265318:missense:MODERATE:exon6/20:c.2168G>A:p.Arg723Lys,OBSL1:ENST00000373876:missense:MODERATE:exon6/20:c.2168G>A:p.Arg723Lys,OBSL1:ENST00000603926:missense:MODERATE:exon6/14:c.2168G>A:p.Arg723Lys,OBSL1:ENST00000373873:missense:MODERATE:exon6/9:c.2168G>A:p.Arg723Lys,OBSL1:ENST00000289656:missense:MODERATE:exon6/9:c.929G>A:p.Arg310Lys,OBSL1:ENST00000465149:non_coding_transcript_exon:MODIFIER:exon6/16:n.1675G>A:		rs1039898	0.7927	0.8655	45551/27067/1985	0.8544	-0.1200	T,T,T,T,T	T	B,B,B,B	T,T,T,T,T	6.75	610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];	RCV000268251.1 [benign]; 		COSM4133496, COSM4133495	2363	550					OBSL1 (inh=AR pLI=0.00)
chr2	220432709	220432709	A	T	het	off-target	QUAL=9152;DP=726;AF=0.48;MQM=60	OBSL1	splice_region&intron	OBSL1:ENST00000404537:splice_region&intron:LOW:exon2/20:c.1283-18T>A:,OBSL1:ENST00000465149:splice_region&intron:LOW:exon2/15:n.790-18T>A:,OBSL1:ENST00000265318:splice_region&intron:LOW:exon2/19:c.1283-18T>A:,OBSL1:ENST00000373876:splice_region&intron:LOW:exon2/19:c.1283-18T>A:,OBSL1:ENST00000603926:splice_region&intron:LOW:exon2/13:c.1283-18T>A:,OBSL1:ENST00000373873:splice_region&intron:LOW:exon2/8:c.1283-18T>A:,OBSL1:ENST00000289656:splice_region&intron:LOW:exon2/8:c.44-18T>A:		rs2292360	0.3678	0.4234	11346/6780/170	0.4181							610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];				276	663					OBSL1 (inh=AR pLI=0.00)
chr2	220435034	220435034	A	G	hom		QUAL=20377;DP=650;AF=1.00;MQM=60	OBSL1,INHA	synonymous,intron,non_coding_transcript_exon	OBSL1:ENST00000404537:synonymous:LOW:exon1/21:c.921T>C:p.Leu307Leu,OBSL1:ENST00000265318:synonymous:LOW:exon1/20:c.921T>C:p.Leu307Leu,OBSL1:ENST00000373876:synonymous:LOW:exon1/20:c.921T>C:p.Leu307Leu,OBSL1:ENST00000603926:synonymous:LOW:exon1/14:c.921T>C:p.Leu307Leu,OBSL1:ENST00000373873:synonymous:LOW:exon1/9:c.921T>C:p.Leu307Leu,OBSL1:ENST00000289656:intron:MODIFIER:exon1/8:c.-228+1082T>C:,INHA:ENST00000489456:intron:MODIFIER:exon1/1:n.285+866A>G:,OBSL1:ENST00000465149:non_coding_transcript_exon:MODIFIER:exon1/16:n.428T>C:,OBSL1:ENST00000465589:non_coding_transcript_exon:MODIFIER:exon2/2:n.480T>C:		rs10180675	0.7833	0.8644	44374/26362/1758	0.8423							610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];	RCV000173448.2 [benign]; RCV000382515.1 [benign]; 		COSM4133504, COSM4133503	2361	549					OBSL1 (inh=AR pLI=0.00), INHA (inh=n/a pLI=0.20)
chr2	220435375	220435375	G	A	het	low_DP	QUAL=376;DP=19;AF=0.84;MQM=60	OBSL1,INHA	synonymous,intron,non_coding_transcript_exon	OBSL1:ENST00000404537:synonymous:LOW:exon1/21:c.580C>T:p.Leu194Leu,OBSL1:ENST00000265318:synonymous:LOW:exon1/20:c.580C>T:p.Leu194Leu,OBSL1:ENST00000373876:synonymous:LOW:exon1/20:c.580C>T:p.Leu194Leu,OBSL1:ENST00000603926:synonymous:LOW:exon1/14:c.580C>T:p.Leu194Leu,OBSL1:ENST00000373873:synonymous:LOW:exon1/9:c.580C>T:p.Leu194Leu,OBSL1:ENST00000289656:intron:MODIFIER:exon1/8:c.-228+741C>T:,INHA:ENST00000489456:intron:MODIFIER:exon1/1:n.285+1207G>A:,OBSL1:ENST00000491370:intron:MODIFIER:exon1/1:n.467-78C>T:,OBSL1:ENST00000465149:non_coding_transcript_exon:MODIFIER:exon1/16:n.87C>T:,OBSL1:ENST00000465589:non_coding_transcript_exon:MODIFIER:exon2/2:n.139C>T:		rs1061399	0.3588	0.4448	1102/271/4	0.1661							610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];	RCV000341440.1 [benign]; RCV000352312.1 [benign]; 		COSM4133505, COSM442371	602	1401					OBSL1 (inh=AR pLI=0.00), INHA (inh=n/a pLI=0.20)
chr3	10076843	10076844	TT	-	het	off-target	QUAL=1941;DP=168;AF=0.45;MQM=60	FANCD2	splice_region&intron	FANCD2:ENST00000287647:splice_region&intron:LOW:exon5/42:c.378-6_378-5delTT:,FANCD2:ENST00000383806:splice_region&intron:LOW:exon5/42:c.378-6_378-5delTT:,FANCD2:ENST00000383807:splice_region&intron:LOW:exon5/43:c.378-6_378-5delTT:,FANCD2:ENST00000419585:splice_region&intron:LOW:exon5/43:c.378-6_378-5delTT:,FANCD2:ENST00000431693:splice_region&intron:LOW:exon4/7:c.378-6_378-5delTT:,FANCD2:ENST00000438741:splice_region&intron:LOW:exon1/5:n.93-6_93-5delTT:		rs397897610;rs55973240	0.2115	0.2080	2296/839/957	0.1594							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	RCV000224506.1 [likely benign]; RCV000356544.1,RCV000224506.1 [benign,likely benign]; RCV000356544.1 [benign]; 			42	377					FANCD2 (inh=AR pLI=0.00)
chr3	10076975	10076975	A	C	het	off-target	QUAL=1279;DP=99;AF=0.48;MQM=60	FANCD2	intron	FANCD2:ENST00000287647:intron:MODIFIER:exon6/42:c.438+58A>C:,FANCD2:ENST00000383806:intron:MODIFIER:exon6/42:c.438+58A>C:,FANCD2:ENST00000383807:intron:MODIFIER:exon6/43:c.438+58A>C:,FANCD2:ENST00000419585:intron:MODIFIER:exon6/43:c.438+58A>C:,FANCD2:ENST00000431693:intron:MODIFIER:exon5/7:c.438+58A>C:,FANCD2:ENST00000438741:intron:MODIFIER:exon2/5:n.153+58A>C:		rs17032276	0.1811	0.0000	0/0/0	0.0318							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];				27	318					FANCD2 (inh=AR pLI=0.00)
chr3	10077955	10077955	A	G	het	off-target	QUAL=553;DP=46;AF=0.63;MQM=60	FANCD2	splice_region&intron	FANCD2:ENST00000287647:splice_region&intron:LOW:exon6/42:c.439-16A>G:,FANCD2:ENST00000383806:splice_region&intron:LOW:exon6/42:c.439-16A>G:,FANCD2:ENST00000383807:splice_region&intron:LOW:exon6/43:c.439-16A>G:,FANCD2:ENST00000419585:splice_region&intron:LOW:exon6/43:c.439-16A>G:,FANCD2:ENST00000431693:splice_region&intron:LOW:exon5/7:c.439-16A>G:,FANCD2:ENST00000438741:splice_region&intron:LOW:exon2/5:n.154-16A>G:		rs17032278	0.1821	0.1662	1918/849/580	0.1617							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	RCV000249626.1 [benign]; 			40	378					FANCD2 (inh=AR pLI=0.00)
chr3	10081545	10081545	G	C	het	off-target	QUAL=5185;DP=484;AF=0.47;MQM=60	FANCD2	splice_region&intron,synonymous	FANCD2:ENST00000287647:splice_region&intron:LOW:exon9/42:c.695+16G>C:,FANCD2:ENST00000383806:splice_region&intron:LOW:exon9/42:c.695+16G>C:,FANCD2:ENST00000383807:splice_region&intron:LOW:exon9/43:c.695+16G>C:,FANCD2:ENST00000419585:splice_region&intron:LOW:exon9/43:c.695+16G>C:,FANCD2:ENST00000438741:splice_region&intron:LOW:exon5/5:n.410+16G>C:,FANCD2:ENST00000431693:synonymous:LOW:exon8/8:c.711G>C:p.Leu237Leu		rs17032283	0.1821	0.1659	1907/843/573	0.1627							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	RCV000248075.1 [benign]; 			44	420					FANCD2 (inh=AR pLI=0.00)
chr3	10084224	10084224	C	T	het	off-target	QUAL=14505;DP=1027;AF=0.54;MQM=60	FANCD2	splice_region&intron	FANCD2:ENST00000287647:splice_region&intron:LOW:exon10/42:c.784-19C>T:,FANCD2:ENST00000383806:splice_region&intron:LOW:exon10/42:c.784-19C>T:,FANCD2:ENST00000383807:splice_region&intron:LOW:exon10/43:c.784-19C>T:,FANCD2:ENST00000419585:splice_region&intron:LOW:exon10/43:c.784-19C>T:		rs9879080	0.2107	0.1743	2300/854/954	0.1686							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	RCV000253247.1 [benign]; 			39	366					FANCD2 (inh=AR pLI=0.00)
chr3	10085130	10085130	C	G	het	off-target;low_DP	QUAL=62;DP=10;AF=0.40;MQM=60	FANCD2	intron	FANCD2:ENST00000287647:intron:MODIFIER:exon12/42:c.990-38C>G:,FANCD2:ENST00000383806:intron:MODIFIER:exon12/42:c.990-38C>G:,FANCD2:ENST00000383807:intron:MODIFIER:exon12/43:c.990-38C>G:,FANCD2:ENST00000419585:intron:MODIFIER:exon12/43:c.990-38C>G:		rs9809061	0.2117	0.1758	2122/785/871	0.1665							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	RCV000245041.1 [benign]; 			28	317					FANCD2 (inh=AR pLI=0.00)
chr3	10085536	10085536	A	G	het		QUAL=2144;DP=294;AF=0.43;MQM=60	FANCD2	synonymous	FANCD2:ENST00000287647:synonymous:LOW:exon14/43:c.1122A>G:p.Val374Val,FANCD2:ENST00000383806:synonymous:LOW:exon14/43:c.1122A>G:p.Val374Val,FANCD2:ENST00000383807:synonymous:LOW:exon14/44:c.1122A>G:p.Val374Val,FANCD2:ENST00000419585:synonymous:LOW:exon14/44:c.1122A>G:p.Val374Val		rs34046352	0.0000	0.1239	37/0/37	0.0074							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	RCV000247209.1 [benign]; RCV000377963.1 [benign]; 		COSM3759562, COSM3759563	1	988	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCD2 (inh=AR pLI=0.00)
chr3	10089773	10089773	A	C	het	off-target	QUAL=1155;DP=94;AF=0.52;MQM=60	FANCD2	intron	FANCD2:ENST00000287647:intron:MODIFIER:exon16/42:c.1413+38A>C:,FANCD2:ENST00000383806:intron:MODIFIER:exon16/42:c.1413+38A>C:,FANCD2:ENST00000383807:intron:MODIFIER:exon16/43:c.1413+38A>C:,FANCD2:ENST00000419585:intron:MODIFIER:exon16/43:c.1413+38A>C:,FANCD2:ENST00000464934:intron:MODIFIER:exon2/2:n.432+38A>C:		rs7615646	0.1791	0.1404	234/75/40	0.0306							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	RCV000248902.1 [benign]; 			3	227					FANCD2 (inh=AR pLI=0.00)
chr3	10094206	10094206	-	T	het	off-target	QUAL=110;DP=25;AF=0.36;MQM=60	FANCD2	intron	FANCD2:ENST00000287647:intron:MODIFIER:exon18/42:c.1656+38dupT:,FANCD2:ENST00000383806:intron:MODIFIER:exon18/42:c.1656+38dupT:,FANCD2:ENST00000383807:intron:MODIFIER:exon18/43:c.1656+38dupT:,FANCD2:ENST00000419585:intron:MODIFIER:exon18/43:c.1656+38dupT:,FANCD2:ENST00000421731:intron:MODIFIER:exon2/26:c.153+38dupT:		rs544799101	0.0000	0.1695	52/15/29	0.1123							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];				13	132					FANCD2 (inh=AR pLI=0.00)
chr3	10106532	10106532	C	T	het		QUAL=1274;DP=76;AF=0.63;MQM=60	FANCD2	missense,non_coding_transcript_exon	FANCD2:ENST00000287647:missense:MODERATE:exon23/43:c.2141C>T:p.Pro714Leu,FANCD2:ENST00000383806:missense:MODERATE:exon23/43:c.2141C>T:p.Pro714Leu,FANCD2:ENST00000383807:missense:MODERATE:exon23/44:c.2141C>T:p.Pro714Leu,FANCD2:ENST00000419585:missense:MODERATE:exon23/44:c.2141C>T:p.Pro714Leu,FANCD2:ENST00000421731:missense:MODERATE:exon7/27:c.638C>T:p.Pro213Leu,FANCD2:ENST00000470757:non_coding_transcript_exon:MODIFIER:exon2/5:n.195C>T:,FANCD2:ENST00000480909:non_coding_transcript_exon:MODIFIER:exon1/5:n.156C>T:		rs3864017	0.0000	0.1545	988/525/211	0.0161	-0.1810	T,T,T,T	T	B,B	T,T,T,T	1.75	613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	RCV000120989.2 [benign]; RCV000372215.1 [benign]; 			66	912	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCD2 (inh=AR pLI=0.00)
chr3	10107520	10107520	G	T	het	off-target	QUAL=12200;DP=1013;AF=0.48;MQM=60	FANCD2	intron	FANCD2:ENST00000287647:intron:MODIFIER:exon24/42:c.2270-28G>T:,FANCD2:ENST00000383806:intron:MODIFIER:exon24/42:c.2270-28G>T:,FANCD2:ENST00000383807:intron:MODIFIER:exon24/43:c.2270-28G>T:,FANCD2:ENST00000419585:intron:MODIFIER:exon24/43:c.2270-28G>T:,FANCD2:ENST00000421731:intron:MODIFIER:exon8/26:c.767-28G>T:,FANCD2:ENST00000470757:intron:MODIFIER:exon3/4:n.324-28G>T:,FANCD2:ENST00000480909:intron:MODIFIER:exon2/4:n.285-28G>T:		rs34608006	0.1753	0.1729	1736/780/494	0.1566							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	RCV000241778.1 [benign]; 			25	281					FANCD2 (inh=AR pLI=0.00)
chr3	10119917	10119917	T	C	het	off-target	QUAL=741;DP=72;AF=0.46;MQM=60	FANCD2	intron	FANCD2:ENST00000287647:intron:MODIFIER:exon30/42:c.2976+36T>C:,FANCD2:ENST00000383806:intron:MODIFIER:exon30/42:c.2976+36T>C:,FANCD2:ENST00000383807:intron:MODIFIER:exon30/43:c.2976+36T>C:,FANCD2:ENST00000419585:intron:MODIFIER:exon30/43:c.2976+36T>C:,FANCD2:ENST00000421731:intron:MODIFIER:exon14/26:c.1473+36T>C:		rs6805869	0.2115	0.1750	2309/845/954	0.1714							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	RCV000247071.1 [benign]; 			28	321					FANCD2 (inh=AR pLI=0.00)
chr3	10128965	10128965	-	TT	het	off-target	QUAL=132;DP=41;AF=0.10;MQM=60	FANCD2,FANCD2OS	intron	FANCD2:ENST00000287647:intron:MODIFIER:exon34/42:c.3466+35_3466+36dupTT:,FANCD2:ENST00000383806:intron:MODIFIER:exon34/42:c.3466+35_3466+36dupTT:,FANCD2:ENST00000383807:intron:MODIFIER:exon34/43:c.3466+35_3466+36dupTT:,FANCD2:ENST00000419585:intron:MODIFIER:exon34/43:c.3466+35_3466+36dupTT:,FANCD2:ENST00000421731:intron:MODIFIER:exon18/26:c.1963+35_1963+36dupTT:,FANCD2OS:ENST00000431315:intron:MODIFIER:exon2/3:n.96-43_96-42dupAA:,FANCD2OS:ENST00000436517:intron:MODIFIER:exon2/3:n.117-43_117-42dupAA:,FANCD2OS:ENST00000524279:intron:MODIFIER:exon2/2:c.*44-5752_*44-5751dupAA:		rs371321981	0.0000	0.0230	49/13/22	0.0189							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];				1	0					FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	10133949	10133949	A	G	het	off-target	QUAL=2575;DP=178;AF=0.55;MQM=60	FANCD2,FANCD2OS	splice_region&intron,intron	FANCD2:ENST00000287647:splice_region&intron:LOW:exon38/42:c.3849+13A>G:,FANCD2:ENST00000383806:splice_region&intron:LOW:exon37/42:c.*5+13A>G:,FANCD2:ENST00000383807:splice_region&intron:LOW:exon38/43:c.3849+13A>G:,FANCD2:ENST00000419585:splice_region&intron:LOW:exon38/43:c.3849+13A>G:,FANCD2:ENST00000421731:splice_region&intron:LOW:exon21/26:c.*5+13A>G:,FANCD2OS:ENST00000431315:intron:MODIFIER:exon2/3:n.95+2601T>C:,FANCD2OS:ENST00000436517:intron:MODIFIER:exon2/3:n.116+2601T>C:,FANCD2OS:ENST00000524279:intron:MODIFIER:exon2/2:c.*44-10734T>C:		rs9811771	0.2542	0.1918	2872/852/1283	0.1877							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	RCV000242722.1 [benign]; RCV000359625.1 [benign]; 			43	396					FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	10138069	10138069	T	G	het		QUAL=9089;DP=785;AF=0.47;MQM=60	FANCD2,FANCD2OS	synonymous,3'UTR,intron,non_coding_transcript_exon	FANCD2:ENST00000287647:synonymous:LOW:exon42/43:c.4098T>G:p.Leu1366Leu,FANCD2:ENST00000383807:synonymous:LOW:exon42/44:c.4098T>G:p.Leu1366Leu,FANCD2:ENST00000419585:synonymous:LOW:exon42/44:c.4098T>G:p.Leu1366Leu,FANCD2:ENST00000383806:3'UTR:MODIFIER:exon41/43:c.*254T>G:,FANCD2:ENST00000421731:3'UTR:MODIFIER:exon25/27:c.*254T>G:,FANCD2OS:ENST00000431315:intron:MODIFIER:exon1/3:n.71-1495A>C:,FANCD2OS:ENST00000524279:intron:MODIFIER:exon2/2:c.*43+7813A>C:,FANCD2:ENST00000470028:non_coding_transcript_exon:MODIFIER:exon3/5:n.171T>G:		rs2272125	0.2422	0.1868	2695/850/1177	0.1836							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	RCV000252662.1 [benign]; RCV000264931.1 [benign]; 	CM066071 [CLASS=DP MUT=ALT PHEN="Breast cancer increased risk association with" GENE=FANCD2]; 	COSM3759565, COSM3759566	92	925	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	10138189	10138189	T	C	het	off-target	QUAL=2797;DP=207;AF=0.53;MQM=60	FANCD2,FANCD2OS	intron	FANCD2:ENST00000287647:intron:MODIFIER:exon42/42:c.4185+33T>C:,FANCD2:ENST00000383806:intron:MODIFIER:exon41/42:c.*341+33T>C:,FANCD2:ENST00000383807:intron:MODIFIER:exon42/43:c.4185+33T>C:,FANCD2:ENST00000419585:intron:MODIFIER:exon42/43:c.4185+33T>C:,FANCD2:ENST00000421731:intron:MODIFIER:exon25/26:c.*341+33T>C:,FANCD2OS:ENST00000431315:intron:MODIFIER:exon1/3:n.71-1615A>G:,FANCD2OS:ENST00000524279:intron:MODIFIER:exon2/2:c.*43+7693A>G:,FANCD2:ENST00000470028:intron:MODIFIER:exon3/4:n.258+33T>C:		rs2272124	0.2418	0.1869	2676/845/1171	0.1833							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	RCV000244460.1 [benign]; 			30	327					FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	10140671	10140671	G	A	het	off-target	QUAL=10294;DP=680;AF=0.54;MQM=60	FANCD2,FANCD2OS	3'UTR,intron	FANCD2:ENST00000287647:3'UTR:MODIFIER:exon43/43:c.*37G>A:,FANCD2:ENST00000383806:intron:MODIFIER:exon42/42:c.*437+172G>A:,FANCD2:ENST00000383807:intron:MODIFIER:exon43/43:c.4281+172G>A:,FANCD2:ENST00000419585:intron:MODIFIER:exon43/43:c.4281+172G>A:,FANCD2:ENST00000421731:intron:MODIFIER:exon26/26:c.*437+172G>A:,FANCD2OS:ENST00000431315:intron:MODIFIER:exon1/3:n.71-4097C>T:,FANCD2OS:ENST00000524279:intron:MODIFIER:exon2/2:c.*43+5211C>T:,FANCD2:ENST00000470028:intron:MODIFIER:exon4/4:n.354+172G>A:		rs7626117	0.3452	0.2285	4893/1088/2964	0.2213							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	RCV000325651.1 [benign]; 			45	377					FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	37067097	37067097	A	T	het	off-target	QUAL=1328;DP=239;AF=0.28;MQM=60	MLH1	intron	MLH1:ENST00000231790:intron:MODIFIER:exon11/18:c.1039-31A>T:,MLH1:ENST00000456676:intron:MODIFIER:exon11/16:c.1012-31A>T:,MLH1:ENST00000458205:intron:MODIFIER:exon12/19:c.316-31A>T:,MLH1:ENST00000539477:intron:MODIFIER:exon10/17:c.316-31A>T:,MLH1:ENST00000455445:intron:MODIFIER:exon11/18:c.316-31A>T:,MLH1:ENST00000435176:intron:MODIFIER:exon11/18:c.745-31A>T:,MLH1:ENST00000536378:intron:MODIFIER:exon11/18:c.316-31A>T:,MLH1:ENST00000447829:intron:MODIFIER:exon3/3:c.*150-31A>T:,MLH1:ENST00000458009:intron:MODIFIER:exon3/4:c.225-31A>T:,MLH1:ENST00000413212:intron:MODIFIER:exon1/3:c.113-31A>T:	(TA)n	rs59684491	0.0000	0.0613	2/0/0	0.0036							120436 [MLH1 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 2,609310|Mismatch repair cancer syndrome,276300|Muir-Torre syndrome,158320];				3	100					MLH1 (inh=AR+AD pLI=0.74)
chr3	37067099	37067099	A	T	het	off-target	QUAL=1328;DP=239;AF=0.28;MQM=60	MLH1	intron	MLH1:ENST00000231790:intron:MODIFIER:exon11/18:c.1039-29A>T:,MLH1:ENST00000456676:intron:MODIFIER:exon11/16:c.1012-29A>T:,MLH1:ENST00000458205:intron:MODIFIER:exon12/19:c.316-29A>T:,MLH1:ENST00000539477:intron:MODIFIER:exon10/17:c.316-29A>T:,MLH1:ENST00000455445:intron:MODIFIER:exon11/18:c.316-29A>T:,MLH1:ENST00000435176:intron:MODIFIER:exon11/18:c.745-29A>T:,MLH1:ENST00000536378:intron:MODIFIER:exon11/18:c.316-29A>T:,MLH1:ENST00000447829:intron:MODIFIER:exon3/3:c.*150-29A>T:,MLH1:ENST00000458009:intron:MODIFIER:exon3/4:c.225-29A>T:,MLH1:ENST00000413212:intron:MODIFIER:exon1/3:c.113-29A>T:	(TA)n	rs6771325	0.0000	0.0185	14/4/0	0.0076							120436 [MLH1 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 2,609310|Mismatch repair cancer syndrome,276300|Muir-Torre syndrome,158320];				31	141					MLH1 (inh=AR+AD pLI=0.74)
chr3	142168331	142168331	C	T	hom		QUAL=1594;DP=49;AF=1.00;MQM=60	ATR	synonymous,3'UTR,non_coding_transcript_exon	ATR:ENST00000350721:synonymous:LOW:exon47/47:c.7875G>A:p.Gln2625Gln,ATR:ENST00000383101:synonymous:LOW:exon46/46:c.7683G>A:p.Gln2561Gln,ATR:ENST00000504521:3'UTR:MODIFIER:exon4/4:c.*221G>A:,ATR:ENST00000515810:3'UTR:MODIFIER:exon3/3:c.*181G>A:,ATR:ENST00000513291:3'UTR:MODIFIER:exon9/9:c.*3567G>A:,ATR:ENST00000515107:non_coding_transcript_exon:MODIFIER:exon3/3:n.375G>A:		rs1802904	0.9163	0.8646	45665/23944/4913	0.8579							601215 [ATR (confirmed) Seckel syndrome 1,210600|Cutaneous telangiectasia and cancer syndrome,familial,614564];	RCV000079601.6 [other]; RCV000366216.1 [benign]; 			2444	773	1	[1] Ilnaz Sepahi 29-03-2016 batch import			ATR (inh=AR pLI=0.70)
chr3	142178144	142178144	C	T	het		QUAL=1052;DP=77;AF=0.55;MQM=60	ATR	missense	ATR:ENST00000350721:missense:MODERATE:exon43/47:c.7274G>A:p.Arg2425Gln,ATR:ENST00000513291:missense:MODERATE:exon6/9:c.812G>A:p.Arg271Gln,ATR:ENST00000383101:missense:MODERATE:exon42/46:c.7082G>A:p.Arg2361Gln		rs2229032	0.1022	0.1328	1212/874/28	0.1324	0.0440	T,T	T	B	T,T	11.30	601215 [ATR (confirmed) Seckel syndrome 1,210600|Cutaneous telangiectasia and cancer syndrome,familial,614564];	RCV000145330.2 [benign]; RCV000321936.1 [likely benign]; 		COSM149485	78	804	1	[1] Ilnaz Sepahi 29-03-2016 batch import			ATR (inh=AR pLI=0.70)
chr3	142188337	142188337	A	C	het	pred_pathogenic	QUAL=9942;DP=682;AF=0.56;MQM=60	ATR,RP11-383G6.3	missense,intron	ATR:ENST00000350721:missense:MODERATE:exon38/47:c.6394T>G:p.Tyr2132Asp,ATR:ENST00000383101:missense:MODERATE:exon37/46:c.6202T>G:p.Tyr2068Asp,RP11-383G6.3:ENST00000460977:intron:MODIFIER:exon1/1:n.268+2575T>G:		rs28910273	0.0020	0.0033	2/1/0	0.0035	2.3460	T,D	T	B	T,T	6.31	601215 [ATR (confirmed) Seckel syndrome 1,210600|Cutaneous telangiectasia and cancer syndrome,familial,614564];	RCV000145327.1 [uncertain significance]; RCV000224032.1 [likely benign]; 			0	23	2	[2] Ilnaz Sepahi 29-03-2016 batch import			ATR (inh=AR pLI=0.70), RP11-383G6.3 (inh=n/a pLI=n/a)
chr3	142215171	142215171	T	C	het	off-target;low_DP	QUAL=123;DP=8;AF=0.75;MQM=60	ATR	intron	ATR:ENST00000350721:intron:MODIFIER:exon34/46:c.5898+32A>G:,ATR:ENST00000383101:intron:MODIFIER:exon33/45:c.5706+32A>G:	(TA)n	rs11719960	0.0000	0.0594	291/230/2	0.0172							601215 [ATR (confirmed) Seckel syndrome 1,210600|Cutaneous telangiectasia and cancer syndrome,familial,614564];	RCV000145325.1 [likely benign]; 			24	183					ATR (inh=AR pLI=0.70)
chr3	142215178	142215178	A	C	het	off-target;low_DP	QUAL=123;DP=8;AF=0.75;MQM=60	ATR	intron	ATR:ENST00000350721:intron:MODIFIER:exon34/46:c.5898+25T>G:,ATR:ENST00000383101:intron:MODIFIER:exon33/45:c.5706+25T>G:	(TA)n	rs7620648	0.0000	0.0000	0/0/0	0.0398							601215 [ATR (confirmed) Seckel syndrome 1,210600|Cutaneous telangiectasia and cancer syndrome,familial,614564];	RCV000145324.1 [likely benign]; 			375	573					ATR (inh=AR pLI=0.70)
chr3	142217537	142217537	A	G	het		QUAL=3564;DP=350;AF=0.51;MQM=60	ATR	missense,synonymous,non_coding_transcript_exon	ATR:ENST00000514393:missense:MODERATE:exon2/4:c.143T>C:p.Met48Thr,ATR:ENST00000350721:synonymous:LOW:exon32/47:c.5460T>C:p.Tyr1820Tyr,ATR:ENST00000383101:synonymous:LOW:exon31/46:c.5268T>C:p.Tyr1756Tyr,ATR:ENST00000507620:non_coding_transcript_exon:MODIFIER:exon2/4:n.556T>C:		rs2227932	0.0669	0.0942	705/391/2	0.0915							601215 [ATR (confirmed) Seckel syndrome 1,210600|Cutaneous telangiectasia and cancer syndrome,familial,614564];	RCV000145320.2 [other]; RCV000330742.1 [likely benign]; 			40	548	1	[1] Ilnaz Sepahi 29-03-2016 batch import			ATR (inh=AR pLI=0.70)
chr3	142231062	142231062	-	A	het	off-target;low_QUAL	QUAL=5;DP=31;AF=0.16;MQM=56	ATR	intron	ATR:ENST00000350721:intron:MODIFIER:exon27/46:c.4852+39dupT:,ATR:ENST00000383101:intron:MODIFIER:exon26/45:c.4660+39dupT:		rs566002577;rs771446118	0.0000	0.0152	6/3/2	0.0073							601215 [ATR (confirmed) Seckel syndrome 1,210600|Cutaneous telangiectasia and cancer syndrome,familial,614564];				1	17					ATR (inh=AR pLI=0.70)
chr3	142255090	142255090	T	C	het	off-target	QUAL=1306;DP=111;AF=0.46;MQM=60	ATR	intron	ATR:ENST00000350721:intron:MODIFIER:exon19/46:c.3726-47A>G:,ATR:ENST00000383101:intron:MODIFIER:exon18/45:c.3534-47A>G:		rs73240314	0.1172	0.1374	1200/832/62	0.1333							601215 [ATR (confirmed) Seckel syndrome 1,210600|Cutaneous telangiectasia and cancer syndrome,familial,614564];	RCV000145305.1 [likely benign]; 		COSN167032	26	227					ATR (inh=AR pLI=0.70)
chr3	142259707	142259707	A	-	het	off-target	QUAL=9283;DP=907;AF=0.43;MQM=60	ATR	intron	ATR:ENST00000350721:intron:MODIFIER:exon18/46:c.3581+39delT:,ATR:ENST00000383101:intron:MODIFIER:exon17/45:c.3389+39delT:		rs201551475	0.0000	0.4574	74/42/18	0.1266							601215 [ATR (confirmed) Seckel syndrome 1,210600|Cutaneous telangiectasia and cancer syndrome,familial,614564];				25	388					ATR (inh=AR pLI=0.70)
chr3	142277427	142277427	A	G	het	off-target	QUAL=6988;DP=587;AF=0.48;MQM=60	ATR	intron	ATR:ENST00000350721:intron:MODIFIER:exon8/46:c.1885+39T>C:,ATR:ENST00000383101:intron:MODIFIER:exon7/45:c.1693+39T>C:,ATR:ENST00000515863:intron:MODIFIER:exon1/2:n.378+39T>C:,ATR:ENST00000515149:intron:MODIFIER:exon4/4:c.736+39T>C:	(TAGA)n	rs73240318	0.1122	0.0745	414/288/4	0.0174							601215 [ATR (confirmed) Seckel syndrome 1,210600|Cutaneous telangiectasia and cancer syndrome,familial,614564];	RCV000145293.1 [likely benign]; 			26	218					ATR (inh=AR pLI=0.70)
chr3	142277575	142277575	A	T	het		QUAL=3151;DP=274;AF=0.47;MQM=60	ATR	synonymous,non_coding_transcript_exon	ATR:ENST00000350721:synonymous:LOW:exon8/47:c.1776T>A:p.Gly592Gly,ATR:ENST00000383101:synonymous:LOW:exon7/46:c.1584T>A:p.Gly528Gly,ATR:ENST00000515149:synonymous:LOW:exon4/5:c.627T>A:p.Gly209Gly,ATR:ENST00000515863:non_coding_transcript_exon:MODIFIER:exon1/3:n.269T>A:		rs2227930	0.5980	0.5529	19239/11031/3356	0.5329							601215 [ATR (confirmed) Seckel syndrome 1,210600|Cutaneous telangiectasia and cancer syndrome,familial,614564];	RCV000145291.5 [other]; RCV000306424.1 [benign]; 		COSM149486	1110	1567	1	[1] Ilnaz Sepahi 29-03-2016 batch import			ATR (inh=AR pLI=0.70)
chr3	142281612	142281612	A	G	het		QUAL=6583;DP=530;AF=0.49;MQM=60	ATR	missense,intron	ATR:ENST00000350721:missense:MODERATE:exon4/47:c.632T>C:p.Met211Thr,ATR:ENST00000383101:missense:MODERATE:exon4/46:c.632T>C:p.Met211Thr,ATR:ENST00000507148:intron:MODIFIER:exon3/5:c.293-422T>C:		rs2227928	0.5974	0.5540	19098/10972/3300	0.5505	1.2730	T,T	T	B	T,T	1.62	601215 [ATR (confirmed) Seckel syndrome 1,210600|Cutaneous telangiectasia and cancer syndrome,familial,614564];	RCV000079600.6 [other]; RCV000267092.1 [benign]; 		COSM149487	1108	1566	1	[1] Ilnaz Sepahi 29-03-2016 batch import			ATR (inh=AR pLI=0.70)
chr3	156413615	156413615	C	T	hom	off-target	QUAL=1298;DP=275;AF=0.20;MQM=53	TIPARP	intron	TIPARP:ENST00000295924:intron:MODIFIER:exon3/5:c.1087-39C>T:,TIPARP:ENST00000486483:intron:MODIFIER:exon3/5:c.1087-39C>T:,TIPARP:ENST00000461166:intron:MODIFIER:exon3/5:c.1087-39C>T:,TIPARP:ENST00000473702:intron:MODIFIER:exon3/4:c.1087-39C>T:,TIPARP:ENST00000481853:intron:MODIFIER:exon3/5:c.1087-39C>T:,TIPARP:ENST00000542783:intron:MODIFIER:exon3/5:c.1087-39C>T:,TIPARP:ENST00000495891:intron:MODIFIER:exon2/4:c.193-39C>T:			0.0000	0.0000	0/0/0	0.0001											74	13					TIPARP (inh=n/a pLI=1.00)
chr3	156421525	156421525	G	T	het	off-target	QUAL=5995;DP=480;AF=0.51;MQM=60	TIPARP	intron	TIPARP:ENST00000295924:intron:MODIFIER:exon5/5:c.1526+34G>T:,TIPARP:ENST00000486483:intron:MODIFIER:exon5/5:c.1526+34G>T:,TIPARP:ENST00000461166:intron:MODIFIER:exon5/5:c.1526+34G>T:,TIPARP:ENST00000481853:intron:MODIFIER:exon5/5:c.1526+34G>T:,TIPARP:ENST00000542783:intron:MODIFIER:exon5/5:c.1526+34G>T:,TIPARP:ENST00000495891:intron:MODIFIER:exon4/4:c.632+34G>T:	AluYm1	rs34277251	0.3832	0.4306	10742/5291/26	0.3948											166	422					TIPARP (inh=n/a pLI=1.00)
chr3	178917005	178917005	A	G	het	off-target	QUAL=850;DP=54;AF=0.63;MQM=60	PIK3CA	intron	PIK3CA:ENST00000263967:intron:MODIFIER:exon2/20:c.352+40A>G:		rs3729674	0.2734	0.2156	2868/1297/889	0.1982							171834 [PIK3CA (provisional) Ovarian cancer,somatic,167000|Breast cancer,somatic,114480|Colorectal cancer,somatic,114500|Gastric cancer,somatic,613659|Hepatocellular carcinoma,somatic,114550|Nonsmall cell lung cancer,somatic,211980|Keratosis,seborrheic,somatic,182000|Nevus,epidermal,somatic,162900|CLOVE syndrome,somatic,612918|Megalencephaly-capillary malformation-polymicrogyria syndrome,somatic,602501|Cowden syndrome 5,615108];				38	353					PIK3CA (inh=AR+AD pLI=1.00)
chr3	178922274	178922274	C	A	hom	off-target	QUAL=13692;DP=480;AF=1.00;MQM=60	PIK3CA	splice_region&intron	PIK3CA:ENST00000263967:splice_region&intron:LOW:exon5/20:c.1060-17C>A:		rs2699896	0.5847	0.5614	20164/11339/3659	0.5448							171834 [PIK3CA (provisional) Ovarian cancer,somatic,167000|Breast cancer,somatic,114480|Colorectal cancer,somatic,114500|Gastric cancer,somatic,613659|Hepatocellular carcinoma,somatic,114550|Nonsmall cell lung cancer,somatic,211980|Keratosis,seborrheic,somatic,182000|Nevus,epidermal,somatic,162900|CLOVE syndrome,somatic,612918|Megalencephaly-capillary malformation-polymicrogyria syndrome,somatic,602501|Cowden syndrome 5,615108];	RCV000253634.1 [benign]; 			597	822					PIK3CA (inh=AR+AD pLI=1.00)
chr3	178922430	178922430	A	G	hom	off-target	QUAL=1931;DP=64;AF=1.00;MQM=60	PIK3CA	sequence_feature,intron	PIK3CA:ENST00000263967:sequence_feature:LOW::c.1145+54A>G:,PIK3CA:ENST00000263967:intron:MODIFIER:exon6/20:c.1145+54A>G:		rs3729679	0.5180	0.0000	0/0/0	0.0975							171834 [PIK3CA (provisional) Ovarian cancer,somatic,167000|Breast cancer,somatic,114480|Colorectal cancer,somatic,114500|Gastric cancer,somatic,613659|Hepatocellular carcinoma,somatic,114550|Nonsmall cell lung cancer,somatic,211980|Keratosis,seborrheic,somatic,182000|Nevus,epidermal,somatic,162900|CLOVE syndrome,somatic,612918|Megalencephaly-capillary malformation-polymicrogyria syndrome,somatic,602501|Cowden syndrome 5,615108];			COSN167081	280	500					PIK3CA (inh=AR+AD pLI=1.00)
chr3	178938747	178938747	A	T	het	off-target	QUAL=4435;DP=376;AF=0.47;MQM=55	PIK3CA	intron	PIK3CA:ENST00000263967:intron:MODIFIER:exon13/20:c.2016-27A>T:,PIK3CA:ENST00000462255:intron:MODIFIER:exon2/5:n.290-27A>T:		rs6443625	0.2730	0.2911	1131/461/300	0.1736							171834 [PIK3CA (provisional) Ovarian cancer,somatic,167000|Breast cancer,somatic,114480|Colorectal cancer,somatic,114500|Gastric cancer,somatic,613659|Hepatocellular carcinoma,somatic,114550|Nonsmall cell lung cancer,somatic,211980|Keratosis,seborrheic,somatic,182000|Nevus,epidermal,somatic,162900|CLOVE syndrome,somatic,612918|Megalencephaly-capillary malformation-polymicrogyria syndrome,somatic,602501|Cowden syndrome 5,615108];				57	403					PIK3CA (inh=AR+AD pLI=1.00)
chr3	178942431	178942431	C	G	hom	off-target;low_DP	QUAL=183;DP=7;AF=1.00;MQM=60	PIK3CA	intron	PIK3CA:ENST00000263967:intron:MODIFIER:exon15/20:c.2295-57C>G:,PIK3CA:ENST00000462255:intron:MODIFIER:exon4/5:n.569-57C>G:		rs2699889	0.6294	0.0000	0/0/0	0.1074							171834 [PIK3CA (provisional) Ovarian cancer,somatic,167000|Breast cancer,somatic,114480|Colorectal cancer,somatic,114500|Gastric cancer,somatic,613659|Hepatocellular carcinoma,somatic,114550|Nonsmall cell lung cancer,somatic,211980|Keratosis,seborrheic,somatic,182000|Nevus,epidermal,somatic,162900|CLOVE syndrome,somatic,612918|Megalencephaly-capillary malformation-polymicrogyria syndrome,somatic,602501|Cowden syndrome 5,615108];				393	444					PIK3CA (inh=AR+AD pLI=1.00)
chr4	185999587	185999587	T	A	het	off-target	QUAL=686;DP=71;AF=0.46;MQM=60	RP11-386B13.3	intron	RP11-386B13.3:ENST00000509017:intron:MODIFIER:exon5/8:n.1340+6360T>A:		rs6818170	0.6675	0.6436	23810/13741/2802	0.5995											471	413					RP11-386B13.3 (inh=n/a pLI=n/a)
chr5	57617403	57617403	G	C	het		QUAL=11921;DP=940;AF=0.50;MQM=60	PGAM1P1-PLK2	intergenic_region	PGAM1P1-PLK2:ENSG00000248271-ENSG00000145632:intergenic_region:MODIFIER::n.57617403G>C:	MLT1E1A	rs37535	0.5719	0.0000	0/0/0	0.5688											310	437					PGAM1P1-PLK2 (inh=n/a pLI=n/a)
chr5	79950508	79950508	C	T	hom	off-target	QUAL=2919;DP=109;AF=1.00;MQM=60	MSH3,DHFR	5'UTR_premature_start_codon_gain,5'UTR	MSH3:ENST00000265081:5'UTR_premature_start_codon_gain:LOW:exon1/24:c.-39C>T:,DHFR:ENST00000439211:5'UTR:MODIFIER:exon1/6:c.-200G>A:,MSH3:ENST00000265081:5'UTR:MODIFIER:exon1/24:c.-39C>T:		rs1105525	0.1230	0.1997	1596/914/9	0.1309							126060 [DHFR (confirmed) Megaloblastic anemia due to dihydrofolate reductase deficiency,613839]:600887 [MSH3 (provisional) Endometrial carcinoma,somatic,608089|Familial adenomatous polyposis 4,617100];				51	360					MSH3 (inh=n/a pLI=0.00), DHFR (inh=AR pLI=0.28)
chr5	79950512	79950512	A	G	hom	off-target	QUAL=2919;DP=109;AF=1.00;MQM=60	DHFR,MSH3	5'UTR	DHFR:ENST00000439211:5'UTR:MODIFIER:exon1/6:c.-204T>C:,MSH3:ENST00000265081:5'UTR:MODIFIER:exon1/24:c.-35A>G:		rs1105524	0.7043	0.6744	22308/11896/3085	0.5697							126060 [DHFR (confirmed) Megaloblastic anemia due to dihydrofolate reductase deficiency,613839]:600887 [MSH3 (provisional) Endometrial carcinoma,somatic,608089|Familial adenomatous polyposis 4,617100];				600	503					DHFR (inh=AR pLI=0.28), MSH3 (inh=n/a pLI=0.00)
chr5	79950781	79950781	A	G	het	pred_pathogenic	QUAL=420;DP=38;AF=0.47;MQM=60	MSH3,DHFR	missense&splice_region,5'UTR	MSH3:ENST00000265081:missense&splice_region:MODERATE:exon1/24:c.235A>G:p.Ile79Val,DHFR:ENST00000439211:5'UTR:MODIFIER:exon1/6:c.-473T>C:		rs1650697	0.7686	0.9029	4978/2224/393	0.4128	-0.4930	T,T	T	B	D	0.01	126060 [DHFR (confirmed) Megaloblastic anemia due to dihydrofolate reductase deficiency,613839]:600887 [MSH3 (provisional) Endometrial carcinoma,somatic,608089|Familial adenomatous polyposis 4,617100];		CM003459 [CLASS=DP MUT=REF PHEN="Colon cancer association with" GENE=MSH3]; 	COSM4160035	1670	1153	1	[1] Ilnaz Sepahi 29-03-2016 batch import			MSH3 (inh=n/a pLI=0.00), DHFR (inh=AR pLI=0.28)
chr5	79966178	79966178	G	A	het	off-target	QUAL=5439;DP=416;AF=0.50;MQM=60	MSH3	intron	MSH3:ENST00000265081:intron:MODIFIER:exon4/23:c.792+50G>A:		rs6151630	0.0232	0.0419	129/87/1	0.0403							600887 [MSH3 (provisional) Endometrial carcinoma,somatic,608089|Familial adenomatous polyposis 4,617100];				2	88					MSH3 (inh=n/a pLI=0.00)
chr5	80149981	80149981	A	G	hom	pred_pathogenic	QUAL=28046;DP=904;AF=1.00;MQM=60	MSH3	missense	MSH3:ENST00000265081:missense:MODERATE:exon21/24:c.2846A>G:p.Gln949Arg		rs184967	0.9022	0.8731	46317/23581/4199	0.8489	0.4010	T,T	T	B	D	4.93	600887 [MSH3 (provisional) Endometrial carcinoma,somatic,608089|Familial adenomatous polyposis 4,617100];		CM076322 [CLASS=DP MUT=REF PHEN="Proximal colon cancer increased risk association with" GENE=MSH3]; 	COSM4160036	2176	816	1	[1] Ilnaz Sepahi 29-03-2016 batch import			MSH3 (inh=n/a pLI=0.00)
chr5	80160597	80160600	AATG	-	het	off-target;low_DP	QUAL=58;DP=16;AF=0.38;MQM=60	MSH3	intron	MSH3:ENST00000265081:intron:MODIFIER:exon21/23:c.3001-33_3001-30delTGAA:		rs34486413	0.4030	0.5059	13685/8991/244	0.4481							600887 [MSH3 (provisional) Endometrial carcinoma,somatic,608089|Familial adenomatous polyposis 4,617100];				269	500					MSH3 (inh=n/a pLI=0.00)
chr5	80168937	80168937	G	A	hom	pred_pathogenic	QUAL=3771;DP=114;AF=1.00;MQM=60	MSH3	missense&splice_region	MSH3:ENST00000265081:missense&splice_region:MODERATE:exon23/24:c.3133G>A:p.Ala1045Thr		rs26279	0.7202	0.7305	32457/17163/2349	0.7223	1.0140	T,T	T	B	D	7.28	600887 [MSH3 (provisional) Endometrial carcinoma,somatic,608089|Familial adenomatous polyposis 4,617100];		CM076321 [CLASS=DP MUT=REF PHEN="Colorectal cancer increased risk association with" GENE=MSH3]; 		1536	1269	1	[1] Ilnaz Sepahi 29-03-2016 batch import			MSH3 (inh=n/a pLI=0.00)
chr5	112162854	112162854	T	C	het		QUAL=1678;DP=184;AF=0.42;MQM=60	APC	synonymous,3'UTR,intron	APC:ENST00000257430:synonymous:LOW:exon12/16:c.1458T>C:p.Tyr486Tyr,APC:ENST00000457016:synonymous:LOW:exon12/16:c.1458T>C:p.Tyr486Tyr,APC:ENST00000507379:synonymous:LOW:exon10/14:c.1404T>C:p.Tyr468Tyr,APC:ENST00000508376:synonymous:LOW:exon13/17:c.1458T>C:p.Tyr486Tyr,APC:ENST00000512211:synonymous:LOW:exon12/16:c.1458T>C:p.Tyr486Tyr,APC:ENST00000504915:synonymous:LOW:exon3/7:c.147T>C:p.Tyr49Tyr,APC:ENST00000508624:3'UTR:MODIFIER:exon13/17:c.*780T>C:,APC:ENST00000502371:intron:MODIFIER:exon1/2:n.96+5166T>C:		rs2229992	0.5100	0.5780	21255/11677/216	0.5753							611731 [APC (confirmed) Adenomatous polyposis coli,175100|Gastric cancer,somatic,613659|Adenoma,periampullary,somatic|Hepatoblastoma,somatic,114550|Desmoid disease,hereditary,135290|Colorectal cancer,somatic,114500|Brain tumor-polyposis syndrome 2,175100|Gardner syndrome,175100];	RCV000035064.9 [benign]; RCV000074147.1 [other]; RCV000131423.2 [benign]; RCV000275522.1 [benign]; 		COSM1432175	1074	1524	1	[1] old entry - no details available			APC (inh=AD pLI=1.00)
chr5	112164561	112164561	G	A	het		QUAL=2531;DP=179;AF=0.51;MQM=60	APC,CTC-554D6.1	synonymous,3'UTR,intron,non_coding_transcript_exon	APC:ENST00000257430:synonymous:LOW:exon14/16:c.1635G>A:p.Ala545Ala,CTC-554D6.1:ENST00000520401:synonymous:LOW:exon3/8:c.120G>A:p.Ala40Ala,APC:ENST00000457016:synonymous:LOW:exon14/16:c.1635G>A:p.Ala545Ala,APC:ENST00000507379:synonymous:LOW:exon12/14:c.1581G>A:p.Ala527Ala,APC:ENST00000508376:synonymous:LOW:exon15/17:c.1635G>A:p.Ala545Ala,APC:ENST00000512211:synonymous:LOW:exon14/16:c.1635G>A:p.Ala545Ala,APC:ENST00000504915:synonymous:LOW:exon5/7:c.324G>A:p.Ala108Ala,APC:ENST00000508624:3'UTR:MODIFIER:exon15/17:c.*957G>A:,APC:ENST00000502371:intron:MODIFIER:exon1/2:n.97-6087G>A:,APC:ENST00000505084:non_coding_transcript_exon:MODIFIER:exon3/3:n.122G>A:,APC:ENST00000514164:non_coding_transcript_exon:MODIFIER:exon1/3:n.30G>A:		rs351771	0.6661	0.6481	25918/12755/1477	0.6434							611731 [APC (confirmed) Adenomatous polyposis coli,175100|Gastric cancer,somatic,613659|Adenoma,periampullary,somatic|Hepatoblastoma,somatic,114550|Desmoid disease,hereditary,135290|Colorectal cancer,somatic,114500|Brain tumor-polyposis syndrome 2,175100|Gardner syndrome,175100];	RCV000035066.9 [benign]; RCV000074153.1 [other]; RCV000162371.1 [benign]; RCV000375983.1 [benign]; RCV000411329.1 [benign]; 		COSM3760868	1234	1449	1	[1] old entry - no details available			APC (inh=AD pLI=1.00), CTC-554D6.1 (inh=n/a pLI=n/a)
chr5	112175770	112175770	G	A	het		QUAL=5170;DP=423;AF=0.49;MQM=60	APC,CTC-554D6.1	synonymous,3'UTR,intron	APC:ENST00000257430:synonymous:LOW:exon16/16:c.4479G>A:p.Thr1493Thr,APC:ENST00000457016:synonymous:LOW:exon16/16:c.4479G>A:p.Thr1493Thr,APC:ENST00000508376:synonymous:LOW:exon17/17:c.4479G>A:p.Thr1493Thr,APC:ENST00000508624:3'UTR:MODIFIER:exon17/17:c.*3801G>A:,CTC-554D6.1:ENST00000520401:intron:MODIFIER:exon3/7:c.228+11101G>A:		rs41115	0.6655	0.6486	25933/12779/1447	0.6435							611731 [APC (confirmed) Adenomatous polyposis coli,175100|Gastric cancer,somatic,613659|Adenoma,periampullary,somatic|Hepatoblastoma,somatic,114550|Desmoid disease,hereditary,135290|Colorectal cancer,somatic,114500|Brain tumor-polyposis syndrome 2,175100|Gardner syndrome,175100];	RCV000035071.9 [benign]; RCV000074234.1 [other]; RCV000162372.1 [benign]; RCV000383485.1 [benign]; 		COSM3760869	1233	1455	1	[1] old entry - no details available			APC (inh=AD pLI=1.00), CTC-554D6.1 (inh=n/a pLI=n/a)
chr5	112176325	112176325	G	A	het		QUAL=233;DP=26;AF=0.50;MQM=60	APC,CTC-554D6.1	synonymous,3'UTR,intron	APC:ENST00000257430:synonymous:LOW:exon16/16:c.5034G>A:p.Gly1678Gly,APC:ENST00000457016:synonymous:LOW:exon16/16:c.5034G>A:p.Gly1678Gly,APC:ENST00000508376:synonymous:LOW:exon17/17:c.5034G>A:p.Gly1678Gly,APC:ENST00000508624:3'UTR:MODIFIER:exon17/17:c.*4356G>A:,CTC-554D6.1:ENST00000520401:intron:MODIFIER:exon3/7:c.228+11656G>A:		rs42427	0.6667	0.6514	26051/12877/1489	0.6444							611731 [APC (confirmed) Adenomatous polyposis coli,175100|Gastric cancer,somatic,613659|Adenoma,periampullary,somatic|Hepatoblastoma,somatic,114550|Desmoid disease,hereditary,135290|Colorectal cancer,somatic,114500|Brain tumor-polyposis syndrome 2,175100|Gardner syndrome,175100];	RCV000035074.9 [benign]; RCV000074235.1 [other]; RCV000162373.1 [benign]; RCV000390083.1 [benign]; 		COSM3760870	1243	1439	1	[1] old entry - no details available			APC (inh=AD pLI=1.00), CTC-554D6.1 (inh=n/a pLI=n/a)
chr5	112176559	112176559	T	G	het		QUAL=3246;DP=262;AF=0.49;MQM=60	APC,CTC-554D6.1	synonymous,3'UTR,intron	APC:ENST00000257430:synonymous:LOW:exon16/16:c.5268T>G:p.Ser1756Ser,APC:ENST00000457016:synonymous:LOW:exon16/16:c.5268T>G:p.Ser1756Ser,APC:ENST00000508376:synonymous:LOW:exon17/17:c.5268T>G:p.Ser1756Ser,APC:ENST00000508624:3'UTR:MODIFIER:exon17/17:c.*4590T>G:,CTC-554D6.1:ENST00000520401:intron:MODIFIER:exon3/7:c.228+11890T>G:		rs866006	0.6669	0.6508	26034/12847/1478	0.6435							611731 [APC (confirmed) Adenomatous polyposis coli,175100|Gastric cancer,somatic,613659|Adenoma,periampullary,somatic|Hepatoblastoma,somatic,114550|Desmoid disease,hereditary,135290|Colorectal cancer,somatic,114500|Brain tumor-polyposis syndrome 2,175100|Gardner syndrome,175100];	RCV000166360.1 [likely benign]; RCV000035076.9 [benign]; RCV000074236.1 [other]; RCV000162374.1 [benign]; RCV000359973.1 [benign]; 			1238	1438	1	[1] old entry - no details available			APC (inh=AD pLI=1.00), CTC-554D6.1 (inh=n/a pLI=n/a)
chr5	112176756	112176756	T	A	het	pred_pathogenic	QUAL=4289;DP=382;AF=0.45;MQM=60	APC,CTC-554D6.1	missense,3'UTR,intron	APC:ENST00000257430:missense:MODERATE:exon16/16:c.5465T>A:p.Val1822Asp,APC:ENST00000457016:missense:MODERATE:exon16/16:c.5465T>A:p.Val1822Asp,APC:ENST00000508376:missense:MODERATE:exon17/17:c.5465T>A:p.Val1822Asp,APC:ENST00000508624:3'UTR:MODIFIER:exon17/17:c.*4787T>A:,CTC-554D6.1:ENST00000520401:intron:MODIFIER:exon3/7:c.228+12087T>A:		rs459552	0.8654	0.7981	38872/19648/4738	0.7914	3.6530	T,T,T	T	B,B	D,D,D	13.24	611731 [APC (confirmed) Adenomatous polyposis coli,175100|Gastric cancer,somatic,613659|Adenoma,periampullary,somatic|Hepatoblastoma,somatic,114550|Desmoid disease,hereditary,135290|Colorectal cancer,somatic,114500|Brain tumor-polyposis syndrome 2,175100|Gardner syndrome,175100];	RCV000020089.2 [benign]; RCV000034393.1 [benign]; RCV000035078.10 [benign]; RCV000074239.1 [other]; RCV000132160.2 [benign]; RCV000358689.1 [benign]; RCV000216852.1 [uncertain significance]; 	CM990164 [CLASS=DP MUT=REF PHEN="Adenomatous polyposis coli association with" GENE=APC]; 	COSM3760871	1883	1098	1	[1] old entry - no details available			APC (inh=AD pLI=1.00), CTC-554D6.1 (inh=n/a pLI=n/a)
chr5	112177171	112177171	G	A	het		QUAL=9897;DP=815;AF=0.48;MQM=60	APC,CTC-554D6.1	synonymous,3'UTR,intron	APC:ENST00000257430:synonymous:LOW:exon16/16:c.5880G>A:p.Pro1960Pro,APC:ENST00000457016:synonymous:LOW:exon16/16:c.5880G>A:p.Pro1960Pro,APC:ENST00000508376:synonymous:LOW:exon17/17:c.5880G>A:p.Pro1960Pro,APC:ENST00000508624:3'UTR:MODIFIER:exon17/17:c.*5202G>A:,CTC-554D6.1:ENST00000520401:intron:MODIFIER:exon3/7:c.228+12502G>A:		rs465899	0.6665	0.6488	25923/12754/1497	0.6438							611731 [APC (confirmed) Adenomatous polyposis coli,175100|Gastric cancer,somatic,613659|Adenoma,periampullary,somatic|Hepatoblastoma,somatic,114550|Desmoid disease,hereditary,135290|Colorectal cancer,somatic,114500|Brain tumor-polyposis syndrome 2,175100|Gardner syndrome,175100];	RCV000035080.9 [benign]; RCV000074242.1 [other]; RCV000162375.1 [benign]; RCV000270059.1 [benign]; 		COSM3760872	1231	1450	1	[1] old entry - no details available			APC (inh=AD pLI=1.00), CTC-554D6.1 (inh=n/a pLI=n/a)
chr5	131892979	131892979	G	A	hom	off-target	QUAL=1592;DP=66;AF=0.98;MQM=60	RAD50	5'UTR,intron	RAD50:ENST00000265335:5'UTR:MODIFIER:exon1/25:c.-38G>A:,RAD50:ENST00000378823:5'UTR:MODIFIER:exon1/25:c.-455G>A:,RAD50:ENST00000533482:5'UTR:MODIFIER:exon1/25:c.-38G>A:,RAD50:ENST00000453394:5'UTR:MODIFIER:exon1/12:c.-38G>A:,RAD50:ENST00000423956:5'UTR:MODIFIER:exon1/18:c.-38G>A:,RAD50:ENST00000416135:intron:MODIFIER:exon1/4:c.-169+814G>A:		rs4526098	0.9249	0.9752	57988/33161/2994	0.9411							604040 [RAD50 (provisional) Nijmegen breakage syndrome-like disorder,613078];	RCV000160912.1 [benign]; 			1224	15					RAD50 (inh=AR pLI=0.00)
chr5	131915213	131915213	G	A	het	off-target	QUAL=1499;DP=145;AF=0.46;MQM=60	RAD50	splice_region&intron	RAD50:ENST00000265335:splice_region&intron:LOW:exon4/24:c.551+19G>A:,RAD50:ENST00000416135:splice_region&intron:LOW:exon4/4:c.254+19G>A:,RAD50:ENST00000378823:splice_region&intron:LOW:exon4/24:c.134+19G>A:,RAD50:ENST00000533482:splice_region&intron:LOW:exon4/24:c.*177+19G>A:,RAD50:ENST00000453394:splice_region&intron:LOW:exon4/11:c.551+19G>A:,RAD50:ENST00000423956:splice_region&intron:LOW:exon4/17:c.551+19G>A:		rs17166050	0.1677	0.1988	2524/1547/69	0.1936							604040 [RAD50 (provisional) Nijmegen breakage syndrome-like disorder,613078];	RCV000245201.1 [benign]; 	CS139954 [CLASS=DFP MUT=ALT PHEN="Acute lymphoblastic leukaemia decreased risk" GENE=RAD50]; 		86	548					RAD50 (inh=AR pLI=0.00)
chr5	131925483	131925483	G	C	het	pred_pathogenic	QUAL=814;DP=67;AF=0.49;MQM=60	RAD50	missense,3'UTR	RAD50:ENST00000265335:missense:MODERATE:exon9/25:c.1406G>C:p.Gly469Ala,RAD50:ENST00000378823:missense:MODERATE:exon9/25:c.989G>C:p.Gly330Ala,RAD50:ENST00000453394:missense:MODERATE:exon9/12:c.1406G>C:p.Gly469Ala,RAD50:ENST00000423956:missense:MODERATE:exon9/18:c.1406G>C:p.Gly469Ala,RAD50:ENST00000533482:3'UTR:MODIFIER:exon9/25:c.*1032G>C:		rs55653181	0.0002	0.0001	0/0/0	0.0001	6.3310	T,T,T	T	B	T,T,T	18.91	604040 [RAD50 (provisional) Nijmegen breakage syndrome-like disorder,613078];	RCV000199031.1 [uncertain significance]; 			0	2					RAD50 (inh=AR pLI=0.00)
chr5	176334195	176334195	C	T	het	off-target	QUAL=11593;DP=625;AF=0.69;MQM=60	UIMC1	splice_region&intron,non_coding_transcript_exon	UIMC1:ENST00000377219:splice_region&intron:LOW:exon12/14:c.1852-17G>A:,UIMC1:ENST00000377227:splice_region&intron:LOW:exon12/14:c.1849-17G>A:,UIMC1:ENST00000506128:splice_region&intron:LOW:exon12/14:c.1351-17G>A:,UIMC1:ENST00000511320:splice_region&intron:LOW:exon12/14:c.1849-17G>A:,UIMC1:ENST00000512031:splice_region&intron:LOW:exon12/14:c.*1352-17G>A:,UIMC1:ENST00000510698:splice_region&intron:LOW:exon10/12:c.*246-17G>A:,UIMC1:ENST00000505229:non_coding_transcript_exon:MODIFIER:exon1/2:n.114G>A:		rs2292255	0.5905	0.5247	15293/7868/3362	0.5016											385	678					UIMC1 (inh=n/a pLI=0.03)
chr5	176338288	176338288	C	T	het	off-target	QUAL=3679;DP=323;AF=0.48;MQM=60	UIMC1	intron	UIMC1:ENST00000377219:intron:MODIFIER:exon11/14:c.1679+24G>A:,UIMC1:ENST00000377227:intron:MODIFIER:exon11/14:c.1676+24G>A:,UIMC1:ENST00000506128:intron:MODIFIER:exon11/14:c.1178+24G>A:,UIMC1:ENST00000511320:intron:MODIFIER:exon11/14:c.1676+24G>A:,UIMC1:ENST00000512031:intron:MODIFIER:exon11/14:c.*1179+24G>A:,UIMC1:ENST00000510698:intron:MODIFIER:exon9/12:c.*73+24G>A:,UIMC1:ENST00000503273:intron:MODIFIER:exon7/7:n.893+24G>A:		rs17078630	0.0092	0.0238	52/45/0	0.0235											2	66					UIMC1 (inh=n/a pLI=0.03)
chr6	35420628	35420628	A	C	het	off-target;low_DP	QUAL=67;DP=8;AF=0.50;MQM=60	FANCE	intron	FANCE:ENST00000229769:intron:MODIFIER:exon1/9:c.248+58A>C:		rs9470029	0.6172	0.0000	0/0/0	0.1057							613976 [FANCE (provisional) Fanconi anemia,complementation group E,600901];				310	377					FANCE (inh=AR pLI=0.00)
chr6	35423489	35423489	A	G	het	off-target	QUAL=7904;DP=636;AF=0.49;MQM=60	FANCE	intron	FANCE:ENST00000229769:intron:MODIFIER:exon1/9:c.249-35A>G:		rs7757405	0.7766	0.7201	31745/15391/3873	0.7056							613976 [FANCE (provisional) Fanconi anemia,complementation group E,600901];	RCV000253913.1 [benign]; 			449	459					FANCE (inh=AR pLI=0.00)
chr6	35423662	35423662	A	C	het		QUAL=884;DP=100;AF=0.41;MQM=60	FANCE	synonymous	FANCE:ENST00000229769:synonymous:LOW:exon2/10:c.387A>C:p.Pro129Pro		rs4713867	0.7780	0.7211	31791/15371/3918	0.7107							613976 [FANCE (provisional) Fanconi anemia,complementation group E,600901];	RCV000246343.1 [benign]; RCV000357472.1 [benign]; 			1513	1425	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCE (inh=AR pLI=0.00)
chr6	35424188	35424188	A	G	het	off-target	QUAL=1441;DP=106;AF=0.53;MQM=60	FANCE	intron	FANCE:ENST00000229769:intron:MODIFIER:exon2/9:c.855+58A>G:		rs3800377	0.7191	0.0000	0/0/0	0.1337							613976 [FANCE (provisional) Fanconi anemia,complementation group E,600901];				493	530					FANCE (inh=AR pLI=0.00)
chr6	35425416	35425416	A	G	het	off-target	QUAL=10912;DP=832;AF=0.50;MQM=60	FANCE	intron	FANCE:ENST00000229769:intron:MODIFIER:exon3/9:c.900+39A>G:		rs13214239	0.3596	0.4966	15583/9793/110	0.4840							613976 [FANCE (provisional) Fanconi anemia,complementation group E,600901];	RCV000254211.1 [benign]; 			319	577					FANCE (inh=AR pLI=0.00)
chr6	131148863	131148863	A	T	het		QUAL=4396;DP=373;AF=0.52;MQM=60	SMLR1	intron	SMLR1:ENST00000541421:intron:MODIFIER:exon1/1:c.238+72A>T:		rs9388856	0.4794	0.0000	0/0/0	0.3918											83	322					SMLR1 (inh=n/a pLI=n/a)
chr6	131148891	131148891	-	AT	het	off-target	QUAL=6759;DP=703;AF=0.41;MQM=60	SMLR1	intron	SMLR1:ENST00000541421:intron:MODIFIER:exon1/1:c.238+113_238+114dupAT:		rs113795427;rs753973009	0.4884	0.0000	0/0/0	0.2629											11	117					SMLR1 (inh=n/a pLI=n/a)
chr7	6026775	6026775	T	C	hom	pred_pathogenic	QUAL=527;DP=22;AF=1.00;MQM=60	PMS2	missense,intron	PMS2:ENST00000265849:missense:MODERATE:exon11/15:c.1621A>G:p.Lys541Glu,PMS2:ENST00000441476:missense:MODERATE:exon8/12:c.1303A>G:p.Lys435Glu,PMS2:ENST00000406569:missense:MODERATE:exon11/12:c.1621A>G:p.Lys541Glu,PMS2:ENST00000382321:intron:MODIFIER:exon7/10:c.804-4153A>G:,PMS2:ENST00000469652:intron:MODIFIER:exon2/2:n.63-4239A>G:		rs2228006	0.8832	0.8514	44055/24216/4305	0.8176	1.4430	T,T,T,T	T	B,B,B	T,T,D	0.14	600259 [PMS2 (confirmed) Mismatch repair cancer syndrome,276300|Colorectal cancer,hereditary nonpolyposis,type 4,614337];	RCV000030365.3 [benign]; RCV000034619.3 [benign]; RCV000212862.1 [benign]; RCV000121840.3 [benign]; 	BM1497492 [CLASS=R MUT=REF PHEN="Colorectal cancer non-polyposis" GENE=PMS2]; 	COSM4162329	2630	864	1	[1] Tanja Benkert 16.04.2015			PMS2 (inh=AR+AD pLI=0.00)
chr7	6036980	6036980	G	C	hom		QUAL=763;DP=26;AF=1.00;MQM=60	PMS2	synonymous,intron	PMS2:ENST00000265849:synonymous:LOW:exon7/15:c.780C>G:p.Ser260Ser,PMS2:ENST00000441476:synonymous:LOW:exon4/12:c.462C>G:p.Ser154Ser,PMS2:ENST00000382321:synonymous:LOW:exon7/11:c.780C>G:p.Ser260Ser,PMS2:ENST00000406569:synonymous:LOW:exon7/12:c.780C>G:p.Ser260Ser,PMS2:ENST00000469652:intron:MODIFIER:exon2/2:n.62+8644C>G:		rs1805319	0.8313	0.8109	39906/22309/3695	0.7970							600259 [PMS2 (confirmed) Mismatch repair cancer syndrome,276300|Colorectal cancer,hereditary nonpolyposis,type 4,614337];	RCV000162392.1 [benign]; RCV000030372.4 [benign]; RCV000079112.6 [benign]; RCV000131484.2 [benign]; RCV000229294.1 [likely benign]; 		COSM4162330	2407	1044	1	[1] Ilnaz Sepahi 29-03-2016 batch import			PMS2 (inh=AR+AD pLI=0.00)
chr7	6037057	6037057	-	A	het		QUAL=192;DP=28;AF=0.46;MQM=60	PMS2	splice_region&intron,intron	PMS2:ENST00000265849:splice_region&intron:LOW:exon6/14:c.706-4dupT:,PMS2:ENST00000441476:splice_region&intron:LOW:exon3/11:c.388-4dupT:,PMS2:ENST00000382321:splice_region&intron:LOW:exon6/10:c.706-4dupT:,PMS2:ENST00000406569:splice_region&intron:LOW:exon6/11:c.706-4dupT:,PMS2:ENST00000469652:intron:MODIFIER:exon2/2:n.62+8566dupT:		rs570998668;rs61373265;rs774538869	0.0264	0.0393	0/0/0	0.0302							600259 [PMS2 (confirmed) Mismatch repair cancer syndrome,276300|Colorectal cancer,hereditary nonpolyposis,type 4,614337];	RCV000179768.1 [benign]; RCV000202996.1 [benign]; RCV000409009.1 [uncertain significance]; 		COSM1735804	4	246					PMS2 (inh=AR+AD pLI=0.00)
chr7	128843169	128843169	C	T	hom	off-target;low_DP	QUAL=315;DP=12;AF=1.00;MQM=60	SMO	intron	SMO:ENST00000249373:intron:MODIFIER:exon1/11:c.332-56C>T:		rs2566871	0.4615	0.0000	0/0/0	0.4787							601500 [SMO (provisional) Basal cell carcinoma,somatic,605462|Curry-Jones syndrome,somatic mosaic,601707];				263	487					SMO (inh=n/a pLI=0.06)
chr7	128845018	128845018	C	T	hom	off-target	QUAL=6716;DP=206;AF=1.00;MQM=60	SMO	intron	SMO:ENST00000249373:intron:MODIFIER:exon2/11:c.538-26C>T:		rs2703091	0.7524	0.7960	38561/23420/2469	0.7884							601500 [SMO (provisional) Basal cell carcinoma,somatic,605462|Curry-Jones syndrome,somatic mosaic,601707];				813	307					SMO (inh=n/a pLI=0.06)
chr7	128845277	128845277	G	C	hom	off-target	QUAL=1590;DP=55;AF=1.00;MQM=60	SMO	intron	SMO:ENST00000249373:intron:MODIFIER:exon3/11:c.747+24G>C:		rs2075777	0.7520	0.8012	30520/18440/1802	0.7500							601500 [SMO (provisional) Basal cell carcinoma,somatic,605462|Curry-Jones syndrome,somatic mosaic,601707];				727	282					SMO (inh=n/a pLI=0.06)
chr7	128846328	128846328	G	C	hom		QUAL=28469;DP=909;AF=1.00;MQM=60	SMO	synonymous,non_coding_transcript_exon	SMO:ENST00000249373:synonymous:LOW:exon6/12:c.1164G>C:p.Gly388Gly,SMO:ENST00000462420:synonymous:LOW:exon3/6:c.246G>C:p.Gly82Gly,SMO:ENST00000495998:non_coding_transcript_exon:MODIFIER:exon2/3:n.109G>C:		rs2228617	0.7562	0.7975	38862/23503/2520	0.7922							601500 [SMO (provisional) Basal cell carcinoma,somatic,605462|Curry-Jones syndrome,somatic mosaic,601707];			COSM4004294	1944	626					SMO (inh=n/a pLI=0.06)
chr7	128846469	128846469	A	G	hom	off-target	QUAL=27652;DP=857;AF=1.00;MQM=60	SMO	intron	SMO:ENST00000249373:intron:MODIFIER:exon6/11:c.1264+41A>G:,SMO:ENST00000462420:intron:MODIFIER:exon3/5:c.346+41A>G:,SMO:ENST00000495998:intron:MODIFIER:exon2/2:n.209+41A>G:		rs2735842	0.7532	0.7971	38446/23377/2515	0.7832							601500 [SMO (provisional) Basal cell carcinoma,somatic,605462|Curry-Jones syndrome,somatic mosaic,601707];				704	279					SMO (inh=n/a pLI=0.06)
chr7	142460261	142460261	T	A	hom	off-target	QUAL=2051;DP=69;AF=1.00;MQM=60	PRSS1	intron	PRSS1:ENST00000486171:intron:MODIFIER:exon4/5:c.497-21T>A:,PRSS1:ENST00000311737:intron:MODIFIER:exon3/4:c.455-21T>A:,PRSS1:ENST00000492062:intron:MODIFIER:exon2/3:c.305-21T>A:,PRSS1:ENST00000463701:intron:MODIFIER:exon1/2:n.919-21T>A:		rs201825825	0.9980	0.5815	9485/5327/520	0.0863							276000 [PRSS1 (confirmed) Pancreatitis,hereditary,167800|Trypsinogen deficiency,614044];				62	963					PRSS1 (inh=AR+AD pLI=0.00)
chr7	142460313	142460313	T	C	hom		QUAL=4965;DP=165;AF=1.00;MQM=60	PRSS1	synonymous,non_coding_transcript_exon	PRSS1:ENST00000486171:synonymous:LOW:exon5/6:c.528T>C:p.Asp176Asp,PRSS1:ENST00000311737:synonymous:LOW:exon4/5:c.486T>C:p.Asp162Asp,PRSS1:ENST00000492062:synonymous:LOW:exon3/4:c.336T>C:p.Asp112Asp,PRSS1:ENST00000463701:non_coding_transcript_exon:MODIFIER:exon2/3:n.950T>C:		rs6666	0.3966	0.3693	0/0/0	0.0368							276000 [PRSS1 (confirmed) Pancreatitis,hereditary,167800|Trypsinogen deficiency,614044];	RCV000231064.1 [likely benign]; RCV000244488.1 [benign]; 	CM086253 [CLASS=DP MUT=REF PHEN="Pancreatitis chronic association with" GENE=PRSS1]; 	COSM4161889	348	2070	1	[1] Ilnaz Sepahi 29-03-2016 batch import			PRSS1 (inh=AR+AD pLI=0.00)
chr7	142460865	142460865	T	C	hom		QUAL=10142;DP=357;AF=1.00;MQM=60	PRSS1	synonymous,3'UTR,non_coding_transcript_exon	PRSS1:ENST00000486171:synonymous:LOW:exon6/6:c.780T>C:p.Asn260Asn,PRSS1:ENST00000311737:synonymous:LOW:exon5/5:c.738T>C:p.Asn246Asn,PRSS1:ENST00000492062:3'UTR:MODIFIER:exon4/4:c.*142T>C:,PRSS1:ENST00000463701:non_coding_transcript_exon:MODIFIER:exon3/3:n.1202T>C:		rs6667	0.3938	0.5041	16344/11218/985	0.4946							276000 [PRSS1 (confirmed) Pancreatitis,hereditary,167800|Trypsinogen deficiency,614044];	RCV000248971.1 [benign]; 			982	1482	1	[1] Ilnaz Sepahi 29-03-2016 batch import			PRSS1 (inh=AR+AD pLI=0.00)
chr8	90955624	90955624	T	A	het	off-target	QUAL=411;DP=31;AF=0.55;MQM=60	NBN	intron	NBN:ENST00000265433:intron:MODIFIER:exon13/15:c.2071-30A>T:,NBN:ENST00000396252:intron:MODIFIER:exon16/18:c.*1944-30A>T:,NBN:ENST00000409330:intron:MODIFIER:exon13/15:c.1825-30A>T:,NBN:ENST00000520325:intron:MODIFIER:exon1/1:n.487-30A>T:		rs3736639	0.3792	0.3535	7667/3557/535	0.3451							602667 [NBN (confirmed) Nijmegen breakage syndrome,251260|Aplastic anemia,609135|Leukemia,acute lymphoblastic,613065];	RCV000248307.1 [benign]; 			125	426					NBN (inh=AR pLI=0.00)
chr8	90958422	90958422	T	C	het		QUAL=584;DP=47;AF=0.55;MQM=60	NBN	synonymous,3'UTR,non_coding_transcript_exon	NBN:ENST00000265433:synonymous:LOW:exon13/16:c.2016A>G:p.Pro672Pro,NBN:ENST00000409330:synonymous:LOW:exon13/16:c.1770A>G:p.Pro590Pro,NBN:ENST00000396252:3'UTR:MODIFIER:exon16/19:c.*1889A>G:,NBN:ENST00000520325:non_coding_transcript_exon:MODIFIER:exon1/2:n.432A>G:		rs1061302	0.3528	0.3451	7411/3552/277	0.3422							602667 [NBN (confirmed) Nijmegen breakage syndrome,251260|Aplastic anemia,609135|Leukemia,acute lymphoblastic,613065];	RCV000162357.1 [benign]; RCV000243757.1 [benign]; RCV000393183.1 [benign]; 		COSM3763441	402	1580	1	[1] Alexandra Doehring 27.08.2015			NBN (inh=AR pLI=0.00)
chr8	90958530	90958530	T	C	het		QUAL=377;DP=36;AF=0.44;MQM=60	NBN	splice_region&intron,non_coding_transcript_exon	NBN:ENST00000265433:splice_region&intron:LOW:exon12/15:c.1915-7A>G:,NBN:ENST00000396252:splice_region&intron:LOW:exon15/18:c.*1788-7A>G:,NBN:ENST00000409330:splice_region&intron:LOW:exon12/15:c.1669-7A>G:,NBN:ENST00000520325:non_coding_transcript_exon:MODIFIER:exon1/2:n.324A>G:		rs2308962	0.3790	0.3529	7684/3567/522	0.3497							602667 [NBN (confirmed) Nijmegen breakage syndrome,251260|Aplastic anemia,609135|Leukemia,acute lymphoblastic,613065];	RCV000251758.1 [benign]; RCV000363485.1 [benign]; 			403	1589	1	[1] Alexandra Doehring 27.08.2015			NBN (inh=AR pLI=0.00)
chr8	90967711	90967711	A	G	het		QUAL=349;DP=37;AF=0.43;MQM=60	NBN	synonymous,3'UTR	NBN:ENST00000265433:synonymous:LOW:exon10/16:c.1197T>C:p.Asp399Asp,NBN:ENST00000409330:synonymous:LOW:exon10/16:c.951T>C:p.Asp317Asp,NBN:ENST00000396252:3'UTR:MODIFIER:exon13/19:c.*1070T>C:		rs709816	0.6086	0.4676	14308/4457/3067	0.4608							602667 [NBN (confirmed) Nijmegen breakage syndrome,251260|Aplastic anemia,609135|Leukemia,acute lymphoblastic,613065];	RCV000162376.1 [benign]; RCV000173761.2 [benign]; RCV000322749.1 [benign]; 		COSM3763442	516	1662	1	[1] Alexandra Doehring 27.08.2015			NBN (inh=AR pLI=0.00)
chr8	90970935	90970935	G	A	het	off-target	QUAL=463;DP=48;AF=0.42;MQM=60	NBN	splice_region&intron	NBN:ENST00000265433:splice_region&intron:LOW:exon9/15:c.1124+18C>T:,NBN:ENST00000396252:splice_region&intron:LOW:exon12/18:c.*997+18C>T:,NBN:ENST00000409330:splice_region&intron:LOW:exon9/15:c.878+18C>T:		rs2234744	0.3530	0.3446	7405/3556/278	0.3420							602667 [NBN (confirmed) Nijmegen breakage syndrome,251260|Aplastic anemia,609135|Leukemia,acute lymphoblastic,613065];	RCV000180586.2 [benign]; 			193	751					NBN (inh=AR pLI=0.00)
chr8	90990479	90990479	C	G	het	pred_pathogenic	QUAL=10738;DP=828;AF=0.50;MQM=60	NBN	missense,3'UTR,intron	NBN:ENST00000265433:missense:MODERATE:exon5/16:c.553G>C:p.Glu185Gln,NBN:ENST00000409330:missense:MODERATE:exon5/16:c.307G>C:p.Glu103Gln,NBN:ENST00000517772:missense:MODERATE:exon3/5:c.307G>C:p.Glu103Gln,NBN:ENST00000396252:3'UTR:MODIFIER:exon8/19:c.*426G>C:,NBN:ENST00000519426:intron:MODIFIER:exon3/4:c.320+3124G>C:		rs1805794	0.3570	0.3453	7417/3546/292	0.3425	2.1330	T,T,T,T	T	B	T,T,T	6.33	602667 [NBN (confirmed) Nijmegen breakage syndrome,251260|Aplastic anemia,609135|Leukemia,acute lymphoblastic,613065];	RCV000121620.3 [benign]; RCV000162358.2 [benign]; RCV000374656.1 [benign]; 	CM034886 [CLASS=DP MUT=ALT PHEN="Lung cancer association with" GENE=NBN]; 	COSM3763443	398	1588	1	[1] Christopher Schroeder 27.04.2015			NBN (inh=AR pLI=0.00)
chr8	90995019	90995019	C	T	het	low_DP	QUAL=99;DP=19;AF=0.37;MQM=60	NBN	synonymous,5'UTR,non_coding_transcript_exon	NBN:ENST00000265433:synonymous:LOW:exon2/16:c.102G>A:p.Leu34Leu,NBN:ENST00000396252:synonymous:LOW:exon4/19:c.102G>A:p.Leu34Leu,NBN:ENST00000519426:synonymous:LOW:exon2/5:c.102G>A:p.Leu34Leu,NBN:ENST00000523444:synonymous:LOW:exon2/6:c.102G>A:p.Leu34Leu,NBN:ENST00000409330:5'UTR:MODIFIER:exon2/16:c.-145G>A:,NBN:ENST00000517337:5'UTR:MODIFIER:exon2/6:c.-195G>A:,NBN:ENST00000494804:non_coding_transcript_exon:MODIFIER:exon2/2:n.206G>A:		rs1063045	0.3792	0.3527	7704/3573/531	0.3497							602667 [NBN (confirmed) Nijmegen breakage syndrome,251260|Aplastic anemia,609135|Leukemia,acute lymphoblastic,613065];	RCV000162359.1 [benign]; RCV000242759.1 [benign]; RCV000387572.1 [benign]; 		COSM3763444	405	1568	1	[1] Alexandra Doehring 27.08.2015			NBN (inh=AR pLI=0.00)
chr8	107236280	107236280	G	T	hom		QUAL=20602;DP=650;AF=1.00;MQM=60	SLC16A14P1-RP11-778D12.2	intergenic_region	SLC16A14P1-RP11-778D12.2:ENSG00000213708-ENSG00000254021:intergenic_region:MODIFIER::n.107236280G>T:	LTR33	rs1393978	0.6096	0.0000	0/0/0	0.6664											400	385					SLC16A14P1-RP11-778D12.2 (inh=n/a pLI=n/a)
chr9	5921881	5921881	G	A	het	pred_pathogenic	QUAL=15214;DP=1060;AF=0.54;MQM=60	KIAA2026	missense,3'UTR	KIAA2026:ENST00000399933:missense:MODERATE:exon8/8:c.4115C>T:p.Thr1372Ile,KIAA2026:ENST00000381461:missense:MODERATE:exon7/7:c.4025C>T:p.Thr1342Ile,KIAA2026:ENST00000540714:3'UTR:MODIFIER:exon7/7:c.*1702C>T:		rs72697396	0.0002	0.0001	0/0/0	0.0001	1.9050	D,D	T	B		10.38					0	2					KIAA2026 (inh=n/a pLI=n/a)
chr9	17235643	17235643	T	-	het	off-target	QUAL=521;DP=40;AF=0.60;MQM=60	CNTLN	splice_region&intron	CNTLN:ENST00000380647:splice_region&intron:LOW:exon3/25:c.535-7delT:,CNTLN:ENST00000262360:splice_region&intron:LOW:exon3/25:c.535-7delT:,CNTLN:ENST00000425824:splice_region&intron:LOW:exon3/25:c.535-7delT:,CNTLN:ENST00000380641:splice_region&intron:LOW:exon3/6:c.535-7delT:		rs397708736	0.9133	0.8147	40766/18442/4471	0.7579											894	368					CNTLN (inh=n/a pLI=n/a)
chr9	17273878	17273878	A	G	het		QUAL=1145;DP=64;AF=0.72;MQM=60	CNTLN	splice_region&intron	CNTLN:ENST00000380647:splice_region&intron:LOW:exon6/25:c.983+14A>G:,CNTLN:ENST00000262360:splice_region&intron:LOW:exon6/25:c.987+10A>G:,CNTLN:ENST00000425824:splice_region&intron:LOW:exon6/25:c.987+10A>G:,CNTLN:ENST00000380641:splice_region&intron:LOW:exon6/6:c.983+14A>G:		rs12376938	0.2258	0.2539	4272/2504/149	0.2471											217	942					CNTLN (inh=n/a pLI=n/a)
chr9	17273926	17273926	C	G	het	off-target;low_DP	QUAL=173;DP=16;AF=0.50;MQM=60	CNTLN	intron	CNTLN:ENST00000380647:intron:MODIFIER:exon6/25:c.983+62C>G:,CNTLN:ENST00000262360:intron:MODIFIER:exon6/25:c.987+58C>G:,CNTLN:ENST00000425824:intron:MODIFIER:exon6/25:c.987+58C>G:,CNTLN:ENST00000380641:intron:MODIFIER:exon6/6:c.983+62C>G:		rs12379655	0.3343	0.0000	0/0/0	0.0559											103	397					CNTLN (inh=n/a pLI=n/a)
chr9	17342383	17342383	C	T	hom		QUAL=983;DP=30;AF=1.00;MQM=60	CNTLN	synonymous	CNTLN:ENST00000380647:synonymous:LOW:exon12/26:c.1827C>T:p.Asp609Asp,CNTLN:ENST00000262360:synonymous:LOW:exon12/26:c.1827C>T:p.Asp609Asp,CNTLN:ENST00000425824:synonymous:LOW:exon12/26:c.1827C>T:p.Asp609Asp		rs1442527	0.9495	0.9865	58803/33327/3518	0.9181											2526	8					CNTLN (inh=n/a pLI=n/a)
chr9	17394536	17394536	C	T	hom		QUAL=1783;DP=56;AF=1.00;MQM=60	CNTLN	missense	CNTLN:ENST00000380647:missense:MODERATE:exon15/26:c.2084C>T:p.Thr695Ile,CNTLN:ENST00000262360:missense:MODERATE:exon15/26:c.2084C>T:p.Thr695Ile,CNTLN:ENST00000425824:missense:MODERATE:exon15/26:c.2084C>T:p.Thr695Ile		rs7035276	0.7806	0.8284	39183/24109/2187	0.8011	0.3250	T,T,T	T	B,B,B	T,T,T	7.83					1833	597					CNTLN (inh=n/a pLI=n/a)
chr9	17394996	17394996	T	C	hom		QUAL=3142;DP=98;AF=1.00;MQM=60	CNTLN	synonymous	CNTLN:ENST00000380647:synonymous:LOW:exon15/26:c.2544T>C:p.His848His,CNTLN:ENST00000262360:synonymous:LOW:exon15/26:c.2544T>C:p.His848His,CNTLN:ENST00000425824:synonymous:LOW:exon15/26:c.2544T>C:p.His848His		rs3739489	0.8411	0.8799	46938/28083/2939	0.8623											2118	410					CNTLN (inh=n/a pLI=n/a)
chr9	17395108	17395108	C	T	hom	off-target	QUAL=6825;DP=215;AF=1.00;MQM=60	CNTLN	intron	CNTLN:ENST00000380647:intron:MODIFIER:exon15/25:c.2615+41C>T:,CNTLN:ENST00000262360:intron:MODIFIER:exon15/25:c.2615+41C>T:,CNTLN:ENST00000425824:intron:MODIFIER:exon15/25:c.2615+41C>T:		rs3739488	0.7819	0.8306	38889/24447/2325	0.8030											677	278					CNTLN (inh=n/a pLI=n/a)
chr9	17409366	17409366	G	A	hom		QUAL=12154;DP=384;AF=1.00;MQM=60	CNTLN	synonymous	CNTLN:ENST00000380647:synonymous:LOW:exon16/26:c.2691G>A:p.Thr897Thr,CNTLN:ENST00000262360:synonymous:LOW:exon16/26:c.2691G>A:p.Thr897Thr,CNTLN:ENST00000425824:synonymous:LOW:exon16/26:c.2691G>A:p.Thr897Thr		rs2780211	0.8389	0.8747	46375/27819/2946	0.8566										COSM3982792	2090	436					CNTLN (inh=n/a pLI=n/a)
chr9	17457513	17457513	A	-	hom	low_DP;anno_high_impact	QUAL=104;DP=4;AF=1.00;MQM=60	CNTLN	splice_acceptor	CNTLN:ENST00000380647:splice_acceptor:HIGH:exon18/25:c.3115-2delA:,CNTLN:ENST00000262360:splice_acceptor:HIGH:exon18/25:c.3115-2delA:,CNTLN:ENST00000425824:splice_acceptor:HIGH:exon18/25:c.3115-2delA:,CNTLN:ENST00000461247:splice_acceptor:HIGH:exon3/4:n.339-2delA:	(TATATT)n	rs35399020;rs397766990	0.7342	0.8450	40782/25898/1543	0.7481											1885	389	1	[1] auto-classification 16.06.2016  ahdoeha1 21.04.2016 Artefakt ssHC			CNTLN (inh=n/a pLI=n/a)
chr9	17494875	17494877	TTT	-	het	off-target	QUAL=317;DP=53;AF=0.28;MQM=60	CNTLN	splice_region&intron,intron	CNTLN:ENST00000262360:splice_region&intron:LOW:exon25/25:c.4120-11_4120-9delTTT:,CNTLN:ENST00000380647:intron:MODIFIER:exon25/25:c.4120-7655_4120-7653delTTT:,CNTLN:ENST00000425824:intron:MODIFIER:exon25/25:c.4120-7655_4120-7653delTTT:	Tigger3b:AluSx	rs776507555	0.0000	0.0003	0/0/0	0.0165											1	0					CNTLN (inh=n/a pLI=n/a)
chr9	17494875	17494875	T	-	het	off-target	QUAL=317;DP=53;AF=0.19;MQM=60	CNTLN	splice_region&intron,intron	CNTLN:ENST00000262360:splice_region&intron:LOW:exon25/25:c.4120-9delT:,CNTLN:ENST00000380647:intron:MODIFIER:exon25/25:c.4120-7653delT:,CNTLN:ENST00000425824:intron:MODIFIER:exon25/25:c.4120-7653delT:	Tigger3b:AluSx	rs35224903	0.0000	0.0003	0/0/0	0.0001											10	19					CNTLN (inh=n/a pLI=n/a)
chr9	35074917	35074917	T	C	hom		QUAL=3127;DP=99;AF=1.00;MQM=60	FANCG	splice_region&intron,intron,non_coding_transcript_exon	FANCG:ENST00000378643:splice_region&intron:LOW:exon12/13:c.1636+7A>G:,FANCG:ENST00000425676:splice_region&intron:LOW:exon11/12:c.*1112+7A>G:,FANCG:ENST00000476212:intron:MODIFIER:exon1/2:n.45-488A>G:,FANCG:ENST00000481254:non_coding_transcript_exon:MODIFIER:exon2/2:n.451A>G:		rs587118	0.2202	0.3957	11389/8269/33	0.3923							602956 [FANCG (confirmed) Fanconi anemia,complementation group G,614082];	RCV000247570.1 [benign]; RCV000275986.1 [benign]; RCV000367549.1 [benign]; RCV000394450.1 [benign]; 			787	1592	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCG (inh=n/a pLI=0.00)
chr9	35077441	35077441	T	C	hom	off-target	QUAL=6891;DP=209;AF=1.00;MQM=60	FANCG	intron	FANCG:ENST00000378643:intron:MODIFIER:exon4/13:c.511-45A>G:,FANCG:ENST00000425676:intron:MODIFIER:exon3/12:c.308-45A>G:,FANCG:ENST00000448890:intron:MODIFIER:exon5/5:c.511-45A>G:		rs554098	0.7015	0.7459	34313/20097/2882	0.7374							602956 [FANCG (confirmed) Fanconi anemia,complementation group G,614082];	RCV000252107.1 [benign]; 		COSN168536	700	392					FANCG (inh=n/a pLI=0.00)
chr9	90062823	90062823	A	G	hom		QUAL=14896;DP=528;AF=1.00;MQM=60	RP11-497K15.1-DAPK1	intergenic_region	RP11-497K15.1-DAPK1:ENSG00000228373-ENSG00000196730:intergenic_region:MODIFIER::n.90062823A>G:		rs12682834	0.6368	0.6466	23839/12412/915	0.6054											738	727					RP11-497K15.1-DAPK1 (inh=n/a pLI=n/a)
chr9	98209594	98209594	G	A	het	pred_pathogenic	QUAL=1180;DP=71;AF=0.66;MQM=60	PTCH1	missense,3'UTR,non_coding_transcript_exon	PTCH1:ENST00000331920:missense:MODERATE:exon23/24:c.3944C>T:p.Pro1315Leu,PTCH1:ENST00000418258:missense:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu,PTCH1:ENST00000421141:missense:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu,PTCH1:ENST00000437951:missense:MODERATE:exon23/24:c.3746C>T:p.Pro1249Leu,PTCH1:ENST00000430669:missense:MODERATE:exon23/23:c.3746C>T:p.Pro1249Leu,PTCH1:ENST00000429896:missense:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu,PTCH1:ENST00000375274:missense:MODERATE:exon23/24:c.3941C>T:p.Pro1314Leu,PTCH1:ENST00000375290:3'UTR:MODIFIER:exon20/21:c.*5789C>T:,PTCH1:ENST00000546744:non_coding_transcript_exon:MODIFIER:exon2/3:n.1008C>T:		rs357564	0.3968	0.3855	9126/3704/255	0.3700	9.4050	D,D,D,D,D,D,D,D	T	P,P,B	D,D,D,D,D,D,D	28.80	601309 [PTCH1 (confirmed) Basal cell nevus syndrome,109400|Basal cell carcinoma,somatic,605462|Holoprosencephaly 7,610828];	RCV000034575.1 [benign]; RCV000078463.7 [benign]; RCV000285014.1 [benign]; RCV000378947.1 [benign]; 	CM056376 [CLASS=DP MUT=REF PHEN="Skin cancer association with" GENE=PTCH1]; 	COSM1638395, COSM1638394, COSM1638396, COSM1638397	363	1445	1	[1] Ilnaz Sepahi 29-03-2016 batch import			PTCH1 (inh=AD pLI=1.00)
chr9	98232224	98232224	A	-	het		QUAL=263;DP=59;AF=0.54;MQM=60	PTCH1	splice_region&intron	PTCH1:ENST00000331920:splice_region&intron:LOW:exon12/23:c.1729-11delT:,PTCH1:ENST00000418258:splice_region&intron:LOW:exon12/23:c.1276-11delT:,PTCH1:ENST00000421141:splice_region&intron:LOW:exon12/23:c.1276-11delT:,PTCH1:ENST00000437951:splice_region&intron:LOW:exon12/23:c.1531-11delT:,PTCH1:ENST00000375290:splice_region&intron:LOW:exon10/20:c.*37-11delT:,PTCH1:ENST00000430669:splice_region&intron:LOW:exon12/22:c.1531-11delT:,PTCH1:ENST00000429896:splice_region&intron:LOW:exon12/23:c.1276-11delT:,PTCH1:ENST00000375274:splice_region&intron:LOW:exon12/23:c.1726-11delT:,PTCH1:ENST00000375271:splice_region&intron:LOW:exon6/7:c.724-11delT:		rs779000277	0.0000	0.0014	2/2/0	0.0012							601309 [PTCH1 (confirmed) Basal cell nevus syndrome,109400|Basal cell carcinoma,somatic,605462|Holoprosencephaly 7,610828];				0	14					PTCH1 (inh=AD pLI=1.00)
chr9	98239190	98239190	G	C	hom	off-target	QUAL=1285;DP=42;AF=1.00;MQM=60	PTCH1	intron	PTCH1:ENST00000331920:intron:MODIFIER:exon10/23:c.1504-51C>G:,PTCH1:ENST00000418258:intron:MODIFIER:exon10/23:c.1051-51C>G:,PTCH1:ENST00000421141:intron:MODIFIER:exon10/23:c.1051-51C>G:,PTCH1:ENST00000437951:intron:MODIFIER:exon10/23:c.1306-51C>G:,PTCH1:ENST00000375290:intron:MODIFIER:exon7/20:c.1141-51C>G:,PTCH1:ENST00000430669:intron:MODIFIER:exon10/22:c.1306-51C>G:,PTCH1:ENST00000429896:intron:MODIFIER:exon10/23:c.1051-51C>G:,PTCH1:ENST00000375274:intron:MODIFIER:exon10/23:c.1501-51C>G:,PTCH1:ENST00000375271:intron:MODIFIER:exon4/7:c.499-51C>G:		rs574688	0.1627	0.2302	2455/1639/15	0.2105							601309 [PTCH1 (confirmed) Basal cell nevus syndrome,109400|Basal cell carcinoma,somatic,605462|Holoprosencephaly 7,610828];				78	440					PTCH1 (inh=AD pLI=1.00)
chr10	43595968	43595968	A	G	hom		QUAL=16324;DP=535;AF=1.00;MQM=60	RET	synonymous,intron	RET:ENST00000355710:synonymous:LOW:exon2/20:c.135A>G:p.Ala45Ala,RET:ENST00000340058:synonymous:LOW:exon2/19:c.135A>G:p.Ala45Ala,RET:ENST00000498820:intron:MODIFIER:exon1/4:c.74-11579A>G:		rs1800858	0.7536	0.7365	33200/17899/4676	0.7262							164761 [RET (confirmed) Multiple endocrine neoplasia IIA,171400|Medullary thyroid carcinoma,155240|Multiple endocrine neoplasia IIB,162300|Central hypoventilation syndrome,congenital,209880|Pheochromocytoma,171300|Hirschsprung disease,susceptibility to,1,142623];	RCV000014967.2 [other]; RCV000127776.1 [benign]; RCV000205827.1 [benign]; RCV000216697.1 [not provided]; RCV000153833.3 [benign]; 	CM020759 [CLASS=DP MUT=REF PHEN="Hirschsprung disease association with" GENE=RET]; 	COSM4144677, COSM4144678	1820	1271	1	[1] old entry - no details available			RET (inh=AR+AD pLI=1.00)
chr10	43612226	43612226	C	T	het	off-target	QUAL=2409;DP=326;AF=0.45;MQM=60	RET	intron	RET:ENST00000355710:intron:MODIFIER:exon12/19:c.2284+47C>T:,RET:ENST00000340058:intron:MODIFIER:exon12/18:c.2284+47C>T:		rs760466	0.1206	0.2144	3184/2585/13	0.1982							164761 [RET (confirmed) Multiple endocrine neoplasia IIA,171400|Medullary thyroid carcinoma,155240|Multiple endocrine neoplasia IIB,162300|Central hypoventilation syndrome,congenital,209880|Pheochromocytoma,171300|Hirschsprung disease,susceptibility to,1,142623];	RCV000247832.1 [benign]; 			59	344					RET (inh=AR+AD pLI=1.00)
chr10	43613843	43613843	G	T	hom		QUAL=37745;DP=1158;AF=1.00;MQM=60	RET	synonymous	RET:ENST00000355710:synonymous:LOW:exon13/20:c.2307G>T:p.Leu769Leu,RET:ENST00000340058:synonymous:LOW:exon13/19:c.2307G>T:p.Leu769Leu		rs1800861	0.7125	0.7419	33769/19608/4074	0.7333							164761 [RET (confirmed) Multiple endocrine neoplasia IIA,171400|Medullary thyroid carcinoma,155240|Multiple endocrine neoplasia IIB,162300|Central hypoventilation syndrome,congenital,209880|Pheochromocytoma,171300|Hirschsprung disease,susceptibility to,1,142623];	RCV000021844.1 [benign]; RCV000127779.1 [benign]; RCV000154625.1 [benign]; RCV000203706.1 [benign]; RCV000153835.3 [benign]; 	CM014825 [CLASS=DP MUT=REF PHEN="Hirschsprung disease association with" GENE=RET]; 		1875	1238	1	[1] Ilnaz Sepahi 29-03-2016 batch import			RET (inh=AR+AD pLI=1.00)
chr10	43615505	43615505	G	A	het	off-target	QUAL=9231;DP=736;AF=0.51;MQM=60	RET	intron	RET:ENST00000355710:intron:MODIFIER:exon14/19:c.2608-24G>A:,RET:ENST00000340058:intron:MODIFIER:exon14/18:c.2608-24G>A:		rs2472737	0.1731	0.2127	2529/1606/104	0.2020							164761 [RET (confirmed) Multiple endocrine neoplasia IIA,171400|Medullary thyroid carcinoma,155240|Multiple endocrine neoplasia IIB,162300|Central hypoventilation syndrome,congenital,209880|Pheochromocytoma,171300|Hirschsprung disease,susceptibility to,1,142623];	RCV000021870.1 [benign]; RCV000082053.5 [benign]; 	CS116395 [CLASS=DP MUT=ALT PHEN="Hirschsprung disease association with" GENE=RET]; 		38	324					RET (inh=AR+AD pLI=1.00)
chr10	43622217	43622217	T	C	hom	off-target	QUAL=1163;DP=42;AF=1.00;MQM=60	RET	3'UTR,intron	RET:ENST00000340058:3'UTR:MODIFIER:exon19/19:c.*15T>C:,RET:ENST00000355710:intron:MODIFIER:exon19/19:c.3187+47T>C:		rs2075912	0.7550	0.8031	33460/19436/3910	0.7666							164761 [RET (confirmed) Multiple endocrine neoplasia IIA,171400|Medullary thyroid carcinoma,155240|Multiple endocrine neoplasia IIB,162300|Central hypoventilation syndrome,congenital,209880|Pheochromocytoma,171300|Hirschsprung disease,susceptibility to,1,142623];	RCV000151742.2 [benign]; 	CS032426 [CLASS=DP MUT=ALT PHEN="Hirschsprung disease association with" GENE=RET]; 		977	486					RET (inh=AR+AD pLI=1.00)
chr10	88635779	88635779	C	A	het	pred_pathogenic	QUAL=850;DP=71;AF=0.56;MQM=52	BMPR1A	missense,non_coding_transcript_exon	BMPR1A:ENST00000372037:missense:MODERATE:exon3/13:c.4C>A:p.Pro2Thr,BMPR1A:ENST00000480152:non_coding_transcript_exon:MODIFIER:exon3/4:n.302C>A:		rs11528010	0.4998	0.3558	9160/2415/2340	0.3486	3.7680	T,T	T	B	D	8.67	601299 [BMPR1A (confirmed) Polyposis,juvenile intestinal,174900|Polyposis syndrome,hereditary mixed,2,610069|Juvenile polyposis syndrome,infantile form,174900];	RCV000034703.1 [benign]; RCV000120253.2 [benign]; RCV000131909.2 [benign]; RCV000309392.1 [benign]; 		COSM3752019, COSM3752020	269	1211	1	[1] Ilnaz Sepahi 29-03-2016 batch import			BMPR1A (inh=AD pLI=0.77)
chr10	88649763	88649763	C	T	het	off-target	QUAL=672;DP=53;AF=0.49;MQM=60	BMPR1A	intron	BMPR1A:ENST00000372037:intron:MODIFIER:exon3/12:c.68-56C>T:,BMPR1A:ENST00000480152:intron:MODIFIER:exon3/3:n.366-56C>T:		rs7087358	0.5312	0.0000	0/0/0	0.0790							601299 [BMPR1A (confirmed) Polyposis,juvenile intestinal,174900|Polyposis syndrome,hereditary mixed,2,610069|Juvenile polyposis syndrome,infantile form,174900];				113	351					BMPR1A (inh=AD pLI=0.77)
chr10	88683122	88683122	T	C	het	off-target	QUAL=5568;DP=620;AF=0.45;MQM=60	BMPR1A	splice_region&intron	BMPR1A:ENST00000372037:splice_region&intron:LOW:exon11/12:c.1343-11T>C:		rs7074064	0.4966	0.3538	9075/2400/2368	0.3452							601299 [BMPR1A (confirmed) Polyposis,juvenile intestinal,174900|Polyposis syndrome,hereditary mixed,2,610069|Juvenile polyposis syndrome,infantile form,174900];	RCV000243319.1 [benign]; RCV000405260.1 [benign]; 			133	519					BMPR1A (inh=AD pLI=0.77)
chr10	89720907	89720907	T	G	het	off-target	QUAL=251;DP=29;AF=0.52;MQM=60	PTEN	intron,non_coding_transcript_exon	PTEN:ENST00000371953:intron:MODIFIER:exon8/8:c.1026+32T>G:,PTEN:ENST00000472832:non_coding_transcript_exon:MODIFIER:exon3/3:n.485T>G:		rs555895	0.4325	0.3699	8381/3687/1202	0.3478							601728 [PTEN (confirmed) Cowden syndrome 1,158350|Lhermitte-Duclos syndrome,158350|Bannayan-Riley-Ruvalcaba syndrome,153480|Meningioma,607174|Glioma susceptibility 2,613028|Macrocephaly/autism syndrome,605309|PTEN hamartoma tumor syndrome|VATER association with macrocephaly and ventriculomegaly,276950|Prostate cancer,somatic,176807|Malignant melanoma,somatic,155600|Endometrial carcinoma,somatic,608089|Squamous cell carcinoma,head and neck,somatic,275355];	RCV000078603.4 [benign]; 			114	408					PTEN (inh=AD pLI=0.98)
chr10	104264107	104264107	C	T	hom		QUAL=9942;DP=414;AF=1.00;MQM=60	SUFU	splice_region&intron	SUFU:ENST00000369902:splice_region&intron:LOW:exon1/11:c.182+16C>T:,SUFU:ENST00000369899:splice_region&intron:LOW:exon1/10:c.182+16C>T:,SUFU:ENST00000423559:splice_region&intron:LOW:exon1/9:c.182+16C>T:		rs2274351	0.3962	0.4857	14438/9985/516	0.4624							607035 [SUFU (confirmed) Medulloblastoma,desmoplastic,155255|Meningioma,familial,susceptibility to,607174|Basal cell nevus syndrome,109400];	RCV000243512.1 [benign]; 			557	840					SUFU (inh=AD pLI=1.00)
chr10	104356822	104356822	A	G	hom	off-target	QUAL=2286;DP=74;AF=1.00;MQM=60	SUFU	intron	SUFU:ENST00000369902:intron:MODIFIER:exon6/11:c.757-75A>G:,SUFU:ENST00000369899:intron:MODIFIER:exon6/10:c.757-75A>G:,SUFU:ENST00000423559:intron:MODIFIER:exon6/9:c.757-75A>G:,SUFU:ENST00000471000:intron:MODIFIER:exon4/5:n.539-75A>G:		rs10786690	0.9902	0.0000	0/0/0	0.1534							607035 [SUFU (confirmed) Medulloblastoma,desmoplastic,155255|Meningioma,familial,susceptibility to,607174|Basal cell nevus syndrome,109400];				318	1					SUFU (inh=AD pLI=1.00)
chr10	104387019	104387019	T	C	het		QUAL=14824;DP=1200;AF=0.49;MQM=60	SUFU	splice_region&intron	SUFU:ENST00000369902:splice_region&intron:LOW:exon11/11:c.1365+19T>C:		rs12414407	0.7196	0.6628	26892/13897/2970	0.6569							607035 [SUFU (confirmed) Medulloblastoma,desmoplastic,155255|Meningioma,familial,susceptibility to,607174|Basal cell nevus syndrome,109400];	RCV000251718.1 [benign]; 			857	788					SUFU (inh=AD pLI=1.00)
chr10	104389932	104389932	T	G	hom		QUAL=59615;DP=1897;AF=1.00;MQM=60	SUFU	3'UTR	SUFU:ENST00000369902:3'UTR:MODIFIER:exon12/12:c.*20T>G:		rs4917980	0.9974	0.9994	60625/33359/5139	0.9284							607035 [SUFU (confirmed) Medulloblastoma,desmoplastic,155255|Meningioma,familial,susceptibility to,607174|Basal cell nevus syndrome,109400];				1897	0					SUFU (inh=AD pLI=1.00)
chr11	13102890	13102890	C	A	het	off-target	QUAL=22536;DP=1762;AF=0.50;MQM=60	CTC-497E21.5	intron	CTC-497E21.5:ENST00000531136:intron:MODIFIER:exon1/1:n.48-26309G>T:		rs2727397	0.5050	0.0000	0/0/0	0.5410											97	130					CTC-497E21.5 (inh=n/a pLI=n/a)
chr11	13102924	13102924	G	A	het		QUAL=293;DP=26;AF=0.54;MQM=60	CTC-497E21.5	intron	CTC-497E21.5:ENST00000531136:intron:MODIFIER:exon1/1:n.48-26343C>T:		rs2583136	0.5052	0.0000	0/0/0	0.5376											289	408					CTC-497E21.5 (inh=n/a pLI=n/a)
chr11	64572018	64572018	T	C	hom	pred_pathogenic	QUAL=8209;DP=259;AF=1.00;MQM=60	MEN1	missense,non_coding_transcript_exon	MEN1:ENST00000337652:missense:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala,MEN1:ENST00000377316:missense:MODERATE:exon8/8:c.1456A>G:p.Thr486Ala,MEN1:ENST00000377321:missense:MODERATE:exon10/10:c.1516A>G:p.Thr506Ala,MEN1:ENST00000377326:missense:MODERATE:exon9/9:c.1621A>G:p.Thr541Ala,MEN1:ENST00000312049:missense:MODERATE:exon10/10:c.1621A>G:p.Thr541Ala,MEN1:ENST00000315422:missense:MODERATE:exon10/10:c.1621A>G:p.Thr541Ala,MEN1:ENST00000443283:missense:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala,MEN1:ENST00000394374:missense:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala,MEN1:ENST00000394376:missense:MODERATE:exon11/11:c.1636A>G:p.Thr546Ala,MEN1:ENST00000377313:missense:MODERATE:exon9/9:c.1636A>G:p.Thr546Ala,MEN1:ENST00000478548:non_coding_transcript_exon:MODIFIER:exon3/3:n.1170A>G:		rs2959656	0.8345	0.9378	54048/33008/2619	0.9289	0.1310	T,T,T,T,T,T,T,T,T,T	T	B,B,B	D,D,D,D,D,D,D,D,D,D	0.03	613733 [MEN1 (confirmed) Multiple endocrine neoplasia 1,131100|Carcinoid tumor of lung|Parathyroid adenoma,somatic|Lipoma,somatic|Angiofibroma,somatic|Adrenal adenoma,somatic];	RCV000034785.3 [benign]; RCV000082334.5 [benign]; RCV000204881.1 [benign]; RCV000210359.1 [uncertain significance]; RCV000121334.3 [benign]; 	CM085535 [CLASS=DFP MUT=REF PHEN="Impaired sensitisation to apoptosis" GENE=MEN1]; 	COSM255213	3086	44	1	[1] Ilnaz Sepahi 29-03-2016 batch import			MEN1 (inh=AD pLI=1.00)
chr11	64572557	64572557	A	G	hom		QUAL=6555;DP=204;AF=1.00;MQM=60	MEN1	synonymous,intron,non_coding_transcript_exon	MEN1:ENST00000337652:synonymous:LOW:exon9/10:c.1314T>C:p.His438His,MEN1:ENST00000377321:synonymous:LOW:exon9/10:c.1194T>C:p.His398His,MEN1:ENST00000377326:synonymous:LOW:exon8/9:c.1299T>C:p.His433His,MEN1:ENST00000312049:synonymous:LOW:exon9/10:c.1299T>C:p.His433His,MEN1:ENST00000315422:synonymous:LOW:exon9/10:c.1299T>C:p.His433His,MEN1:ENST00000443283:synonymous:LOW:exon9/10:c.1314T>C:p.His438His,MEN1:ENST00000394374:synonymous:LOW:exon9/10:c.1314T>C:p.His438His,MEN1:ENST00000394376:synonymous:LOW:exon10/11:c.1314T>C:p.His438His,MEN1:ENST00000377313:synonymous:LOW:exon8/9:c.1314T>C:p.His438His,MEN1:ENST00000377316:intron:MODIFIER:exon7/7:c.1186-269T>C:,MEN1:ENST00000478548:non_coding_transcript_exon:MODIFIER:exon2/3:n.848T>C:		rs540012	0.9760	0.9927	59759/33299/4389	0.9387							613733 [MEN1 (confirmed) Multiple endocrine neoplasia 1,131100|Carcinoid tumor of lung|Parathyroid adenoma,somatic|Lipoma,somatic|Angiofibroma,somatic|Adrenal adenoma,somatic];	RCV000205798.2 [benign]; RCV000153486.2 [benign]; 			3136	4	1	[1] Ilnaz Sepahi 29-03-2016 batch import			MEN1 (inh=AD pLI=1.00)
chr11	64577620	64577620	G	C	het	off-target	QUAL=269;DP=43;AF=0.49;MQM=60	MEN1	splice_region&intron,5'UTR	MEN1:ENST00000337652:splice_region&intron:LOW:exon1/9:c.-23-16C>G:,MEN1:ENST00000377321:splice_region&intron:LOW:exon1/9:c.-23-16C>G:,MEN1:ENST00000312049:splice_region&intron:LOW:exon1/9:c.-23-16C>G:,MEN1:ENST00000315422:splice_region&intron:LOW:exon1/9:c.-23-16C>G:,MEN1:ENST00000443283:splice_region&intron:LOW:exon1/9:c.-23-16C>G:,MEN1:ENST00000394374:splice_region&intron:LOW:exon1/9:c.-23-16C>G:,MEN1:ENST00000394376:splice_region&intron:LOW:exon2/10:c.-23-16C>G:,MEN1:ENST00000440873:splice_region&intron:LOW:exon1/6:c.-23-16C>G:,MEN1:ENST00000450708:splice_region&intron:LOW:exon1/5:c.-23-16C>G:,MEN1:ENST00000413626:splice_region&intron:LOW:exon1/3:c.-23-16C>G:,MEN1:ENST00000424912:splice_region&intron:LOW:exon2/2:c.-23-16C>G:,MEN1:ENST00000429702:splice_region&intron:LOW:exon1/1:c.-23-16C>G:,MEN1:ENST00000377316:5'UTR:MODIFIER:exon1/8:c.-39C>G:,MEN1:ENST00000377326:5'UTR:MODIFIER:exon1/9:c.-39C>G:		rs509606	0.1749	0.3084	333/73/6	0.0960							613733 [MEN1 (confirmed) Multiple endocrine neoplasia 1,131100|Carcinoid tumor of lung|Parathyroid adenoma,somatic|Lipoma,somatic|Angiofibroma,somatic|Adrenal adenoma,somatic];				17	214					MEN1 (inh=AD pLI=1.00)
chr11	108100105	108100105	-	TT	het	off-target	QUAL=406;DP=50;AF=0.20;MQM=60	ATM	intron	ATM:ENST00000278616:intron:MODIFIER:exon4/62:c.331+68_331+69dupTT:,ATM:ENST00000527805:intron:MODIFIER:exon4/26:c.331+68_331+69dupTT:,ATM:ENST00000527891:intron:MODIFIER:exon4/4:c.331+68_331+69dupTT:,ATM:ENST00000530958:intron:MODIFIER:exon3/3:n.4853+68_4853+69dupTT:,ATM:ENST00000452508:intron:MODIFIER:exon5/63:c.331+68_331+69dupTT:,ATM:ENST00000601453:intron:MODIFIER:exon5/5:c.331+68_331+69dupTT:		rs11390378	0.0000	0.1206	5/4/0	0.0430							607585 [ATM (confirmed) Ataxia-telangiectasia,208900|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to,114480|Lymphoma,mantle cell,somatic|T-cell prolymphocytic leukemia,somatic];				2	112					ATM (inh=AR+AD pLI=0.00)
chr11	108100105	108100105	-	T	het	off-target	QUAL=406;DP=50;AF=0.44;MQM=60	ATM	intron	ATM:ENST00000278616:intron:MODIFIER:exon4/62:c.331+69dupT:,ATM:ENST00000527805:intron:MODIFIER:exon4/26:c.331+69dupT:,ATM:ENST00000527891:intron:MODIFIER:exon4/4:c.331+69dupT:,ATM:ENST00000530958:intron:MODIFIER:exon3/3:n.4853+69dupT:,ATM:ENST00000452508:intron:MODIFIER:exon5/63:c.331+69dupT:,ATM:ENST00000601453:intron:MODIFIER:exon5/5:c.331+69dupT:		rs11390378;rs397713128	0.4848	0.4396	391/165/25	0.2464							607585 [ATM (confirmed) Ataxia-telangiectasia,208900|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to,114480|Lymphoma,mantle cell,somatic|T-cell prolymphocytic leukemia,somatic];				185	368					ATM (inh=AR+AD pLI=0.00)
chr11	108119616	108119616	A	-	het	off-target;low_QUAL	QUAL=11;DP=36;AF=0.14;MQM=60	ATM	intron	ATM:ENST00000278616:intron:MODIFIER:exon8/62:c.1066-31delA:,ATM:ENST00000527805:intron:MODIFIER:exon8/26:c.1066-31delA:,ATM:ENST00000452508:intron:MODIFIER:exon9/63:c.1066-31delA:	AluSp	rs35813860	0.0000	0.3608	0/0/0	0.0744							607585 [ATM (confirmed) Ataxia-telangiectasia,208900|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to,114480|Lymphoma,mantle cell,somatic|T-cell prolymphocytic leukemia,somatic];				4	200					ATM (inh=AR+AD pLI=0.00)
chr11	108129657	108129657	A	G	het	off-target;low_DP	QUAL=38;DP=16;AF=0.25;MQM=60	ATM	intron	ATM:ENST00000278616:intron:MODIFIER:exon15/62:c.2377-56A>G:,ATM:ENST00000527805:intron:MODIFIER:exon15/26:c.2377-56A>G:,ATM:ENST00000452508:intron:MODIFIER:exon16/63:c.2377-56A>G:		rs672655	0.4764	0.0000	0/0/0	0.1079							607585 [ATM (confirmed) Ataxia-telangiectasia,208900|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to,114480|Lymphoma,mantle cell,somatic|T-cell prolymphocytic leukemia,somatic];				479	582					ATM (inh=AR+AD pLI=0.00)
chr11	108141956	108141956	T	-	het	off-target	QUAL=426;DP=192;AF=0.22;MQM=60	ATM	splice_region&intron	ATM:ENST00000278616:splice_region&intron:LOW:exon19/62:c.2922-8delT:,ATM:ENST00000527805:splice_region&intron:LOW:exon19/26:c.2922-8delT:,ATM:ENST00000452508:splice_region&intron:LOW:exon20/63:c.2922-8delT:,ATM:ENST00000419286:splice_region&intron:LOW:exon2/2:n.204-8delT:		rs373881770	0.0000	0.4363	1/0/0	0.0023							607585 [ATM (confirmed) Ataxia-telangiectasia,208900|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to,114480|Lymphoma,mantle cell,somatic|T-cell prolymphocytic leukemia,somatic];				0	1085					ATM (inh=AR+AD pLI=0.00)
chr11	108150208	108150208	T	-	het		QUAL=889;DP=98;AF=0.39;MQM=60	ATM	splice_region&intron	ATM:ENST00000278616:splice_region&intron:LOW:exon22/62:c.3285-9delT:,ATM:ENST00000527805:splice_region&intron:LOW:exon22/26:c.3285-9delT:,ATM:ENST00000452508:splice_region&intron:LOW:exon23/63:c.3285-9delT:	(TTTG)n	rs1799757;rs397779715	0.0675	0.1845	730/488/5	0.0989							607585 [ATM (confirmed) Ataxia-telangiectasia,208900|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to,114480|Lymphoma,mantle cell,somatic|T-cell prolymphocytic leukemia,somatic];	RCV000159613.2 [benign]; RCV000246334.1 [benign]; RCV000282415.1,RCV000159613.2 [likely benign,benign]; RCV000246334.1 [benign]; RCV000282415.1 [likely benign]; 			62	650					ATM (inh=AR+AD pLI=0.00)
chr11	108151707	108151707	-	A	het	off-target	QUAL=1080;DP=77;AF=0.55;MQM=60	ATM	splice_region&intron	ATM:ENST00000278616:splice_region&intron:LOW:exon23/62:c.3403-13dupA:,ATM:ENST00000527805:splice_region&intron:LOW:exon23/26:c.3403-13dupA:,ATM:ENST00000452508:splice_region&intron:LOW:exon24/63:c.3403-13dupA:		rs3218681;rs587781368	0.5421	0.5675	18905/10528/1022	0.4947							607585 [ATM (confirmed) Ataxia-telangiectasia,208900|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to,114480|Lymphoma,mantle cell,somatic|T-cell prolymphocytic leukemia,somatic];	RCV000224503.1 [benign]; RCV000159614.2 [benign]; RCV000192572.2 [other]; RCV000286085.1,RCV000159614.2 [benign,benign]; RCV000192572.2 [other]; RCV000286085.1,RCV000159614.2 [benign,benign]; RCV000192572.2 [other]; RCV000286085.1 [benign]; 			1104	1353					ATM (inh=AR+AD pLI=0.00)
chr11	108175394	108175394	T	C	het	low_DP	QUAL=161;DP=14;AF=0.57;MQM=60	ATM	splice_region&intron	ATM:ENST00000278616:splice_region&intron:LOW:exon36/62:c.5497-8T>C:,ATM:ENST00000452508:splice_region&intron:LOW:exon37/63:c.5497-8T>C:,ATM:ENST00000524792:splice_region&intron:LOW:exon10/36:n.1712-8T>C:,ATM:ENST00000533690:splice_region&intron:LOW:exon4/21:n.901-8T>C:,ATM:ENST00000529588:splice_region&intron:LOW:exon1/4:c.7-8T>C:		rs3092829	0.0132	0.0230	38/34/0	0.0228							607585 [ATM (confirmed) Ataxia-telangiectasia,208900|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to,114480|Lymphoma,mantle cell,somatic|T-cell prolymphocytic leukemia,somatic];	RCV000119146.2 [benign]; RCV000128919.2 [benign]; RCV000246719.1 [benign]; 			8	326	1	[1] Ilnaz Sepahi 29-03-2016 batch import			ATM (inh=AR+AD pLI=0.00)
chr11	108175462	108175462	G	A	het	pred_pathogenic	QUAL=388;DP=30;AF=0.53;MQM=60	ATM	missense,non_coding_transcript_exon	ATM:ENST00000278616:missense:MODERATE:exon37/63:c.5557G>A:p.Asp1853Asn,ATM:ENST00000452508:missense:MODERATE:exon38/64:c.5557G>A:p.Asp1853Asn,ATM:ENST00000529588:missense:MODERATE:exon2/5:c.67G>A:p.Asp23Asn,ATM:ENST00000524792:non_coding_transcript_exon:MODIFIER:exon11/37:n.1772G>A:,ATM:ENST00000533690:non_coding_transcript_exon:MODIFIER:exon5/22:n.961G>A:		rs1801516	0.0669	0.1101	953/666/5	0.1094	6.3420	T,T	T	B	T,T	23.20	607585 [ATM (confirmed) Ataxia-telangiectasia,208900|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to,114480|Lymphoma,mantle cell,somatic|T-cell prolymphocytic leukemia,somatic];	RCV000116427.5 [other]; RCV000131720.3 [benign]; RCV000316554.1 [likely benign]; 	CM077896 [CLASS=DP MUT=ALT PHEN="Breast cancer bilateral association with" GENE=ATM]; 	COSM41596, COSM3736031	106	1078	2	[2] Christopher Schroeder 27.04.2015			ATM (inh=AR+AD pLI=0.00)
chr11	108183167	108183167	A	G	hom		QUAL=14178;DP=445;AF=1.00;MQM=60	ATM,C11orf65	missense,3'UTR,intron,non_coding_transcript_exon	ATM:ENST00000278616:missense:MODERATE:exon40/63:c.5948A>G:p.Asn1983Ser,ATM:ENST00000452508:missense:MODERATE:exon41/64:c.5948A>G:p.Asn1983Ser,ATM:ENST00000529588:3'UTR:MODIFIER:exon4/5:c.*139A>G:,C11orf65:ENST00000525729:intron:MODIFIER:exon6/6:c.641-3369T>C:,ATM:ENST00000524792:non_coding_transcript_exon:MODIFIER:exon14/37:n.2163A>G:,ATM:ENST00000533690:non_coding_transcript_exon:MODIFIER:exon8/22:n.1352A>G:,ATM:ENST00000532765:non_coding_transcript_exon:MODIFIER:exon3/6:n.265A>G:		rs659243	1.0000	1.0000	60654/33353/5170	0.9355	-1.0580	T,T	T	B,B	T,T	0.01	607585 [ATM (confirmed) Ataxia-telangiectasia,208900|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to,114480|Lymphoma,mantle cell,somatic|T-cell prolymphocytic leukemia,somatic];	RCV000128947.1 [benign]; RCV000120149.2 [benign]; 			4923	0	1	[3] Ilnaz Sepahi 29-03-2016 batch import [1] ahdoeha1 31.03.2016: GC-HBOC class 1 [n/a] harmuth 02.09.2016; observed base G is the wildtype base (hg38) which means that we sequenced the wildtype 			ATM (inh=AR+AD pLI=0.00), C11orf65 (inh=n/a pLI=0.00)
chr11	108225483	108225483	C	T	het	off-target	QUAL=1990;DP=159;AF=0.48;MQM=60	ATM,C11orf65	intron	ATM:ENST00000278616:intron:MODIFIER:exon60/62:c.8787-55C>T:,ATM:ENST00000452508:intron:MODIFIER:exon61/63:c.8787-55C>T:,ATM:ENST00000524792:intron:MODIFIER:exon34/36:n.5002-55C>T:,C11orf65:ENST00000525729:intron:MODIFIER:exon6/6:c.640+31164G>A:,C11orf65:ENST00000527531:intron:MODIFIER:exon10/11:c.*1196+159G>A:,C11orf65:ENST00000524755:intron:MODIFIER:exon2/3:c.225-19464G>A:,C11orf65:ENST00000526725:intron:MODIFIER:exon2/2:n.272-14392G>A:,ATM:ENST00000525178:intron:MODIFIER:exon3/5:n.275-55C>T:,ATM:ENST00000527181:intron:MODIFIER:exon1/3:n.126-55C>T:		rs664982	0.5351	0.0000	0/0/0	0.1116							607585 [ATM (confirmed) Ataxia-telangiectasia,208900|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to,114480|Lymphoma,mantle cell,somatic|T-cell prolymphocytic leukemia,somatic];				430	518					ATM (inh=AR+AD pLI=0.00), C11orf65 (inh=n/a pLI=0.00)
chr11	108225661	108225661	A	G	het	off-target	QUAL=4410;DP=275;AF=0.58;MQM=60	C11orf65,ATM	3'UTR,intron	C11orf65:ENST00000527531:3'UTR:MODIFIER:exon10/12:c.*1177T>C:,ATM:ENST00000278616:intron:MODIFIER:exon61/62:c.8850+60A>G:,ATM:ENST00000452508:intron:MODIFIER:exon62/63:c.8850+60A>G:,ATM:ENST00000524792:intron:MODIFIER:exon35/36:n.5065+60A>G:,C11orf65:ENST00000525729:intron:MODIFIER:exon6/6:c.640+30986T>C:,C11orf65:ENST00000524755:intron:MODIFIER:exon2/3:c.225-19642T>C:,C11orf65:ENST00000526725:intron:MODIFIER:exon2/2:n.272-14570T>C:,ATM:ENST00000525178:intron:MODIFIER:exon4/5:n.338+60A>G:,ATM:ENST00000527181:intron:MODIFIER:exon2/3:n.189+60A>G:		rs664143	0.6282	0.0000	0/0/0	0.1168							607585 [ATM (confirmed) Ataxia-telangiectasia,208900|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to,114480|Lymphoma,mantle cell,somatic|T-cell prolymphocytic leukemia,somatic];				514	582					C11orf65 (inh=n/a pLI=0.00), ATM (inh=AR+AD pLI=0.00)
chr11	125497466	125497466	G	T	het	off-target	QUAL=1071;DP=108;AF=0.49;MQM=60	CHEK1	intron	CHEK1:ENST00000427383:intron:MODIFIER:exon2/11:c.337+738G>T:,CHEK1:ENST00000438015:intron:MODIFIER:exon2/12:c.66-36G>T:,CHEK1:ENST00000525396:intron:MODIFIER:exon2/4:c.66-36G>T:,CHEK1:ENST00000428830:intron:MODIFIER:exon2/13:c.66-36G>T:,CHEK1:ENST00000532449:intron:MODIFIER:exon2/11:n.121+738G>T:,CHEK1:ENST00000528761:intron:MODIFIER:exon2/7:n.120+738G>T:,CHEK1:ENST00000544373:intron:MODIFIER:exon2/11:c.66-36G>T:,CHEK1:ENST00000527013:intron:MODIFIER:exon2/5:c.66-36G>T:,CHEK1:ENST00000526937:intron:MODIFIER:exon2/5:c.66-36G>T:,CHEK1:ENST00000534685:intron:MODIFIER:exon3/5:c.66-36G>T:,CHEK1:ENST00000533778:intron:MODIFIER:exon2/2:c.66-36G>T:,CHEK1:ENST00000534070:intron:MODIFIER:exon2/12:c.66-36G>T:,CHEK1:ENST00000524737:intron:MODIFIER:exon1/12:c.66-36G>T:,CHEK1:ENST00000531607:intron:MODIFIER:exon1/4:n.74-36G>T:,CHEK1:ENST00000532669:intron:MODIFIER:exon1/5:c.52+751G>T:,CHEK1:ENST00000278916:intron:MODIFIER:exon1/10:c.66-36G>T:		rs491528	0.3530	0.3481	4414/2078/588	0.2884											129	482					CHEK1 (inh=n/a pLI=0.00)
chr11	125514573	125514573	G	A	het	off-target	QUAL=843;DP=107;AF=0.42;MQM=60	CHEK1	intron	CHEK1:ENST00000427383:intron:MODIFIER:exon10/11:c.1281+35G>A:,CHEK1:ENST00000438015:intron:MODIFIER:exon11/12:c.1233+35G>A:,CHEK1:ENST00000428830:intron:MODIFIER:exon11/13:c.1233+35G>A:,CHEK1:ENST00000532449:intron:MODIFIER:exon10/11:n.1065+35G>A:,CHEK1:ENST00000544373:intron:MODIFIER:exon11/11:c.1233+35G>A:,CHEK1:ENST00000534070:intron:MODIFIER:exon11/12:c.1233+35G>A:,CHEK1:ENST00000524737:intron:MODIFIER:exon10/12:c.1233+35G>A:,CHEK1:ENST00000278916:intron:MODIFIER:exon9/10:c.1101+410G>A:,CHEK1:ENST00000528276:intron:MODIFIER:exon3/4:n.1350+35G>A:,CHEK1:ENST00000498122:intron:MODIFIER:exon1/4:n.72+35G>A:		rs521102	0.4361	0.5059	15784/8765/412	0.4953											241	541					CHEK1 (inh=n/a pLI=0.00)
chr11	125525195	125525195	A	G	hom		QUAL=1962;DP=59;AF=1.00;MQM=60	CHEK1	missense,non_coding_transcript_exon	CHEK1:ENST00000427383:missense:MODERATE:exon12/12:c.1459A>G:p.Ile487Val,CHEK1:ENST00000438015:missense:MODERATE:exon13/13:c.1411A>G:p.Ile471Val,CHEK1:ENST00000428830:missense:MODERATE:exon13/14:c.1411A>G:p.Ile471Val,CHEK1:ENST00000544373:missense:MODERATE:exon12/12:c.1309A>G:p.Ile437Val,CHEK1:ENST00000534070:missense:MODERATE:exon13/13:c.1411A>G:p.Ile471Val,CHEK1:ENST00000524737:missense:MODERATE:exon12/13:c.1411A>G:p.Ile471Val,CHEK1:ENST00000278916:missense:MODERATE:exon11/11:c.1279A>G:p.Ile427Val,CHEK1:ENST00000532449:non_coding_transcript_exon:MODIFIER:exon12/12:n.1243A>G:,CHEK1:ENST00000528276:non_coding_transcript_exon:MODIFIER:exon5/5:n.1528A>G:,CHEK1:ENST00000498122:non_coding_transcript_exon:MODIFIER:exon3/5:n.250A>G:		rs506504	0.9858	0.9726	57363/30871/5146	0.9409	1.1780	T,T,T,T,T,T,T	T	B,B,B	T,T,T,T,T,T,T	0.83					2502	189	1	[1] Ilnaz Sepahi 29-03-2016 batch import			CHEK1 (inh=n/a pLI=0.00)
chr12	58144665	58144665	C	T	het	off-target	QUAL=1951;DP=162;AF=0.49;MQM=60	CDK4	intron,non_coding_transcript_exon	CDK4:ENST00000257904:intron:MODIFIER:exon4/7:c.522+41G>A:,CDK4:ENST00000312990:intron:MODIFIER:exon3/6:c.265-211G>A:,CDK4:ENST00000549606:intron:MODIFIER:exon1/3:c.-158+1293G>A:,CDK4:ENST00000540325:intron:MODIFIER:exon3/6:c.162+41G>A:,CDK4:ENST00000553237:intron:MODIFIER:exon3/6:c.*161+41G>A:,CDK4:ENST00000546489:intron:MODIFIER:exon3/6:c.300+41G>A:,CDK4:ENST00000551888:intron:MODIFIER:exon3/5:n.443-211G>A:,CDK4:ENST00000547281:intron:MODIFIER:exon4/6:c.300+41G>A:,CDK4:ENST00000550419:intron:MODIFIER:exon4/6:c.522+41G>A:,CDK4:ENST00000551800:intron:MODIFIER:exon4/4:c.300+41G>A:,CDK4:ENST00000552254:intron:MODIFIER:exon3/3:c.522+41G>A:,CDK4:ENST00000551706:non_coding_transcript_exon:MODIFIER:exon3/3:n.929G>A:		rs2069502	0.3367	0.3541	8775/3639/30	0.3459							123829 [CDK4 (confirmed) Melanoma,cutaneous malignant,3,609048];				107	451					CDK4 (inh=n/a pLI=0.93)
chr12	58145156	58145156	C	T	het	off-target	QUAL=5467;DP=417;AF=0.58;MQM=60	CDK4	intron,non_coding_transcript_exon	CDK4:ENST00000257904:intron:MODIFIER:exon2/7:c.219-31G>A:,CDK4:ENST00000312990:intron:MODIFIER:exon2/6:c.219-31G>A:,CDK4:ENST00000549606:intron:MODIFIER:exon1/3:c.-158+802G>A:,CDK4:ENST00000540325:intron:MODIFIER:exon2/6:c.-7+127G>A:,CDK4:ENST00000553237:intron:MODIFIER:exon2/6:c.218+127G>A:,CDK4:ENST00000546489:intron:MODIFIER:exon1/6:c.-4-31G>A:,CDK4:ENST00000551888:intron:MODIFIER:exon2/5:n.397-31G>A:,CDK4:ENST00000547281:intron:MODIFIER:exon2/6:c.-4-31G>A:,CDK4:ENST00000550419:intron:MODIFIER:exon2/6:c.219-31G>A:,CDK4:ENST00000551800:intron:MODIFIER:exon2/4:c.-4-31G>A:,CDK4:ENST00000552254:intron:MODIFIER:exon1/3:c.219-31G>A:,CDK4:ENST00000552388:intron:MODIFIER:exon2/3:c.219-31G>A:,CDK4:ENST00000552862:intron:MODIFIER:exon2/2:c.219-31G>A:,CDK4:ENST00000551706:non_coding_transcript_exon:MODIFIER:exon2/3:n.554G>A:		rs2270777	0.2480	0.3392	7925/6306/137	0.3383							123829 [CDK4 (confirmed) Melanoma,cutaneous malignant,3,609048];				182	466					CDK4 (inh=n/a pLI=0.93)
chr13	32890572	32890572	G	A	het	off-target	QUAL=1359;DP=118;AF=0.45;MQM=60	BRCA2	5'UTR	BRCA2:ENST00000380152:5'UTR:MODIFIER:exon2/27:c.-26G>A:,BRCA2:ENST00000544455:5'UTR:MODIFIER:exon2/28:c.-26G>A:,BRCA2:ENST00000530893:5'UTR:MODIFIER:exon2/10:c.-391G>A:		rs1799943	0.2093	0.2465	3755/2063/51	0.2438							600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555|Fanconi anemia,complementation group D1,605724|Prostate cancer,176807|Breast cancer,male,susceptibility to,114480|Wilms tumor,194070|Medulloblastoma,155255|Glioblastoma 3,613029|Pancreatic cancer 2,613347];	RCV000112977.3 [benign]; RCV000114981.1 [not provided]; RCV000246798.1 [benign]; RCV000312794.1 [benign]; RCV000397056.1 [benign]; RCV000112978.1 [benign]; RCV000112979.1 [benign]; 	CR068211 [CLASS=DFP MUT=ALT PHEN="Breast cancer sporadic protection against" GENE=BRCA2]; 		91	586					BRCA2 (inh=AR+AD pLI=0.00)
chr13	32903685	32903685	C	T	het	off-target	QUAL=606;DP=44;AF=0.55;MQM=60	BRCA2	intron	BRCA2:ENST00000380152:intron:MODIFIER:exon8/26:c.681+56C>T:,BRCA2:ENST00000544455:intron:MODIFIER:exon8/27:c.681+56C>T:,BRCA2:ENST00000530893:intron:MODIFIER:exon8/9:c.312+56C>T:		rs2126042	0.1859	0.0000	0/0/0	0.0343							600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555|Fanconi anemia,complementation group D1,605724|Prostate cancer,176807|Breast cancer,male,susceptibility to,114480|Wilms tumor,194070|Medulloblastoma,155255|Glioblastoma 3,613029|Pancreatic cancer 2,613347];	RCV000045058.2 [not provided]; RCV000114010.1 [uncertain significance]; RCV000114007.2 [benign]; 			35	404					BRCA2 (inh=AR+AD pLI=0.00)
chr13	32905219	32905219	-	T	het	off-target	QUAL=103;DP=107;AF=0.17;MQM=60	BRCA2	intron	BRCA2:ENST00000380152:intron:MODIFIER:exon9/26:c.793+64dupT:,BRCA2:ENST00000544455:intron:MODIFIER:exon9/27:c.793+64dupT:,BRCA2:ENST00000530893:intron:MODIFIER:exon9/9:c.424+64dupT:		rs760080447	0.0000	0.0825	0/0/0	0.0225							600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555|Fanconi anemia,complementation group D1,605724|Prostate cancer,176807|Breast cancer,male,susceptibility to,114480|Wilms tumor,194070|Medulloblastoma,155255|Glioblastoma 3,613029|Pancreatic cancer 2,613347];				0	1					BRCA2 (inh=AR+AD pLI=0.00)
chr13	32911888	32911888	A	G	het		QUAL=826;DP=75;AF=0.49;MQM=60	BRCA2	synonymous	BRCA2:ENST00000380152:synonymous:LOW:exon11/27:c.3396A>G:p.Lys1132Lys,BRCA2:ENST00000544455:synonymous:LOW:exon11/28:c.3396A>G:p.Lys1132Lys		rs1801406	0.2668	0.2945	5391/3115/273	0.2927							600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555|Fanconi anemia,complementation group D1,605724|Prostate cancer,176807|Breast cancer,male,susceptibility to,114480|Wilms tumor,194070|Medulloblastoma,155255|Glioblastoma 3,613029|Pancreatic cancer 2,613347];	RCV000113169.1 [benign]; RCV000113170.4 [benign]; RCV000114982.2 [benign]; RCV000130987.2 [benign]; RCV000152873.5 [benign]; RCV000337515.1 [benign]; RCV000375777.1 [benign]; 			343	1582	1	[1] Ulrike Faust 13.06.2015			BRCA2 (inh=AR+AD pLI=0.00)
chr13	32913055	32913055	A	G	hom		QUAL=32057;DP=994;AF=1.00;MQM=60	BRCA2	synonymous	BRCA2:ENST00000380152:synonymous:LOW:exon11/27:c.4563A>G:p.Leu1521Leu,BRCA2:ENST00000544455:synonymous:LOW:exon11/28:c.4563A>G:p.Leu1521Leu		rs206075	0.9740	0.9931	59672/33182/4417	0.9551							600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555|Fanconi anemia,complementation group D1,605724|Prostate cancer,176807|Breast cancer,male,susceptibility to,114480|Wilms tumor,194070|Medulloblastoma,155255|Glioblastoma 3,613029|Pancreatic cancer 2,613347];	RCV000113321.1 [benign]; RCV000160224.1 [benign]; RCV000164515.2 [likely benign]; RCV000198429.1 [likely benign]; RCV000412372.1 [likely benign]; RCV000119245.2 [benign]; RCV000132170.2 [benign]; RCV000152875.8 [benign]; RCV000257902.2 [benign]; RCV000340564.1 [benign]; 			3662	11	1	[1] Ulrike Faust 13.06.2015			BRCA2 (inh=AR+AD pLI=0.00)
chr13	32915005	32915005	G	C	hom		QUAL=857;DP=26;AF=1.00;MQM=60	BRCA2	synonymous	BRCA2:ENST00000380152:synonymous:LOW:exon11/27:c.6513G>C:p.Val2171Val,BRCA2:ENST00000544455:synonymous:LOW:exon11/28:c.6513G>C:p.Val2171Val		rs206076	0.9736	0.9930	59677/33272/4398	0.9628							600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555|Fanconi anemia,complementation group D1,605724|Prostate cancer,176807|Breast cancer,male,susceptibility to,114480|Wilms tumor,194070|Medulloblastoma,155255|Glioblastoma 3,613029|Pancreatic cancer 2,613347];	RCV000113602.1 [not provided]; RCV000119246.2 [benign]; RCV000152878.8 [benign]; RCV000162377.1 [benign]; RCV000257903.2 [benign]; RCV000261979.1 [benign]; RCV000163332.1 [likely benign]; RCV000168590.4 [other]; RCV000195987.2 [other]; 		COSM4147690, COSM4147689	3663	14	1	[1] old entry - no details available			BRCA2 (inh=AR+AD pLI=0.00)
chr13	32929232	32929232	A	G	het		QUAL=437;DP=38;AF=0.50;MQM=60	BRCA2	synonymous	BRCA2:ENST00000380152:synonymous:LOW:exon14/27:c.7242A>G:p.Ser2414Ser,BRCA2:ENST00000544455:synonymous:LOW:exon14/28:c.7242A>G:p.Ser2414Ser		rs1799955	0.2326	0.2244	3228/1556/231	0.2239							600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555|Fanconi anemia,complementation group D1,605724|Prostate cancer,176807|Breast cancer,male,susceptibility to,114480|Wilms tumor,194070|Medulloblastoma,155255|Glioblastoma 3,613029|Pancreatic cancer 2,613347];	RCV000113739.4 [benign]; RCV000123992.2 [benign]; RCV000130994.2 [benign]; RCV000152882.5 [benign]; RCV000336026.1 [benign]; RCV000394273.1 [benign]; 			168	1308	1	[1] Ulrike Faust 13.06.2015			BRCA2 (inh=AR+AD pLI=0.00)
chr13	32929387	32929387	T	C	hom	pred_pathogenic;anno_pathogenic_hgmd	QUAL=19363;DP=598;AF=1.00;MQM=60	BRCA2	missense	BRCA2:ENST00000380152:missense:MODERATE:exon14/27:c.7397T>C:p.Val2466Ala,BRCA2:ENST00000544455:missense:MODERATE:exon14/28:c.7397T>C:p.Val2466Ala		rs169547	0.9758	0.9937	59912/33304/4522	0.9638	2.3530	T,T	T		T,T	0.37	600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555|Fanconi anemia,complementation group D1,605724|Prostate cancer,176807|Breast cancer,male,susceptibility to,114480|Wilms tumor,194070|Medulloblastoma,155255|Glioblastoma 3,613029|Pancreatic cancer 2,613347];	RCV000045197.4 [benign]; RCV000113751.2 [benign]; RCV000168597.1 [benign]; RCV000203672.1 [benign]; RCV000120357.6 [benign]; RCV000207137.1 [uncertain significance]; 	CM960194 [CLASS=DM? MUT=REF PHEN="Breast cancer" GENE=BRCA2]; 		3670	11	2	[2] old entry - no details available			BRCA2 (inh=AR+AD pLI=0.00)
chr13	32936646	32936646	T	C	hom	off-target	QUAL=2098;DP=63;AF=1.00;MQM=60	BRCA2	splice_region&intron	BRCA2:ENST00000380152:splice_region&intron:LOW:exon16/26:c.7806-14T>C:,BRCA2:ENST00000544455:splice_region&intron:LOW:exon16/27:c.7806-14T>C:		rs9534262	0.5316	0.5208	16490/8840/1661	0.5132							600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555|Fanconi anemia,complementation group D1,605724|Prostate cancer,176807|Breast cancer,male,susceptibility to,114480|Wilms tumor,194070|Medulloblastoma,155255|Glioblastoma 3,613029|Pancreatic cancer 2,613347];	RCV000113823.3 [benign]; RCV000124004.2 [benign]; RCV000132168.2 [benign]; RCV000152883.5 [benign]; RCV000331967.1 [benign]; RCV000386451.1 [benign]; 	CS147979 [CLASS=FP MUT=ALT PHEN="Alternative splicing" GENE=BRCA2]; 		453	900	1	[1] Ulrike Faust 13.06.2015			BRCA2 (inh=AR+AD pLI=0.00)
chr13	79766188	79766188	A	G	het		QUAL=10953;DP=825;AF=0.52;MQM=60	BCAS2P3-RBM26	intergenic_region	BCAS2P3-RBM26:ENSG00000226670-ENSG00000139746:intergenic_region:MODIFIER::n.79766188A>G:		rs2988039	0.5066	0.3571	7871/1863/1908	0.3276											144	646					BCAS2P3-RBM26 (inh=n/a pLI=n/a)
chr14	45606387	45606387	A	G	het	pred_pathogenic	QUAL=593;DP=53;AF=0.47;MQM=60	FANCM	missense,non_coding_transcript_exon	FANCM:ENST00000267430:missense:MODERATE:exon2/23:c.624A>G:p.Ile208Met,FANCM:ENST00000556036:missense:MODERATE:exon2/11:c.624A>G:p.Ile208Met,FANCM:ENST00000542564:missense:MODERATE:exon2/22:c.624A>G:p.Ile208Met,FANCM:ENST00000554030:non_coding_transcript_exon:MODIFIER:exon2/2:n.142A>G:		rs45547534	0.0054	0.0107	9/6/0	0.0111	0.1250	D,D,D	T	D,D,P	T,T,T	24.00		RCV000230015.1 [benign]; 		COSM3753963	1	75	2	[2] Ilnaz Sepahi 12-10-2016 batch import			FANCM (inh=n/a pLI=0.00)
chr14	68290372	68290372	T	G	het	off-target	QUAL=6800;DP=523;AF=0.50;MQM=60	RAD51B	intron	RAD51B:ENST00000487861:intron:MODIFIER:exon2/10:c.84+28T>G:,RAD51B:ENST00000479335:intron:MODIFIER:exon2/11:c.84+28T>G:,RAD51B:ENST00000471583:intron:MODIFIER:exon2/10:c.84+28T>G:,RAD51B:ENST00000487270:intron:MODIFIER:exon2/10:c.84+28T>G:,RAD51B:ENST00000488612:intron:MODIFIER:exon2/11:c.84+28T>G:,RAD51B:ENST00000485181:intron:MODIFIER:exon2/4:c.84+28T>G:,RAD51B:ENST00000553334:intron:MODIFIER:exon1/2:c.84+28T>G:,RAD51B:ENST00000390683:intron:MODIFIER:exon1/9:c.84+28T>G:		rs17783124	0.2504	0.3030	5813/4121/633	0.2920											105	414					RAD51B (inh=n/a pLI=0.00)
chr14	68301767	68301767	-	A	het	off-target	QUAL=2995;DP=253;AF=0.49;MQM=60	RAD51B	intron	RAD51B:ENST00000487861:intron:MODIFIER:exon3/10:c.199-22dupA:,RAD51B:ENST00000479335:intron:MODIFIER:exon3/11:c.199-22dupA:,RAD51B:ENST00000471583:intron:MODIFIER:exon3/10:c.199-22dupA:,RAD51B:ENST00000487270:intron:MODIFIER:exon3/10:c.199-22dupA:,RAD51B:ENST00000488612:intron:MODIFIER:exon3/11:c.199-22dupA:,RAD51B:ENST00000485181:intron:MODIFIER:exon3/4:c.199-22dupA:,RAD51B:ENST00000553334:intron:MODIFIER:exon2/2:c.199-22dupA:,RAD51B:ENST00000390683:intron:MODIFIER:exon2/9:c.199-22dupA:		rs397897257;rs531055380	0.3195	0.3203	6502/4087/1269	0.2985											109	417					RAD51B (inh=n/a pLI=0.00)
chr14	68331675	68331675	A	T	hom	off-target	QUAL=12348;DP=535;AF=0.91;MQM=60	RAD51B	intron	RAD51B:ENST00000487861:intron:MODIFIER:exon4/10:c.316-45A>T:,RAD51B:ENST00000479335:intron:MODIFIER:exon5/11:c.*87-45A>T:,RAD51B:ENST00000471583:intron:MODIFIER:exon4/10:c.316-45A>T:,RAD51B:ENST00000487270:intron:MODIFIER:exon4/10:c.316-45A>T:,RAD51B:ENST00000488612:intron:MODIFIER:exon4/11:c.316-45A>T:,RAD51B:ENST00000485181:intron:MODIFIER:exon4/4:c.316-45A>T:,RAD51B:ENST00000390683:intron:MODIFIER:exon3/9:c.316-45A>T:,RAD51B:ENST00000553734:intron:MODIFIER:exon1/3:n.69-45A>T:,RAD51B:ENST00000555907:intron:MODIFIER:exon1/3:n.167-45A>T:		rs1474939	0.0000	0.9998	9038/3595/1015	0.3552											879	90					RAD51B (inh=n/a pLI=0.00)
chr14	68944344	68944344	T	-	het	off-target	QUAL=901;DP=397;AF=0.20;MQM=60	RAD51B	splice_region&intron,intron	RAD51B:ENST00000479335:splice_region&intron:LOW:exon11/11:c.*808-8delT:,RAD51B:ENST00000471583:splice_region&intron:LOW:exon10/10:c.1037-8delT:,RAD51B:ENST00000555782:splice_region&intron:LOW:exon1/1:n.88-8delT:,RAD51B:ENST00000487861:intron:MODIFIER:exon10/10:c.1036+9390delT:,RAD51B:ENST00000487270:intron:MODIFIER:exon10/10:c.1036+9390delT:,RAD51B:ENST00000488612:intron:MODIFIER:exon10/11:c.1036+9390delT:,RAD51B:ENST00000390683:intron:MODIFIER:exon9/9:c.1036+9390delT:,RAD51B:ENST00000553595:intron:MODIFIER:exon5/5:n.613+66113delT:,RAD51B:ENST00000497460:intron:MODIFIER:exon5/5:n.496+9390delT:,RAD51B:ENST00000554244:intron:MODIFIER:exon4/5:n.418+9390delT:,RAD51B:ENST00000478014:intron:MODIFIER:exon4/4:n.383+9390delT:,RAD51B:ENST00000460526:intron:MODIFIER:exon4/4:n.355+9390delT:,RAD51B:ENST00000469165:intron:MODIFIER:exon5/5:n.400+9041delT:,RAD51B:ENST00000557045:intron:MODIFIER:exon5/5:n.394+9390delT:,RAD51B:ENST00000554183:intron:MODIFIER:exon3/3:n.233+9390delT:	(T)n	rs567396898;rs768547850	0.2957	0.3406	2/0/2	0.1985											2	90					RAD51B (inh=n/a pLI=0.00)
chr14	104165753	104165753	G	A	het		QUAL=12801;DP=968;AF=0.51;MQM=60	XRCC3,KLC1	missense,intron,non_coding_transcript_exon	XRCC3:ENST00000352127:missense:MODERATE:exon7/9:c.722C>T:p.Thr241Met,XRCC3:ENST00000554913:missense:MODERATE:exon8/10:c.722C>T:p.Thr241Met,XRCC3:ENST00000553264:missense:MODERATE:exon6/8:c.722C>T:p.Thr241Met,XRCC3:ENST00000555055:missense:MODERATE:exon8/10:c.722C>T:p.Thr241Met,XRCC3:ENST00000445556:missense:MODERATE:exon7/9:c.722C>T:p.Thr241Met,XRCC3:ENST00000554974:missense:MODERATE:exon2/4:c.107C>T:p.Thr36Met,KLC1:ENST00000334553:intron:MODIFIER:exon15/16:c.1849-1239G>A:,KLC1:ENST00000348520:intron:MODIFIER:exon13/14:c.1651-1239G>A:,KLC1:ENST00000555836:intron:MODIFIER:exon15/16:c.1822-1239G>A:,KLC1:ENST00000557450:intron:MODIFIER:exon13/14:c.1624-1239G>A:,KLC1:ENST00000452929:intron:MODIFIER:exon14/15:c.1782-1239G>A:,KLC1:ENST00000554280:intron:MODIFIER:exon14/15:c.1755-1239G>A:,KLC1:ENST00000538504:intron:MODIFIER:exon1/2:n.406-1239G>A:,KLC1:ENST00000557686:intron:MODIFIER:exon2/3:c.*17-1239G>A:,XRCC3:ENST00000554811:non_coding_transcript_exon:MODIFIER:exon3/5:n.2169C>T:,XRCC3:ENST00000554774:non_coding_transcript_exon:MODIFIER:exon2/4:n.336C>T:		rs861539	0.2169	0.3075	5751/4513/219	0.2913	0.6420	T,T,T,T,T,T	T	B	T,T,T,T,T,T	10.54	600675 [XRCC3 (provisional) Melanoma,cutaneous malignant,6,613972|Breast cancer,susceptibility to,114480];	RCV000009500.2 [other]; 	CM003625 [CLASS=DFP MUT=ALT PHEN="Melanoma association with" GENE=XRCC3]; 	COSM1128325	435	1442	1	[1] old entry - no details available			XRCC3 (inh=n/a pLI=0.00), KLC1 (inh=n/a pLI=0.51)
chr14	105242966	105242966	T	C	het	off-target	QUAL=1980;DP=134;AF=0.61;MQM=60	AKT1	intron,non_coding_transcript_exon	AKT1:ENST00000349310:intron:MODIFIER:exon5/14:c.287+30A>G:,AKT1:ENST00000554581:intron:MODIFIER:exon3/12:c.287+30A>G:,AKT1:ENST00000407796:intron:MODIFIER:exon4/13:c.287+30A>G:,AKT1:ENST00000402615:intron:MODIFIER:exon4/13:c.287+30A>G:,AKT1:ENST00000555528:intron:MODIFIER:exon4/13:c.287+30A>G:,AKT1:ENST00000544168:intron:MODIFIER:exon2/11:c.101+30A>G:,AKT1:ENST00000554848:intron:MODIFIER:exon4/13:c.287+30A>G:,AKT1:ENST00000554826:intron:MODIFIER:exon1/4:n.36+30A>G:,AKT1:ENST00000555380:intron:MODIFIER:exon3/4:c.101+30A>G:,AKT1:ENST00000557552:non_coding_transcript_exon:MODIFIER:exon1/4:n.1943A>G:		rs2494735	0.5964	0.4648	13485/4174/2524	0.4407							164730 [AKT1 (confirmed) Breast cancer,somatic,114480|Colorectal cancer,somatic,114500|Ovarian cancer,somatic,167000|Schizophrenia,susceptibility to,181500|Proteus syndrome,somatic,176920|Cowden syndrome 6,615109];				196	534					AKT1 (inh=AD pLI=0.98)
chr14	105258892	105258892	C	T	hom	off-target	QUAL=3612;DP=111;AF=1.00;MQM=60	AKT1	intron	AKT1:ENST00000349310:intron:MODIFIER:exon3/14:c.46+43G>A:,AKT1:ENST00000554581:intron:MODIFIER:exon1/12:c.46+43G>A:,AKT1:ENST00000407796:intron:MODIFIER:exon2/13:c.46+43G>A:,AKT1:ENST00000402615:intron:MODIFIER:exon2/13:c.46+43G>A:,AKT1:ENST00000555528:intron:MODIFIER:exon2/13:c.46+43G>A:,AKT1:ENST00000554848:intron:MODIFIER:exon2/13:c.46+43G>A:,AKT1:ENST00000555926:intron:MODIFIER:exon3/4:c.46+43G>A:		rs2494748	0.3562	0.5107	16940/12430/349	0.4751							164730 [AKT1 (confirmed) Breast cancer,somatic,114480|Colorectal cancer,somatic,114500|Ovarian cancer,somatic,167000|Schizophrenia,susceptibility to,181500|Proteus syndrome,somatic,176920|Cowden syndrome 6,615109];				380	534					AKT1 (inh=AD pLI=0.98)
chr14	105258893	105258893	A	G	hom	off-target	QUAL=3612;DP=111;AF=1.00;MQM=60	AKT1	intron	AKT1:ENST00000349310:intron:MODIFIER:exon3/14:c.46+42T>C:,AKT1:ENST00000554581:intron:MODIFIER:exon1/12:c.46+42T>C:,AKT1:ENST00000407796:intron:MODIFIER:exon2/13:c.46+42T>C:,AKT1:ENST00000402615:intron:MODIFIER:exon2/13:c.46+42T>C:,AKT1:ENST00000555528:intron:MODIFIER:exon2/13:c.46+42T>C:,AKT1:ENST00000554848:intron:MODIFIER:exon2/13:c.46+42T>C:,AKT1:ENST00000555926:intron:MODIFIER:exon3/4:c.46+42T>C:		rs2494749	0.7093	0.8237	42310/27943/4018	0.7770							164730 [AKT1 (confirmed) Breast cancer,somatic,114480|Colorectal cancer,somatic,114500|Ovarian cancer,somatic,167000|Schizophrenia,susceptibility to,181500|Proteus syndrome,somatic,176920|Cowden syndrome 6,615109];				885	243					AKT1 (inh=AD pLI=0.98)
chr15	40998342	40998342	T	G	het	off-target	QUAL=1309;DP=99;AF=0.56;MQM=60	RAD51	intron	RAD51:ENST00000382643:intron:MODIFIER:exon4/9:c.347-2881T>G:,RAD51:ENST00000527860:intron:MODIFIER:exon3/5:c.226-33T>G:,RAD51:ENST00000423169:intron:MODIFIER:exon3/8:c.226-33T>G:,RAD51:ENST00000267868:intron:MODIFIER:exon3/9:c.226-33T>G:,RAD51:ENST00000557850:intron:MODIFIER:exon3/7:c.225+4943T>G:,RAD51:ENST00000532743:intron:MODIFIER:exon4/9:c.347-2881T>G:,RAD51:ENST00000525066:intron:MODIFIER:exon3/8:c.226-33T>G:,RAD51:ENST00000531277:intron:MODIFIER:exon2/5:c.226-2881T>G:,RAD51:ENST00000533741:intron:MODIFIER:exon2/4:c.191-33T>G:		rs45457497	0.3542	0.2652	6006/1024/329	0.2597							179617 [RAD51 (confirmed) Breast cancer,susceptibility to,114480|Mirror movements 2,614508|Fanconi anemia,complementation group R,617244];				32	288					RAD51 (inh=AD pLI=0.99)
chr15	43701947	43701947	A	-	het		QUAL=368;DP=58;AF=0.43;MQM=60	TP53BP1	splice_region&intron	TP53BP1:ENST00000382044:splice_region&intron:LOW:exon24/27:c.5306-8delT:,TP53BP1:ENST00000263801:splice_region&intron:LOW:exon24/27:c.5291-8delT:,TP53BP1:ENST00000476454:splice_region&intron:LOW:exon3/6:n.1425-8delT:,TP53BP1:ENST00000411772:splice_region&intron:LOW:exon14/17:c.*2602-8delT:,TP53BP1:ENST00000382039:splice_region&intron:LOW:exon23/26:c.5156-8delT:,TP53BP1:ENST00000450115:splice_region&intron:LOW:exon24/27:c.5300-8delT:,TP53BP1:ENST00000434595:splice_region&intron:LOW:exon2/3:c.263-8delT:		rs397711844;rs56813954	0.2502	0.3694	2441/1310/43	0.2272										COSM1608394	263	1089	1	[1] old entry - no details available			TP53BP1 (inh=n/a pLI=1.00)
chr15	43707808	43707808	A	T	het		QUAL=1611;DP=136;AF=0.46;MQM=60	TP53BP1	synonymous,3'UTR,non_coding_transcript_exon	TP53BP1:ENST00000382044:synonymous:LOW:exon23/28:c.5073T>A:p.Ser1691Ser,TP53BP1:ENST00000263801:synonymous:LOW:exon23/28:c.5058T>A:p.Ser1686Ser,TP53BP1:ENST00000382039:synonymous:LOW:exon22/27:c.4923T>A:p.Ser1641Ser,TP53BP1:ENST00000450115:synonymous:LOW:exon23/28:c.5073T>A:p.Ser1691Ser,TP53BP1:ENST00000434561:synonymous:LOW:exon3/5:c.462T>A:p.Ser154Ser,TP53BP1:ENST00000411772:3'UTR:MODIFIER:exon13/18:c.*2369T>A:,TP53BP1:ENST00000476454:non_coding_transcript_exon:MODIFIER:exon2/7:n.1192T>A:,TP53BP1:ENST00000572085:non_coding_transcript_exon:MODIFIER:exon23/23:n.5186T>A:		rs2230451	0.1286	0.1634	1830/1156/143	0.1616										COSM3754329	154	980	1	[1] Ilnaz Sepahi 29-03-2016 batch import			TP53BP1 (inh=n/a pLI=1.00)
chr15	43720156	43720156	A	-	het	off-target	QUAL=1195;DP=407;AF=0.17;MQM=60	TP53BP1	intron	TP53BP1:ENST00000382044:intron:MODIFIER:exon18/27:c.3828+58delT:,TP53BP1:ENST00000263801:intron:MODIFIER:exon18/27:c.3813+58delT:,TP53BP1:ENST00000411772:intron:MODIFIER:exon8/17:c.*1124+58delT:,TP53BP1:ENST00000382039:intron:MODIFIER:exon18/26:c.3828+58delT:,TP53BP1:ENST00000450115:intron:MODIFIER:exon18/27:c.3828+58delT:,TP53BP1:ENST00000572085:intron:MODIFIER:exon18/22:n.3941+58delT:,TP53BP1:ENST00000417342:intron:MODIFIER:exon2/3:c.*92+58delT:,TP53BP1:ENST00000467474:intron:MODIFIER:exon1/1:c.99+58delT:	AluJb	rs879219800	0.0000	0.0000	0/0/0	0.0009											4	195					TP53BP1 (inh=n/a pLI=1.00)
chr15	43720197	43720197	C	T	het	off-target	QUAL=4167;DP=354;AF=0.55;MQM=60	TP53BP1	splice_region&intron	TP53BP1:ENST00000382044:splice_region&intron:LOW:exon18/27:c.3828+17G>A:,TP53BP1:ENST00000263801:splice_region&intron:LOW:exon18/27:c.3813+17G>A:,TP53BP1:ENST00000411772:splice_region&intron:LOW:exon8/17:c.*1124+17G>A:,TP53BP1:ENST00000382039:splice_region&intron:LOW:exon18/26:c.3828+17G>A:,TP53BP1:ENST00000450115:splice_region&intron:LOW:exon18/27:c.3828+17G>A:,TP53BP1:ENST00000572085:splice_region&intron:LOW:exon18/22:n.3941+17G>A:,TP53BP1:ENST00000417342:splice_region&intron:LOW:exon2/3:c.*92+17G>A:,TP53BP1:ENST00000467474:splice_region&intron:LOW:exon1/1:c.99+17G>A:		rs550239	0.3804	0.2075	4173/527/2160	0.1992											24	329					TP53BP1 (inh=n/a pLI=1.00)
chr15	43724646	43724646	T	G	hom	pred_pathogenic	QUAL=20028;DP=634;AF=1.00;MQM=60	TP53BP1	missense,3'UTR,intron,non_coding_transcript_exon	TP53BP1:ENST00000382044:missense:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln,TP53BP1:ENST00000263801:missense:MODERATE:exon17/28:c.3406A>C:p.Lys1136Gln,TP53BP1:ENST00000382039:missense:MODERATE:exon17/27:c.3421A>C:p.Lys1141Gln,TP53BP1:ENST00000450115:missense:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln,TP53BP1:ENST00000411772:3'UTR:MODIFIER:exon7/18:c.*717A>C:,TP53BP1:ENST00000417342:intron:MODIFIER:exon1/3:c.84-4280A>C:,TP53BP1:ENST00000572085:non_coding_transcript_exon:MODIFIER:exon17/23:n.3534A>C:		rs2602141	0.5264	0.3750	10244/3163/3807	0.3694	3.2610	T,T,T,T	T	B,B,B,B	T,T,T,T	12.43			CM067476 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=TP53BP1]; 	COSM3754330	388	1312	1	[1] Ilnaz Sepahi 29-03-2016 batch import			TP53BP1 (inh=n/a pLI=1.00)
chr15	43730486	43730486	A	G	het	off-target	QUAL=11449;DP=895;AF=0.49;MQM=60	TP53BP1	intron	TP53BP1:ENST00000382044:intron:MODIFIER:exon16/27:c.3191+36T>C:,TP53BP1:ENST00000263801:intron:MODIFIER:exon16/27:c.3176+36T>C:,TP53BP1:ENST00000411772:intron:MODIFIER:exon6/17:c.*487+36T>C:,TP53BP1:ENST00000382039:intron:MODIFIER:exon16/26:c.3191+36T>C:,TP53BP1:ENST00000450115:intron:MODIFIER:exon16/27:c.3191+36T>C:,TP53BP1:ENST00000572085:intron:MODIFIER:exon16/22:n.3304+36T>C:,TP53BP1:ENST00000417342:intron:MODIFIER:exon1/3:c.83+36T>C:,TP53BP1:ENST00000413546:intron:MODIFIER:exon15/15:c.3071+36T>C:		rs16957730	0.1368	0.1665	1818/1126/187	0.1616											64	381					TP53BP1 (inh=n/a pLI=1.00)
chr15	43739686	43739686	-	A	het	low_QUAL	QUAL=7;DP=21;AF=0.24;MQM=60	TP53BP1	splice_region&intron,intron	TP53BP1:ENST00000382044:splice_region&intron:LOW:exon12/27:c.2717-4dupT:,TP53BP1:ENST00000263801:splice_region&intron:LOW:exon12/27:c.2702-4dupT:,TP53BP1:ENST00000411772:splice_region&intron:LOW:exon1/17:c.440-4dupT:,TP53BP1:ENST00000382039:splice_region&intron:LOW:exon12/26:c.2717-4dupT:,TP53BP1:ENST00000450115:splice_region&intron:LOW:exon12/27:c.2717-4dupT:,TP53BP1:ENST00000572085:splice_region&intron:LOW:exon12/22:n.2830-4dupT:,TP53BP1:ENST00000605155:splice_region&intron:LOW:exon1/3:n.288-4dupT:,TP53BP1:ENST00000414758:splice_region&intron:LOW:exon1/1:n.134-4dupT:,TP53BP1:ENST00000413546:intron:MODIFIER:exon12/15:c.2717-899dupT:,TP53BP1:ENST00000480860:intron:MODIFIER:exon1/1:n.262-5906dupT:		rs753702168	0.0000	0.1141	1/0/0	0.0850										COSM1735775	0	25					TP53BP1 (inh=n/a pLI=1.00)
chr15	43748304	43748304	A	G	hom		QUAL=30186;DP=958;AF=1.00;MQM=60	TP53BP1	synonymous,non_coding_transcript_exon	TP53BP1:ENST00000382044:synonymous:LOW:exon12/28:c.2502T>C:p.Asp834Asp,TP53BP1:ENST00000263801:synonymous:LOW:exon12/28:c.2487T>C:p.Asp829Asp,TP53BP1:ENST00000411772:synonymous:LOW:exon1/18:c.225T>C:p.Asp75Asp,TP53BP1:ENST00000382039:synonymous:LOW:exon12/27:c.2502T>C:p.Asp834Asp,TP53BP1:ENST00000450115:synonymous:LOW:exon12/28:c.2502T>C:p.Asp834Asp,TP53BP1:ENST00000413546:synonymous:LOW:exon12/16:c.2502T>C:p.Asp834Asp,TP53BP1:ENST00000572085:non_coding_transcript_exon:MODIFIER:exon12/23:n.2615T>C:,TP53BP1:ENST00000480860:non_coding_transcript_exon:MODIFIER:exon1/2:n.47T>C:,TP53BP1:ENST00000605155:non_coding_transcript_exon:MODIFIER:exon1/4:n.73T>C:		rs690367	0.5262	0.3739	10243/3157/3934	0.3685										COSM3754331	386	1308	1	[1] Ilnaz Sepahi 29-03-2016 batch import			TP53BP1 (inh=n/a pLI=1.00)
chr15	43762196	43762196	C	T	het	pred_pathogenic	QUAL=3267;DP=207;AF=0.57;MQM=60	TP53BP1	missense,non_coding_transcript_exon	TP53BP1:ENST00000382044:missense:MODERATE:exon11/28:c.1249G>A:p.Gly417Ser,TP53BP1:ENST00000263801:missense:MODERATE:exon11/28:c.1234G>A:p.Gly412Ser,TP53BP1:ENST00000382039:missense:MODERATE:exon11/27:c.1249G>A:p.Gly417Ser,TP53BP1:ENST00000450115:missense:MODERATE:exon11/28:c.1249G>A:p.Gly417Ser,TP53BP1:ENST00000413546:missense:MODERATE:exon11/16:c.1249G>A:p.Gly417Ser,TP53BP1:ENST00000572085:non_coding_transcript_exon:MODIFIER:exon11/23:n.1362G>A:		rs689647	0.3824	0.2064	4213/530/2154	0.2014	1.1390	D,D,D,D,T	T	B,B,B,B	T,T,T,T,T	15.65			CM107902 [CLASS=DP MUT=ALT PHEN="Basal cell carcinoma reduced risk association with" GENE=TP53BP1]; 	COSM3754332	58	674	1	[1] Ilnaz Sepahi 29-03-2016 batch import			TP53BP1 (inh=n/a pLI=1.00)
chr15	43767774	43767774	G	C	hom		QUAL=3605;DP=116;AF=1.00;MQM=60	TP53BP1	missense,non_coding_transcript_exon	TP53BP1:ENST00000382044:missense:MODERATE:exon9/28:c.1074C>G:p.Asp358Glu,TP53BP1:ENST00000263801:missense:MODERATE:exon9/28:c.1059C>G:p.Asp353Glu,TP53BP1:ENST00000382039:missense:MODERATE:exon9/27:c.1074C>G:p.Asp358Glu,TP53BP1:ENST00000450115:missense:MODERATE:exon9/28:c.1074C>G:p.Asp358Glu,TP53BP1:ENST00000413546:missense:MODERATE:exon9/16:c.1074C>G:p.Asp358Glu,TP53BP1:ENST00000572085:non_coding_transcript_exon:MODIFIER:exon9/23:n.1187C>G:		rs560191	0.5258	0.3737	10224/3146/3930	0.3679	0.2260	T,T,T,T,T	T	B,B,B,B	T,T,T,T,T	10.81			CM067475 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=TP53BP1]; 	COSM3744615	387	1307	1	[1] Ilnaz Sepahi 29-03-2016 batch import			TP53BP1 (inh=n/a pLI=1.00)
chr15	43773036	43773036	A	C	het	off-target	QUAL=10479;DP=864;AF=0.48;MQM=60	TP53BP1	intron	TP53BP1:ENST00000382044:intron:MODIFIER:exon5/27:c.499+57T>G:,TP53BP1:ENST00000263801:intron:MODIFIER:exon5/27:c.484+57T>G:,TP53BP1:ENST00000382039:intron:MODIFIER:exon5/26:c.499+57T>G:,TP53BP1:ENST00000450115:intron:MODIFIER:exon5/27:c.499+57T>G:,TP53BP1:ENST00000572085:intron:MODIFIER:exon5/22:n.612+57T>G:,TP53BP1:ENST00000413546:intron:MODIFIER:exon5/15:c.499+57T>G:		rs7173383	0.1368	0.0000	0/0/0	0.0330											56	305					TP53BP1 (inh=n/a pLI=1.00)
chr15	43784000	43784000	C	T	hom	off-target	QUAL=26780;DP=852;AF=1.00;MQM=60	TP53BP1	intron	TP53BP1:ENST00000382044:intron:MODIFIER:exon3/27:c.287-49G>A:,TP53BP1:ENST00000263801:intron:MODIFIER:exon3/27:c.272-49G>A:,TP53BP1:ENST00000382039:intron:MODIFIER:exon3/26:c.287-49G>A:,TP53BP1:ENST00000450115:intron:MODIFIER:exon3/27:c.287-49G>A:,TP53BP1:ENST00000572085:intron:MODIFIER:exon3/22:n.400-49G>A:,TP53BP1:ENST00000413546:intron:MODIFIER:exon3/15:c.287-49G>A:		rs555252	0.9515	0.9843	58805/33322/3976	0.9410											988	2					TP53BP1 (inh=n/a pLI=1.00)
chr15	75643615	75643615	-	T	hom	off-target	QUAL=337;DP=115;AF=0.21;MQM=60	NEIL1	splice_region&intron,intron	NEIL1:ENST00000568519:splice_region&intron:LOW:exon2/3:c.435-8dupT:,NEIL1:ENST00000355059:intron:MODIFIER:exon2/9:c.435-818dupT:,NEIL1:ENST00000561643:intron:MODIFIER:exon3/7:n.749-818dupT:,NEIL1:ENST00000567959:intron:MODIFIER:exon1/2:n.376-1031dupT:,NEIL1:ENST00000567657:intron:MODIFIER:exon3/3:c.435-818dupT:,NEIL1:ENST00000564784:intron:MODIFIER:exon3/10:c.435-818dupT:,NEIL1:ENST00000569035:intron:MODIFIER:exon2/9:c.435-818dupT:,NEIL1:ENST00000565051:intron:MODIFIER:exon3/4:c.435-1031dupT:,NEIL1:ENST00000567005:intron:MODIFIER:exon2/2:c.435-739dupT:,NEIL1:ENST00000564738:intron:MODIFIER:exon1/3:n.406-1031dupT:		rs11422837;rs397739988;rs768966115	0.0000	0.0644	13/2/0	0.0316											0	0					NEIL1 (inh=n/a pLI=0.00)
chr16	3639139	3639139	A	G	het		QUAL=1344;DP=102;AF=0.52;MQM=60	SLX4	synonymous	SLX4:ENST00000294008:synonymous:LOW:exon12/15:c.4500T>C:p.Asn1500Asn		rs3810812	0.7396	0.6116	23691/8817/3963	0.5995							613278 [SLX4 (provisional) Fanconi anemia,complementation group P,613951];	RCV000252099.1 [benign]; RCV000341995.1 [benign]; 			875	1451	1	[1] Ilnaz Sepahi 29-03-2016 batch import			SLX4 (inh=AR pLI=0.00)
chr16	3639230	3639230	G	A	het	pred_pathogenic;anno_pathogenic_hgmd	QUAL=1417;DP=112;AF=0.49;MQM=60	SLX4	missense	SLX4:ENST00000294008:missense:MODERATE:exon12/15:c.4409C>T:p.Pro1470Leu		rs72778139	0.0002	0.0001	0/0/0	0.0001	0.3390	T	T	B	T	20.60	613278 [SLX4 (provisional) Fanconi anemia,complementation group P,613951];		CM136925 [CLASS=DM MUT=ALT PHEN="Breast and/or ovarian cancer" GENE=SLX4]; 		0	3					SLX4 (inh=AR pLI=0.00)
chr16	23625463	23625463	A	T	hom	off-target	QUAL=1216;DP=38;AF=1.00;MQM=60	PALB2,CTD-2196E14.3	intron	PALB2:ENST00000261584:intron:MODIFIER:exon10/12:c.3114-51T>A:,CTD-2196E14.3:ENST00000561764:intron:MODIFIER:exon2/3:n.186-3458A>T:,PALB2:ENST00000566069:intron:MODIFIER:exon1/2:c.27-51T>A:,PALB2:ENST00000568219:intron:MODIFIER:exon10/12:c.*2989-51T>A:		rs249936	0.9968	0.9975	37488/19526/3750	0.9173							610355 [PALB2 (provisional) Fanconi anemia,complementation group N,610832|Breast cancer,susceptibility to,114480|Pancreatic cancer,susceptibility to,3,613348];	RCV000114594.1 [likely benign]; 			1010	3					PALB2 (inh=AR+AD pLI=0.00), CTD-2196E14.3 (inh=n/a pLI=n/a)
chr16	23640467	23640467	G	A	het	off-target	QUAL=249;DP=23;AF=0.48;MQM=60	PALB2	intron	PALB2:ENST00000261584:intron:MODIFIER:exon6/12:c.2586+58C>T:,PALB2:ENST00000568219:intron:MODIFIER:exon6/12:c.*2461+58C>T:,PALB2:ENST00000565038:intron:MODIFIER:exon2/3:c.*67+58C>T:		rs249954	0.3500	0.0000	0/0/0	0.0534							610355 [PALB2 (provisional) Fanconi anemia,complementation group N,610832|Breast cancer,susceptibility to,114480|Pancreatic cancer,susceptibility to,3,613348];	RCV000114539.1 [benign]; 			71	385					PALB2 (inh=AR+AD pLI=0.00)
chr16	68771372	68771372	C	T	hom		QUAL=4027;DP=129;AF=0.99;MQM=60	CDH1	splice_region&intron	CDH1:ENST00000261769:splice_region&intron:LOW:exon1/15:c.48+6C>T:,CDH1:ENST00000566612:splice_region&intron:LOW:exon1/14:c.48+6C>T:,CDH1:ENST00000422392:splice_region&intron:LOW:exon1/14:c.48+6C>T:,CDH1:ENST00000566510:splice_region&intron:LOW:exon1/14:c.48+6C>T:		rs3743674	0.7634	0.8111	5304/2436/102	0.5523							192090 [CDH1 (confirmed) Endometrial carcinoma,somatic,608089|Ovarian carcinoma,somatic,167000|Breast cancer,lobular,114480|Gastric cancer,familial diffuse,with or without cleft lip and/or palate,137215|Prostate cancer,susceptibility to,176807];	RCV000132163.3 [benign]; RCV000173339.2 [benign]; RCV000274668.1 [benign]; 			2613	728	1	[1] Ilnaz Sepahi 29-03-2016 batch import			CDH1 (inh=AD pLI=0.34)
chr16	68771418	68771418	-	GCCCCAGCCCCGT	hom	off-target	QUAL=2621;DP=102;AF=1.00;MQM=60	CDH1	intron	CDH1:ENST00000261769:intron:MODIFIER:exon1/15:c.48+62_48+63insCGTGCCCCAGCCC:,CDH1:ENST00000566612:intron:MODIFIER:exon1/14:c.48+62_48+63insCGTGCCCCAGCCC:,CDH1:ENST00000422392:intron:MODIFIER:exon1/14:c.48+62_48+63insCGTGCCCCAGCCC:,CDH1:ENST00000566510:intron:MODIFIER:exon1/14:c.48+62_48+63insCGTGCCCCAGCCC:		rs147838237;rs74406246	0.6887	0.8100	3615/1177/49	0.3004							192090 [CDH1 (confirmed) Endometrial carcinoma,somatic,608089|Ovarian carcinoma,somatic,167000|Breast cancer,lobular,114480|Gastric cancer,familial diffuse,with or without cleft lip and/or palate,137215|Prostate cancer,susceptibility to,176807];				786	313					CDH1 (inh=AD pLI=0.34)
chr16	68857441	68857441	T	C	het		QUAL=14801;DP=1164;AF=0.52;MQM=60	CDH1	synonymous,3'UTR,non_coding_transcript_exon	CDH1:ENST00000261769:synonymous:LOW:exon13/16:c.2076T>C:p.Ala692Ala,CDH1:ENST00000422392:synonymous:LOW:exon12/15:c.1893T>C:p.Ala631Ala,CDH1:ENST00000566612:3'UTR:MODIFIER:exon12/15:c.*316T>C:,CDH1:ENST00000566510:3'UTR:MODIFIER:exon12/15:c.*742T>C:,CDH1:ENST00000562836:non_coding_transcript_exon:MODIFIER:exon12/15:n.2147T>C:,CDH1:ENST00000562118:non_coding_transcript_exon:MODIFIER:exon1/4:n.294T>C:		rs1801552	0.7187	0.6548	26404/13014/4084	0.6414							192090 [CDH1 (confirmed) Endometrial carcinoma,somatic,608089|Ovarian carcinoma,somatic,167000|Breast cancer,lobular,114480|Gastric cancer,familial diffuse,with or without cleft lip and/or palate,137215|Prostate cancer,susceptibility to,176807];	RCV000132164.2 [benign]; RCV000246442.1 [benign]; RCV000293455.1 [benign]; 	CM1414917 [CLASS=DP MUT=ALT PHEN="Gastric cancer early-onset diffuse association with" GENE=CDH1]; 	COSM3755010	1388	1640	1	[1] Ilnaz Sepahi 29-03-2016 batch import			CDH1 (inh=AD pLI=0.34)
chr16	81816733	81816733	C	T	het		QUAL=4992;DP=430;AF=0.51;MQM=60	PLCG2	intron	PLCG2:ENST00000359376:intron:MODIFIER:exon1/32:c.-47-2815C>T:,PLCG2:ENST00000565054:intron:MODIFIER:exon2/5:c.-47-2815C>T:,PLCG2:ENST00000569929:intron:MODIFIER:exon1/7:n.84-2815C>T:		rs8045964	0.4241	0.5194	6242/2864/337	0.3767							600220 [PLCG2 (provisional) Familial cold autoinflammatory syndrome 3,614468|Autoinflammation,antibody deficiency,and immune dysregulation syndrome,614878];				335	811					PLCG2 (inh=AD pLI=1.00)
chr16	81816787	81816787	T	A	hom	off-target	QUAL=24041;DP=746;AF=1.00;MQM=60	PLCG2	intron	PLCG2:ENST00000359376:intron:MODIFIER:exon1/32:c.-47-2761T>A:,PLCG2:ENST00000565054:intron:MODIFIER:exon2/5:c.-47-2761T>A:,PLCG2:ENST00000569929:intron:MODIFIER:exon1/7:n.84-2761T>A:		rs4476171	0.9980	0.0000	0/0/0	0.1531							600220 [PLCG2 (provisional) Familial cold autoinflammatory syndrome 3,614468|Autoinflammation,antibody deficiency,and immune dysregulation syndrome,614878];				1161	1					PLCG2 (inh=AD pLI=1.00)
chr16	89805261	89805261	A	G	hom	off-target	QUAL=18058;DP=580;AF=1.00;MQM=60	FANCA,ZNF276	synonymous,3'UTR,intron,non_coding_transcript_exon	FANCA:ENST00000564475:synonymous:LOW:exon6/6:c.621T>C:p.His207His,ZNF276:ENST00000289816:3'UTR:MODIFIER:exon11/11:c.*607A>G:,FANCA:ENST00000389301:intron:MODIFIER:exon42/42:c.4260+29T>C:,FANCA:ENST00000568369:intron:MODIFIER:exon42/42:c.4264+29T>C:,FANCA:ENST00000561722:intron:MODIFIER:exon4/4:c.480+29T>C:,FANCA:ENST00000562424:intron:MODIFIER:exon3/3:n.531+29T>C:,FANCA:ENST00000567879:intron:MODIFIER:exon6/6:c.634+29T>C:,ZNF276:ENST00000563983:non_coding_transcript_exon:MODIFIER:exon10/10:n.2440A>G:		rs1800359	0.8508	0.7044	31320/11656/4512	0.6775							607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	RCV000241844.1 [benign]; 			520	590					FANCA (inh=AR pLI=0.00), ZNF276 (inh=n/a pLI=0.00)
chr16	89805977	89805977	G	A	het	off-target	QUAL=2205;DP=181;AF=0.48;MQM=60	FANCA,ZNF276	splice_region&intron,3'UTR,intron,non_coding_transcript_exon	FANCA:ENST00000389301:splice_region&intron:LOW:exon39/42:c.3935-16C>T:,FANCA:ENST00000568369:splice_region&intron:LOW:exon39/42:c.3935-16C>T:,FANCA:ENST00000561722:splice_region&intron:LOW:exon1/4:c.86-16C>T:,FANCA:ENST00000564475:splice_region&intron:LOW:exon3/5:c.263-16C>T:,FANCA:ENST00000564870:splice_region&intron:LOW:exon2/4:c.134-16C>T:,FANCA:ENST00000568626:splice_region&intron:LOW:exon7/8:c.*139-16C>T:,ZNF276:ENST00000289816:3'UTR:MODIFIER:exon11/11:c.*1323G>A:,FANCA:ENST00000567879:intron:MODIFIER:exon4/6:c.413-303C>T:,ZNF276:ENST00000563983:non_coding_transcript_exon:MODIFIER:exon10/10:n.3156G>A:,FANCA:ENST00000562424:non_coding_transcript_exon:MODIFIER:exon1/4:n.190C>T:,FANCA:ENST00000564969:non_coding_transcript_exon:MODIFIER:exon3/3:n.644C>T:		rs1061646	0.5381	0.4098	1784/308/375	0.1691							607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	RCV000242351.1 [benign]; 			179	706					FANCA (inh=AR pLI=0.00), ZNF276 (inh=n/a pLI=0.00)
chr16	89806347	89806347	A	T	het	off-target	QUAL=873;DP=48;AF=0.71;MQM=60	ZNF276,FANCA	3'UTR,intron,non_coding_transcript_exon	ZNF276:ENST00000289816:3'UTR:MODIFIER:exon11/11:c.*1693A>T:,FANCA:ENST00000389301:intron:MODIFIER:exon39/42:c.3934+55T>A:,FANCA:ENST00000568369:intron:MODIFIER:exon39/42:c.3934+55T>A:,FANCA:ENST00000561722:intron:MODIFIER:exon1/4:c.85+55T>A:,FANCA:ENST00000567879:intron:MODIFIER:exon4/6:c.412+55T>A:,FANCA:ENST00000564475:intron:MODIFIER:exon3/5:c.262+55T>A:,FANCA:ENST00000564870:intron:MODIFIER:exon2/4:c.133+55T>A:,FANCA:ENST00000568626:intron:MODIFIER:exon7/8:c.*138+55T>A:,FANCA:ENST00000564969:non_coding_transcript_exon:MODIFIER:exon3/3:n.274T>A:,FANCA:ENST00000305699:non_coding_transcript_exon:MODIFIER:exon11/11:n.1232T>A:		rs7195906	0.7065	0.5227	18679/4716/3149	0.4969	-0.5840		T	B		1.77	607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	RCV000122401.1 [not provided]; 			286	727					ZNF276 (inh=n/a pLI=0.00), FANCA (inh=AR pLI=0.00)
chr16	89815217	89815217	C	T	het	off-target	QUAL=1919;DP=159;AF=0.51;MQM=60	FANCA	intron	FANCA:ENST00000389301:intron:MODIFIER:exon32/42:c.3240-42G>A:,FANCA:ENST00000568369:intron:MODIFIER:exon32/42:c.3240-42G>A:,FANCA:ENST00000568626:intron:MODIFIER:exon1/8:c.87-42G>A:,FANCA:ENST00000305699:intron:MODIFIER:exon4/10:n.483-42G>A:,FANCA:ENST00000567988:intron:MODIFIER:exon4/8:c.*164-42G>A:,FANCA:ENST00000568983:intron:MODIFIER:exon1/4:n.68-42G>A:,FANCA:ENST00000561660:intron:MODIFIER:exon4/7:c.442-42G>A:,FANCA:ENST00000563510:intron:MODIFIER:exon5/5:c.*476-42G>A:		rs1800345	0.5449	0.4311	8845/2051/1234	0.3927							607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	RCV000251643.1 [benign]; 	CS137887 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA]; 		87	430					FANCA (inh=AR pLI=0.00)
chr16	89818491	89818491	T	C	het	off-target	QUAL=9378;DP=751;AF=0.49;MQM=60	FANCA	intron	FANCA:ENST00000389301:intron:MODIFIER:exon31/42:c.3066+55A>G:,FANCA:ENST00000568369:intron:MODIFIER:exon31/42:c.3066+55A>G:,FANCA:ENST00000305699:intron:MODIFIER:exon3/10:n.309+55A>G:,FANCA:ENST00000567988:intron:MODIFIER:exon3/8:c.318-2181A>G:,FANCA:ENST00000561660:intron:MODIFIER:exon4/7:c.441+55A>G:,FANCA:ENST00000563510:intron:MODIFIER:exon4/5:c.*302+55A>G:		rs3743860	0.5865	0.0000	0/0/0	0.0872							607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];				153	480					FANCA (inh=AR pLI=0.00)
chr16	89831510	89831510	C	A	het	off-target	QUAL=11990;DP=972;AF=0.48;MQM=60	FANCA	intron	FANCA:ENST00000389301:intron:MODIFIER:exon27/42:c.2602-36G>T:,FANCA:ENST00000568369:intron:MODIFIER:exon27/42:c.2602-36G>T:,FANCA:ENST00000563318:intron:MODIFIER:exon1/5:c.7-36G>T:		rs2159116	0.0933	0.1518	1622/1173/10	0.1451							607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	RCV000252136.1 [benign]; 			62	338					FANCA (inh=AR pLI=0.00)
chr16	89836323	89836323	C	T	het	pred_pathogenic	QUAL=835;DP=96;AF=0.41;MQM=60	FANCA	missense,splice_region&non_coding_transcript_exon	FANCA:ENST00000389301:missense:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp,FANCA:ENST00000568369:missense:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp,FANCA:ENST00000567205:missense:MODERATE:exon1/2:c.110G>A:p.Gly37Asp,FANCA:ENST00000561667:splice_region&non_coding_transcript_exon:LOW:exon2/2:n.528G>A:		rs7195066	0.6667	0.4690	16070/3144/2387	0.4485	0.3050	T	T	B,B	D	3.27	607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	RCV000120927.2 [benign]; RCV000292806.1 [benign]; 	CM137288 [CLASS=R MUT=ALT PHEN="Fanconi anaemia A" GENE=FANCA]; 	COSM435949	446	1473	2	[2] old entry - no details available			FANCA (inh=AR pLI=0.00)
chr16	89838078	89838078	A	G	het		QUAL=12861;DP=1060;AF=0.48;MQM=60	FANCA	splice_region&intron	FANCA:ENST00000389301:splice_region&intron:LOW:exon23/42:c.2151+8T>C:,FANCA:ENST00000568369:splice_region&intron:LOW:exon23/42:c.2151+8T>C:,FANCA:ENST00000567284:splice_region&intron:LOW:exon4/5:n.375+8T>C:		rs1800340	0.5599	0.4315	12977/3039/1411	0.4236							607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	RCV000244957.1 [benign]; RCV000398159.1 [benign]; 			386	1463	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCA (inh=AR pLI=0.00)
chr16	89845194	89845194	A	G	het	off-target	QUAL=6225;DP=616;AF=0.53;MQM=60	FANCA	splice_region&intron	FANCA:ENST00000389301:splice_region&intron:LOW:exon20/42:c.1826+15T>C:,FANCA:ENST00000568369:splice_region&intron:LOW:exon20/42:c.1826+15T>C:,FANCA:ENST00000567284:splice_region&intron:LOW:exon1/5:n.50+15T>C:,FANCA:ENST00000567510:splice_region&intron:LOW:exon3/5:c.200+15T>C:		rs1800337	0.6825	0.5115	18057/4737/2484	0.4942							607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	RCV000243909.1 [benign]; RCV000359688.1 [benign]; 			279	764					FANCA (inh=AR pLI=0.00)
chr16	89849480	89849480	C	T	hom	pred_pathogenic	QUAL=6739;DP=202;AF=1.00;MQM=60	FANCA	missense	FANCA:ENST00000389301:missense:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser,FANCA:ENST00000568369:missense:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser		rs2239359	0.6240	0.4995	16447/5298/2452	0.4917	-0.0380	T	T	B,B	D	0.07	607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	RCV000120917.3 [benign]; RCV000389853.1 [benign]; 	CM137880 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA]; 		608	1633	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCA (inh=AR pLI=0.00)
chr16	89857964	89857964	T	C	het	off-target	QUAL=14528;DP=1042;AF=0.53;MQM=60	FANCA	splice_region&intron	FANCA:ENST00000389301:splice_region&intron:LOW:exon13/42:c.1226-20A>G:,FANCA:ENST00000568369:splice_region&intron:LOW:exon13/42:c.1226-20A>G:,FANCA:ENST00000563767:splice_region&intron:LOW:exon1/1:n.86-20A>G:,FANCA:ENST00000567621:splice_region&intron:LOW:exon7/7:c.*213-20A>G:		rs1800330	0.5719	0.4370	13077/2988/1621	0.4273							607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	RCV000249965.1 [benign]; 			193	684					FANCA (inh=AR pLI=0.00)
chr16	89858505	89858505	T	C	het	off-target	QUAL=4325;DP=304;AF=0.51;MQM=60	FANCA	intron	FANCA:ENST00000389301:intron:MODIFIER:exon12/42:c.1084-29A>G:,FANCA:ENST00000568369:intron:MODIFIER:exon12/42:c.1084-29A>G:,FANCA:ENST00000567621:intron:MODIFIER:exon6/7:c.*71-29A>G:,FANCA:ENST00000566133:intron:MODIFIER:exon1/1:n.256-29A>G:		rs6500452	0.5317	0.4118	11866/2863/1375	0.4083							607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	RCV000245519.1 [benign]; 			118	473					FANCA (inh=AR pLI=0.00)
chr16	89858525	89858525	C	G	het	off-target	QUAL=4352;DP=307;AF=0.51;MQM=60	FANCA	intron	FANCA:ENST00000389301:intron:MODIFIER:exon12/42:c.1084-49G>C:,FANCA:ENST00000568369:intron:MODIFIER:exon12/42:c.1084-49G>C:,FANCA:ENST00000567621:intron:MODIFIER:exon6/7:c.*71-49G>C:,FANCA:ENST00000566133:intron:MODIFIER:exon1/1:n.256-49G>C:		rs1800287	0.7027	0.5175	18504/4730/2990	0.4955							607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	RCV000250482.1 [benign]; 			192	528					FANCA (inh=AR pLI=0.00)
chr16	89859008	89859008	G	A	het	off-target	QUAL=930;DP=105;AF=0.40;MQM=60	FANCA	intron,non_coding_transcript_exon	FANCA:ENST00000389301:intron:MODIFIER:exon11/42:c.1007-53C>T:,FANCA:ENST00000568369:intron:MODIFIER:exon11/42:c.1007-53C>T:,FANCA:ENST00000567621:intron:MODIFIER:exon5/7:c.369-53C>T:,FANCA:ENST00000566133:non_coding_transcript_exon:MODIFIER:exon1/2:n.126C>T:		rs3856	0.5302	0.0000	0/0/0	0.0807							607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];				97	420					FANCA (inh=AR pLI=0.00)
chr16	89859016	89859016	T	-	het	off-target	QUAL=875;DP=105;AF=0.40;MQM=60	FANCA	intron,non_coding_transcript_exon	FANCA:ENST00000389301:intron:MODIFIER:exon11/42:c.1007-61delA:,FANCA:ENST00000568369:intron:MODIFIER:exon11/42:c.1007-61delA:,FANCA:ENST00000567621:intron:MODIFIER:exon5/7:c.369-61delA:,FANCA:ENST00000566133:non_coding_transcript_exon:MODIFIER:exon1/2:n.118delA:		rs869077718	0.6430	0.0000	0/0/0	0.4539							607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];				162	467					FANCA (inh=AR pLI=0.00)
chr16	89866043	89866043	T	C	het		QUAL=9337;DP=734;AF=0.49;MQM=60	FANCA	missense,non_coding_transcript_exon	FANCA:ENST00000389301:missense:MODERATE:exon9/43:c.796A>G:p.Thr266Ala,FANCA:ENST00000568369:missense:MODERATE:exon9/43:c.796A>G:p.Thr266Ala,FANCA:ENST00000567621:missense:MODERATE:exon4/8:c.271A>G:p.Thr91Ala,FANCA:ENST00000389302:missense:MODERATE:exon9/11:c.796A>G:p.Thr266Ala,FANCA:ENST00000563673:missense:MODERATE:exon9/10:c.796A>G:p.Thr266Ala,FANCA:ENST00000534992:missense:MODERATE:exon9/11:c.796A>G:p.Thr266Ala,FANCA:ENST00000543736:missense:MODERATE:exon8/10:c.700A>G:p.Thr234Ala,FANCA:ENST00000565582:missense:MODERATE:exon7/9:c.626A>G:p.His209Arg,FANCA:ENST00000566889:non_coding_transcript_exon:MODIFIER:exon8/10:n.1378A>G:		rs7190823	0.6905	0.5166	18422/4824/2761	0.4992	0.4020	T,T,T,T	T	B,B,B,B,B,B	T,T,T,T	0.01	607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	RCV000120967.2 [benign]; RCV000308742.1 [benign]; 	CM137879 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA]; 		589	1586	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCA (inh=AR pLI=0.00)
chr16	89869761	89869761	T	C	hom	off-target	QUAL=3854;DP=115;AF=1.00;MQM=60	FANCA	splice_region&intron,intron	FANCA:ENST00000389301:splice_region&intron:LOW:exon7/42:c.710-12A>G:,FANCA:ENST00000568369:splice_region&intron:LOW:exon7/42:c.710-12A>G:,FANCA:ENST00000567621:splice_region&intron:LOW:exon2/7:c.185-12A>G:,FANCA:ENST00000566889:splice_region&intron:LOW:exon6/9:n.1292-12A>G:,FANCA:ENST00000389302:splice_region&intron:LOW:exon7/10:c.710-12A>G:,FANCA:ENST00000563673:splice_region&intron:LOW:exon7/9:c.710-12A>G:,FANCA:ENST00000534992:splice_region&intron:LOW:exon7/10:c.710-12A>G:,FANCA:ENST00000543736:splice_region&intron:LOW:exon6/9:c.614-12A>G:,FANCA:ENST00000565582:intron:MODIFIER:exon6/8:c.622+1927A>G:		rs1800286	0.8429	0.7013	31090/11644/4387	0.6775							607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	RCV000252873.1 [benign]; RCV000333219.1 [benign]; 			657	752					FANCA (inh=AR pLI=0.00)
chr17	7572980	7572980	T	G	het	pred_pathogenic	QUAL=63;DP=224;AF=0.36;MQM=60	TP53	missense,3'UTR,intron,non_coding_transcript_exon	TP53:ENST00000269305:missense:MODERATE:exon11/11:c.1129A>C:p.Thr377Pro,TP53:ENST00000445888:missense:MODERATE:exon11/11:c.1129A>C:p.Thr377Pro,TP53:ENST00000576024:missense:MODERATE:exon2/2:c.80A>C:p.Tyr27Ser,TP53:ENST00000420246:3'UTR:MODIFIER:exon12/12:c.*236A>C:,TP53:ENST00000455263:3'UTR:MODIFIER:exon12/12:c.*148A>C:,TP53:ENST00000413465:intron:MODIFIER:exon6/6:c.782+4519A>C:,TP53:ENST00000359597:intron:MODIFIER:exon8/8:c.994-3418A>C:,TP53:ENST00000504290:non_coding_transcript_exon:MODIFIER:exon8/8:n.1071A>C:,TP53:ENST00000504937:non_coding_transcript_exon:MODIFIER:exon7/7:n.1011A>C:,TP53:ENST00000510385:non_coding_transcript_exon:MODIFIER:exon8/8:n.1144A>C:		rs774269719	0.0000	0.0006	0/0/0	0.0001	0.4640	T,T,T,.	D	B	D,D	14.48	191170 [TP53 (confirmed) Colorectal cancer,114500|Li-Fraumeni syndrome,151623|Hepatocellular carcinoma,114550|Osteosarcoma,259500|Choroid plexus papilloma,260500|Nasopharyngeal carcinoma,607107|Pancreatic cancer,260350|Adrenal cortical carcinoma,202300|Breast cancer,114480|Basal cell carcinoma 7,614740|Glioma susceptibility 1,137800];			COSM1658764, COSM1658763	0	0					TP53 (inh=AD pLI=0.91)
chr17	7572996	7572996	G	T	het		QUAL=37;DP=217;AF=0.32;MQM=60	TP53	missense,synonymous,3'UTR,intron,non_coding_transcript_exon	TP53:ENST00000576024:missense:MODERATE:exon2/2:c.64C>A:p.Gln22Lys,TP53:ENST00000269305:synonymous:LOW:exon11/11:c.1113C>A:p.Ser371Ser,TP53:ENST00000445888:synonymous:LOW:exon11/11:c.1113C>A:p.Ser371Ser,TP53:ENST00000420246:3'UTR:MODIFIER:exon12/12:c.*220C>A:,TP53:ENST00000455263:3'UTR:MODIFIER:exon12/12:c.*132C>A:,TP53:ENST00000413465:intron:MODIFIER:exon6/6:c.782+4503C>A:,TP53:ENST00000359597:intron:MODIFIER:exon8/8:c.994-3434C>A:,TP53:ENST00000504290:non_coding_transcript_exon:MODIFIER:exon8/8:n.1055C>A:,TP53:ENST00000504937:non_coding_transcript_exon:MODIFIER:exon7/7:n.995C>A:,TP53:ENST00000510385:non_coding_transcript_exon:MODIFIER:exon8/8:n.1128C>A:		rs765530090	0.0000	0.0001	0/0/0	0.0001							191170 [TP53 (confirmed) Colorectal cancer,114500|Li-Fraumeni syndrome,151623|Hepatocellular carcinoma,114550|Osteosarcoma,259500|Choroid plexus papilloma,260500|Nasopharyngeal carcinoma,607107|Pancreatic cancer,260350|Adrenal cortical carcinoma,202300|Breast cancer,114480|Basal cell carcinoma 7,614740|Glioma susceptibility 1,137800];				0	0					TP53 (inh=AD pLI=0.91)
chr17	7579472	7579472	G	C	het	pred_pathogenic	QUAL=7662;DP=573;AF=0.54;MQM=60	TP53	missense,intron,non_coding_transcript_exon	TP53:ENST00000269305:missense:MODERATE:exon4/11:c.215C>G:p.Pro72Arg,TP53:ENST00000413465:missense:MODERATE:exon3/7:c.215C>G:p.Pro72Arg,TP53:ENST00000359597:missense:MODERATE:exon3/9:c.215C>G:p.Pro72Arg,TP53:ENST00000420246:missense:MODERATE:exon4/12:c.215C>G:p.Pro72Arg,TP53:ENST00000455263:missense:MODERATE:exon4/12:c.215C>G:p.Pro72Arg,TP53:ENST00000445888:missense:MODERATE:exon4/11:c.215C>G:p.Pro72Arg,TP53:ENST00000508793:missense:MODERATE:exon4/5:c.215C>G:p.Pro72Arg,TP53:ENST00000604348:missense:MODERATE:exon4/5:c.215C>G:p.Pro72Arg,TP53:ENST00000503591:missense:MODERATE:exon5/6:c.215C>G:p.Pro72Arg,TP53:ENST00000509690:intron:MODIFIER:exon1/5:c.-21-918C>G:,TP53:ENST00000514944:intron:MODIFIER:exon3/5:c.96+228C>G:,TP53:ENST00000505014:non_coding_transcript_exon:MODIFIER:exon3/5:n.471C>G:		rs1042522	0.5429	0.6600	27306/18000/773	0.6429	1.0150	T,T,T,T,T,T,T,T,T	T	B,B,B,B,B	D,D,D,D,D,D,D,D	0.36	191170 [TP53 (confirmed) Colorectal cancer,114500|Li-Fraumeni syndrome,151623|Hepatocellular carcinoma,114550|Osteosarcoma,259500|Choroid plexus papilloma,260500|Nasopharyngeal carcinoma,607107|Pancreatic cancer,260350|Adrenal cortical carcinoma,202300|Breast cancer,114480|Basal cell carcinoma 7,614740|Glioma susceptibility 1,137800];	RCV000152112.1 [benign]; RCV000013144.4 [benign]; RCV000034639.1 [benign]; RCV000079202.7 [benign]; RCV000132165.3 [benign]; RCV000144668.1 [uncertain significance]; RCV000211157.1 [drug response]; RCV000211212.1 [drug response]; RCV000211311.1 [drug response]; RCV000211338.1 [drug response]; RCV000211395.1 [drug response]; RCV000300782.1 [benign]; RCV000164487.1 [uncertain significance]; RCV000227427.1 [uncertain significance]; 	CM961374 [CLASS=DFP MUT=REF PHEN="Lung cancer association with" GENE=TP53]; 	COSM250061, COSM3766192, COSM3766191, COSM3766190, COSM3766193	1881	1405	1	[1] old entry - no details available			TP53 (inh=AD pLI=0.91)
chr17	7579644	7579659	CCCCAGCCCTCCAGGT	-	het	off-target	QUAL=124;DP=26;AF=0.58;MQM=60	TP53	intron	TP53:ENST00000269305:intron:MODIFIER:exon3/10:c.96+41_97-54delACCTGGAGGGCTGGGG:,TP53:ENST00000413465:intron:MODIFIER:exon2/6:c.96+41_97-54delACCTGGAGGGCTGGGG:,TP53:ENST00000359597:intron:MODIFIER:exon2/8:c.96+41_97-54delACCTGGAGGGCTGGGG:,TP53:ENST00000420246:intron:MODIFIER:exon3/11:c.96+41_97-54delACCTGGAGGGCTGGGG:,TP53:ENST00000455263:intron:MODIFIER:exon3/11:c.96+41_97-54delACCTGGAGGGCTGGGG:,TP53:ENST00000445888:intron:MODIFIER:exon3/10:c.96+41_97-54delACCTGGAGGGCTGGGG:,TP53:ENST00000509690:intron:MODIFIER:exon1/5:c.-21-1105_-21-1090delACCTGGAGGGCTGGGG:,TP53:ENST00000514944:intron:MODIFIER:exon3/5:c.96+41_96+56delACCTGGAGGGCTGGGG:,TP53:ENST00000505014:intron:MODIFIER:exon2/4:n.352+41_353-54delACCTGGAGGGCTGGGG:,TP53:ENST00000508793:intron:MODIFIER:exon3/4:c.96+41_97-54delACCTGGAGGGCTGGGG:,TP53:ENST00000604348:intron:MODIFIER:exon3/4:c.96+41_97-54delACCTGGAGGGCTGGGG:,TP53:ENST00000503591:intron:MODIFIER:exon4/5:c.96+41_97-54delACCTGGAGGGCTGGGG:		rs150200764	0.5865	0.0000	0/0/0	0.1174							191170 [TP53 (confirmed) Colorectal cancer,114500|Li-Fraumeni syndrome,151623|Hepatocellular carcinoma,114550|Osteosarcoma,259500|Choroid plexus papilloma,260500|Nasopharyngeal carcinoma,607107|Pancreatic cancer,260350|Adrenal cortical carcinoma,202300|Breast cancer,114480|Basal cell carcinoma 7,614740|Glioma susceptibility 1,137800];	RCV000161045.1 [benign]; 			35	1094					TP53 (inh=AD pLI=0.91)
chr17	29553485	29553485	G	A	hom		QUAL=2535;DP=86;AF=1.00;MQM=60	NF1	synonymous,3'UTR,non_coding_transcript_exon	NF1:ENST00000358273:synonymous:LOW:exon18/58:c.2034G>A:p.Pro678Pro,NF1:ENST00000356175:synonymous:LOW:exon18/57:c.2034G>A:p.Pro678Pro,NF1:ENST00000579081:synonymous:LOW:exon18/58:c.2136G>A:p.Pro712Pro,NF1:ENST00000456735:synonymous:LOW:exon10/50:c.1032G>A:p.Pro344Pro,NF1:ENST00000495910:3'UTR:MODIFIER:exon16/29:c.*1435G>A:,NF1:ENST00000493220:non_coding_transcript_exon:MODIFIER:exon2/21:n.201G>A:		rs2285892	0.4968	0.3827	9925/3078/2462	0.3658							613113 [NF1 (confirmed) Neurofibromatosis,type 1,162200|Leukemia,juvenile myelomonocytic,607785|Neurofibromatosis,familial spinal,162210|Neurofibromatosis-Noonan syndrome,601321|Watson syndrome,193520];	RCV000162648.1 [benign]; RCV000219876.2 [benign]; RCV000296834.1 [likely benign]; RCV000356219.1 [likely benign]; RCV000371357.1 [likely benign]; RCV000400800.1 [likely benign]; 			280	1323					NF1 (inh=AD pLI=1.00)
chr17	29559061	29559061	-	T	het	off-target	QUAL=450;DP=157;AF=0.24;MQM=60	NF1	splice_region&intron	NF1:ENST00000358273:splice_region&intron:LOW:exon24/57:c.3198-4dupT:,NF1:ENST00000356175:splice_region&intron:LOW:exon24/56:c.3198-4dupT:,NF1:ENST00000579081:splice_region&intron:LOW:exon24/57:c.3300-4dupT:,NF1:ENST00000495910:splice_region&intron:LOW:exon22/28:c.*2599-4dupT:,NF1:ENST00000456735:splice_region&intron:LOW:exon16/49:c.2196-4dupT:,NF1:ENST00000493220:splice_region&intron:LOW:exon7/20:n.1734-4dupT:		rs371047262	0.0000	0.0052	21/6/0	0.0001							613113 [NF1 (confirmed) Neurofibromatosis,type 1,162200|Leukemia,juvenile myelomonocytic,607785|Neurofibromatosis,familial spinal,162210|Neurofibromatosis-Noonan syndrome,601321|Watson syndrome,193520];				5	8					NF1 (inh=AD pLI=1.00)
chr17	29559932	29559932	C	A	hom	off-target	QUAL=1030;DP=35;AF=1.00;MQM=60	NF1	intron	NF1:ENST00000358273:intron:MODIFIER:exon26/57:c.3496+33C>A:,NF1:ENST00000356175:intron:MODIFIER:exon26/56:c.3496+33C>A:,NF1:ENST00000579081:intron:MODIFIER:exon26/57:c.3598+33C>A:,NF1:ENST00000495910:intron:MODIFIER:exon24/28:c.*2897+33C>A:,NF1:ENST00000456735:intron:MODIFIER:exon18/49:c.2494+33C>A:,NF1:ENST00000493220:intron:MODIFIER:exon9/20:n.2032+33C>A:		rs2066736	0.4581	0.3676	8780/2982/1958	0.3586							613113 [NF1 (confirmed) Neurofibromatosis,type 1,162200|Leukemia,juvenile myelomonocytic,607785|Neurofibromatosis,familial spinal,162210|Neurofibromatosis-Noonan syndrome,601321|Watson syndrome,193520];	RCV000245976.1 [benign]; 			87	465					NF1 (inh=AD pLI=1.00)
chr17	29563077	29563077	T	G	hom	off-target	QUAL=11310;DP=418;AF=0.95;MQM=60	NF1	intron	NF1:ENST00000358273:intron:MODIFIER:exon29/57:c.3974+38T>G:,NF1:ENST00000356175:intron:MODIFIER:exon29/56:c.3974+38T>G:,NF1:ENST00000579081:intron:MODIFIER:exon29/57:c.4076+38T>G:,NF1:ENST00000495910:intron:MODIFIER:exon27/28:c.*3375+38T>G:,NF1:ENST00000456735:intron:MODIFIER:exon21/49:c.2972+38T>G:,NF1:ENST00000493220:intron:MODIFIER:exon12/20:n.2510+38T>G:,NF1:ENST00000466819:intron:MODIFIER:exon3/9:c.449+38T>G:,NF1:ENST00000479614:intron:MODIFIER:exon3/8:c.449+38T>G:	(T)n	rs9894862	0.0000	0.0029	1/1/0	0.0001							613113 [NF1 (confirmed) Neurofibromatosis,type 1,162200|Leukemia,juvenile myelomonocytic,607785|Neurofibromatosis,familial spinal,162210|Neurofibromatosis-Noonan syndrome,601321|Watson syndrome,193520];	RCV000250423.1 [benign]; 			0	2					NF1 (inh=AD pLI=1.00)
chr17	29563085	29563085	-	TG	hom	off-target	QUAL=9581;DP=390;AF=0.94;MQM=60	NF1	intron	NF1:ENST00000358273:intron:MODIFIER:exon29/57:c.3974+47_3974+48insGT:,NF1:ENST00000356175:intron:MODIFIER:exon29/56:c.3974+47_3974+48insGT:,NF1:ENST00000579081:intron:MODIFIER:exon29/57:c.4076+47_4076+48insGT:,NF1:ENST00000495910:intron:MODIFIER:exon27/28:c.*3375+47_*3375+48insGT:,NF1:ENST00000456735:intron:MODIFIER:exon21/49:c.2972+47_2972+48insGT:,NF1:ENST00000493220:intron:MODIFIER:exon12/20:n.2510+47_2510+48insGT:,NF1:ENST00000466819:intron:MODIFIER:exon3/9:c.449+47_449+48insGT:,NF1:ENST00000479614:intron:MODIFIER:exon3/8:c.449+47_449+48insGT:	(T)n		0.0006	0.0011	0/0/0	0.0099							613113 [NF1 (confirmed) Neurofibromatosis,type 1,162200|Leukemia,juvenile myelomonocytic,607785|Neurofibromatosis,familial spinal,162210|Neurofibromatosis-Noonan syndrome,601321|Watson syndrome,193520];				0	0					NF1 (inh=AD pLI=1.00)
chr17	29663625	29663625	-	A	hom	off-target	QUAL=840;DP=41;AF=0.78;MQM=60	NF1	splice_region&intron	NF1:ENST00000358273:splice_region&intron:LOW:exon41/57:c.6148-17dupA:,NF1:ENST00000356175:splice_region&intron:LOW:exon40/56:c.6085-17dupA:,NF1:ENST00000579081:splice_region&intron:LOW:exon41/57:c.*1313-17dupA:,NF1:ENST00000456735:splice_region&intron:LOW:exon32/49:c.5083-17dupA:,NF1:ENST00000479536:splice_region&intron:LOW:exon4/4:c.*329-17dupA:		rs33925668;rs553817239	0.3437	0.2734	758/301/165	0.2008							613113 [NF1 (confirmed) Neurofibromatosis,type 1,162200|Leukemia,juvenile myelomonocytic,607785|Neurofibromatosis,familial spinal,162210|Neurofibromatosis-Noonan syndrome,601321|Watson syndrome,193520];				50	47					NF1 (inh=AD pLI=1.00)
chr17	29670190	29670190	C	G	hom	off-target	QUAL=5223;DP=163;AF=1.00;MQM=60	NF1	intron	NF1:ENST00000358273:intron:MODIFIER:exon48/57:c.7189+37C>G:,NF1:ENST00000356175:intron:MODIFIER:exon47/56:c.7126+37C>G:,NF1:ENST00000579081:intron:MODIFIER:exon48/57:c.*2354+37C>G:,NF1:ENST00000456735:intron:MODIFIER:exon39/49:c.6124+37C>G:,NF1:ENST00000417592:intron:MODIFIER:exon3/10:c.328+37C>G:,NF1:ENST00000581790:intron:MODIFIER:exon3/10:c.331+37C>G:,NF1:ENST00000444181:intron:MODIFIER:exon5/16:c.568+37C>G:,NF1:ENST00000471572:intron:MODIFIER:exon5/16:c.571+37C>G:,NF1:ENST00000582892:intron:MODIFIER:exon2/2:n.431+37C>G:		rs7405740	0.8738	0.9069	47463/26412/3102	0.8764							613113 [NF1 (confirmed) Neurofibromatosis,type 1,162200|Leukemia,juvenile myelomonocytic,607785|Neurofibromatosis,familial spinal,162210|Neurofibromatosis-Noonan syndrome,601321|Watson syndrome,193520];	RCV000250694.1 [benign]; 			853	152					NF1 (inh=AD pLI=1.00)
chr17	33433487	33433487	C	T	hom		QUAL=2531;DP=85;AF=1.00;MQM=60	RAD51L3-RFFL,RAD51D	missense,5'UTR,3'UTR,non_coding_transcript_exon	RAD51L3-RFFL:ENST00000593039:missense:MODERATE:exon2/7:c.17G>A:p.Arg6Gln,RAD51D:ENST00000590016:missense:MODERATE:exon6/10:c.554G>A:p.Arg185Gln,RAD51L3-RFFL:ENST00000592181:missense:MODERATE:exon5/9:c.137G>A:p.Arg46Gln,RAD51D:ENST00000345365:missense:MODERATE:exon6/10:c.494G>A:p.Arg165Gln,RAD51D:ENST00000394589:missense:MODERATE:exon7/11:c.494G>A:p.Arg165Gln,RAD51D:ENST00000588372:missense:MODERATE:exon4/9:c.137G>A:p.Arg46Gln,RAD51D:ENST00000360276:missense:MODERATE:exon5/9:c.359G>A:p.Arg120Gln,RAD51D:ENST00000335858:missense:MODERATE:exon3/7:c.158G>A:p.Arg53Gln,RAD51D:ENST00000460118:missense:MODERATE:exon5/9:c.137G>A:p.Arg46Gln,RAD51D:ENST00000587405:missense:MODERATE:exon4/7:c.137G>A:p.Arg46Gln,RAD51D:ENST00000592577:missense:MODERATE:exon6/9:c.500G>A:p.Arg167Gln,RAD51L3-RFFL:ENST00000591723:5'UTR:MODIFIER:exon3/7:c.-38G>A:,RAD51D:ENST00000590631:5'UTR:MODIFIER:exon2/3:c.-38G>A:,RAD51D:ENST00000588594:3'UTR:MODIFIER:exon4/8:c.*90G>A:,RAD51D:ENST00000586044:3'UTR:MODIFIER:exon5/9:c.*225G>A:,RAD51D:ENST00000587977:3'UTR:MODIFIER:exon6/10:c.*234G>A:,RAD51D:ENST00000586210:3'UTR:MODIFIER:exon5/9:c.*88G>A:,RAD51D:ENST00000585343:3'UTR:MODIFIER:exon6/6:c.*316G>A:,RAD51D:ENST00000586186:3'UTR:MODIFIER:exon4/4:c.*150G>A:,RAD51D:ENST00000592850:3'UTR:MODIFIER:exon4/4:c.*99G>A:,RAD51D:ENST00000592928:3'UTR:MODIFIER:exon3/3:c.*68G>A:,RAD51D:ENST00000590380:non_coding_transcript_exon:MODIFIER:exon5/9:n.445G>A:,RAD51D:ENST00000415064:non_coding_transcript_exon:MODIFIER:exon6/8:n.644G>A:,RAD51D:ENST00000587982:non_coding_transcript_exon:MODIFIER:exon3/4:n.287G>A:,RAD51D:ENST00000592430:non_coding_transcript_exon:MODIFIER:exon4/5:n.463G>A:,RAD51D:ENST00000585947:non_coding_transcript_exon:MODIFIER:exon4/4:n.390G>A:,RAD51D:ENST00000585982:non_coding_transcript_exon:MODIFIER:exon5/5:n.514G>A:		rs4796033	0.0950	0.1593	1568/680/7	0.1412	1.3260	T,T,T,T,T,T,T	T	B,B,B,B	T,T	16.92	602954 [RAD51D (provisional) Breast-ovarian cancer,familial,susceptibility to,4,614291];	RCV000131069.3 [benign]; RCV000245575.1 [benign]; RCV000289914.1 [likely benign]; RCV000409134.1 [benign]; 			78	840	1	[1] Christopher Schroeder 27.04.2015			RAD51L3-RFFL (inh=n/a pLI=n/a), RAD51D (inh=AD pLI=0.00)
chr17	33445549	33445549	G	A	het		QUAL=1637;DP=132;AF=0.55;MQM=60	RAD51D,RAD51L3-RFFL	synonymous,5'UTR,3'UTR,intron,non_coding_transcript_exon	RAD51D:ENST00000345365:synonymous:LOW:exon3/10:c.234C>T:p.Ser78Ser,RAD51D:ENST00000394589:synonymous:LOW:exon4/11:c.234C>T:p.Ser78Ser,RAD51D:ENST00000360276:synonymous:LOW:exon3/9:c.234C>T:p.Ser78Ser,RAD51D:ENST00000587977:synonymous:LOW:exon3/10:c.234C>T:p.Ser78Ser,RAD51D:ENST00000586210:synonymous:LOW:exon3/9:c.234C>T:p.Ser78Ser,RAD51D:ENST00000592577:synonymous:LOW:exon3/9:c.240C>T:p.Ser80Ser,RAD51D:ENST00000585343:synonymous:LOW:exon2/6:c.135C>T:p.Ser45Ser,RAD51D:ENST00000592850:synonymous:LOW:exon2/4:c.135C>T:p.Ser45Ser,RAD51D:ENST00000357906:synonymous:LOW:exon3/4:c.234C>T:p.Ser78Ser,RAD51D:ENST00000460118:5'UTR:MODIFIER:exon3/9:c.-42C>T:,RAD51D:ENST00000586186:3'UTR:MODIFIER:exon2/4:c.*25C>T:,RAD51D:ENST00000592928:3'UTR:MODIFIER:exon2/3:c.*25C>T:,RAD51L3-RFFL:ENST00000593039:intron:MODIFIER:exon1/6:c.3+2761C>T:,RAD51D:ENST00000590016:intron:MODIFIER:exon2/9:c.144+581C>T:,RAD51L3-RFFL:ENST00000591723:intron:MODIFIER:exon1/6:c.-134+2761C>T:,RAD51L3-RFFL:ENST00000592181:intron:MODIFIER:exon2/8:c.-95+581C>T:,RAD51D:ENST00000588372:intron:MODIFIER:exon1/8:c.-95+2761C>T:,RAD51D:ENST00000588594:intron:MODIFIER:exon2/7:c.144+581C>T:,RAD51D:ENST00000335858:intron:MODIFIER:exon2/6:c.144+581C>T:,RAD51D:ENST00000586044:intron:MODIFIER:exon2/8:c.144+581C>T:,RAD51D:ENST00000590380:intron:MODIFIER:exon2/8:n.275+581C>T:,RAD51D:ENST00000587405:intron:MODIFIER:exon1/6:c.-95+2761C>T:,RAD51D:ENST00000590631:intron:MODIFIER:exon1/2:c.-52+581C>T:,RAD51D:ENST00000587982:intron:MODIFIER:exon1/3:n.191+2761C>T:,RAD51D:ENST00000592430:intron:MODIFIER:exon1/4:n.232+2761C>T:,RAD51D:ENST00000585947:intron:MODIFIER:exon1/3:n.159+2761C>T:,RAD51D:ENST00000585982:intron:MODIFIER:exon2/4:n.239+581C>T:,RAD51D:ENST00000589506:intron:MODIFIER:exon2/2:n.355+581C>T:,RAD51D:ENST00000415064:non_coding_transcript_exon:MODIFIER:exon3/8:n.384C>T:		rs9901455	0.1875	0.1184	1176/263/469	0.1175							602954 [RAD51D (provisional) Breast-ovarian cancer,familial,susceptibility to,4,614291];	RCV000162563.1 [benign]; RCV000253532.2 [benign]; RCV000402792.1 [likely benign]; RCV000411810.1 [benign]; 			38	621	1	[1] Ilnaz Sepahi 29-03-2016 batch import			RAD51D (inh=AD pLI=0.00), RAD51L3-RFFL (inh=n/a pLI=n/a)
chr17	41223094	41223094	T	C	het	pred_pathogenic	QUAL=4395;DP=434;AF=0.47;MQM=60	BRCA1	missense,sequence_feature,3'UTR,intron	BRCA1:ENST00000471181:missense:MODERATE:exon16/24:c.4900A>G:p.Ser1634Gly,BRCA1:ENST00000357654:missense:MODERATE:exon15/23:c.4837A>G:p.Ser1613Gly,BRCA1:ENST00000351666:missense:MODERATE:exon11/19:c.1288A>G:p.Ser430Gly,BRCA1:ENST00000309486:missense:MODERATE:exon14/22:c.3949A>G:p.Ser1317Gly,BRCA1:ENST00000352993:missense:MODERATE:exon14/22:c.1411A>G:p.Ser471Gly,BRCA1:ENST00000468300:missense:MODERATE:exon15/22:c.1525A>G:p.Ser509Gly,BRCA1:ENST00000591534:missense:MODERATE:exon3/11:c.310A>G:p.Ser104Gly,BRCA1:ENST00000493795:missense:MODERATE:exon14/22:c.4696A>G:p.Ser1566Gly,BRCA1:ENST00000491747:missense:MODERATE:exon15/23:c.1525A>G:p.Ser509Gly,BRCA1:ENST00000484087:missense:MODERATE:exon9/12:c.1150A>G:p.Ser384Gly,BRCA1:ENST00000478531:missense:MODERATE:exon15/18:c.1525A>G:p.Ser509Gly,BRCA1:ENST00000493919:missense:MODERATE:exon14/17:c.1387A>G:p.Ser463Gly,BRCA1:ENST00000471181:sequence_feature:MODERATE:exon16/24:c.4900A>G:,BRCA1:ENST00000357654:sequence_feature:MODERATE:exon15/23:c.4837A>G:,BRCA1:ENST00000352993:sequence_feature:MODERATE:exon14/22:c.1411A>G:,BRCA1:ENST00000468300:sequence_feature:MODERATE:exon15/22:c.1525A>G:,BRCA1:ENST00000493795:sequence_feature:MODERATE:exon14/22:c.4696A>G:,BRCA1:ENST00000491747:sequence_feature:MODERATE:exon15/23:c.1525A>G:,BRCA1:ENST00000461221:3'UTR:MODIFIER:exon15/23:c.*4620A>G:,BRCA1:ENST00000346315:intron:MODIFIER:exon12/18:c.4358-7126A>G:,BRCA1:ENST00000354071:intron:MODIFIER:exon12/17:c.4358-7704A>G:,BRCA1:ENST00000586385:intron:MODIFIER:exon1/7:c.5-7126A>G:,BRCA1:ENST00000591849:intron:MODIFIER:exon1/4:c.-98-20887A>G:		rs1799966	0.3558	0.3496	7852/3646/290	0.3439	-0.1120	D,T,D,T,D,T,T,T,D,.,D,D,D	T	B,B,B,B,B,B,B,B	D,D,D,D,D,D,D,D,D,D	0.55	113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1,604370|Pancreatic cancer,susceptibility to,4,614320];	RCV000031194.5 [other]; RCV000048673.4 [likely benign]; RCV000130704.3 [likely benign]; RCV000167795.2 [likely benign]; RCV000034753.3 [benign]; RCV000048672.5 [benign]; RCV000112410.5 [benign]; RCV000119096.3 [other]; RCV000120260.6 [benign]; RCV000128996.3 [benign]; 	CM1210129 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=BRCA1]; 	COSM3755560, COSM3755559	427	1574	2	[2] old entry - no details available			BRCA1 (inh=AD pLI=0.00)
chr17	41234470	41234470	A	G	het		QUAL=343;DP=34;AF=0.50;MQM=60	BRCA1	synonymous,3'UTR,intron	BRCA1:ENST00000471181:synonymous:LOW:exon12/24:c.4308T>C:p.Ser1436Ser,BRCA1:ENST00000357654:synonymous:LOW:exon12/23:c.4308T>C:p.Ser1436Ser,BRCA1:ENST00000351666:synonymous:LOW:exon8/19:c.759T>C:p.Ser253Ser,BRCA1:ENST00000309486:synonymous:LOW:exon11/22:c.3420T>C:p.Ser1140Ser,BRCA1:ENST00000346315:synonymous:LOW:exon12/19:c.4308T>C:p.Ser1436Ser,BRCA1:ENST00000352993:synonymous:LOW:exon11/22:c.882T>C:p.Ser294Ser,BRCA1:ENST00000354071:synonymous:LOW:exon12/18:c.4308T>C:p.Ser1436Ser,BRCA1:ENST00000468300:synonymous:LOW:exon12/22:c.999T>C:p.Ser333Ser,BRCA1:ENST00000493795:synonymous:LOW:exon11/22:c.4167T>C:p.Ser1389Ser,BRCA1:ENST00000491747:synonymous:LOW:exon12/23:c.999T>C:p.Ser333Ser,BRCA1:ENST00000484087:synonymous:LOW:exon6/12:c.621T>C:p.Ser207Ser,BRCA1:ENST00000478531:synonymous:LOW:exon12/18:c.996T>C:p.Ser332Ser,BRCA1:ENST00000493919:synonymous:LOW:exon11/17:c.858T>C:p.Ser286Ser,BRCA1:ENST00000487825:synonymous:LOW:exon6/7:c.624T>C:p.Ser208Ser,BRCA1:ENST00000461574:synonymous:LOW:exon3/4:c.600T>C:p.Ser200Ser,BRCA1:ENST00000461221:3'UTR:MODIFIER:exon12/23:c.*4091T>C:,BRCA1:ENST00000586385:intron:MODIFIER:exon1/7:c.5-18502T>C:,BRCA1:ENST00000591534:intron:MODIFIER:exon1/10:c.-43-7932T>C:,BRCA1:ENST00000591849:intron:MODIFIER:exon1/4:c.-98-32263T>C:		rs1060915	0.3363	0.3431	7653/3619/159	0.3380	-0.1190		T			4.96	113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1,604370|Pancreatic cancer,susceptibility to,4,614320];	RCV000112313.5 [benign]; RCV000114988.2 [benign]; RCV000128938.2 [benign]; RCV000152866.6 [benign]; RCV000311915.1 [likely benign]; 			423	1568	1	[1] Ulrike Faust 13.06.2015			BRCA1 (inh=AD pLI=0.00)
chr17	41244000	41244000	T	C	het		QUAL=4694;DP=350;AF=0.49;MQM=60	BRCA1	missense,3'UTR,intron,non_coding_transcript_exon	BRCA1:ENST00000471181:missense:MODERATE:exon10/24:c.3548A>G:p.Lys1183Arg,BRCA1:ENST00000357654:missense:MODERATE:exon10/23:c.3548A>G:p.Lys1183Arg,BRCA1:ENST00000309486:missense:MODERATE:exon9/22:c.2660A>G:p.Lys887Arg,BRCA1:ENST00000346315:missense:MODERATE:exon10/19:c.3548A>G:p.Lys1183Arg,BRCA1:ENST00000354071:missense:MODERATE:exon10/18:c.3548A>G:p.Lys1183Arg,BRCA1:ENST00000493795:missense:MODERATE:exon9/22:c.3407A>G:p.Lys1136Arg,BRCA1:ENST00000461221:3'UTR:MODIFIER:exon10/23:c.*3331A>G:,BRCA1:ENST00000351666:intron:MODIFIER:exon6/18:c.548-951A>G:,BRCA1:ENST00000352993:intron:MODIFIER:exon9/21:c.671-951A>G:,BRCA1:ENST00000468300:intron:MODIFIER:exon10/21:c.788-951A>G:,BRCA1:ENST00000586385:intron:MODIFIER:exon1/7:c.5-28032A>G:,BRCA1:ENST00000591534:intron:MODIFIER:exon1/10:c.-43-17462A>G:,BRCA1:ENST00000591849:intron:MODIFIER:exon1/4:c.-99+33288A>G:,BRCA1:ENST00000491747:intron:MODIFIER:exon10/22:c.788-951A>G:,BRCA1:ENST00000484087:intron:MODIFIER:exon4/11:c.410-951A>G:,BRCA1:ENST00000478531:intron:MODIFIER:exon10/17:c.785-951A>G:,BRCA1:ENST00000493919:intron:MODIFIER:exon9/16:c.647-951A>G:,BRCA1:ENST00000487825:intron:MODIFIER:exon4/6:c.413-951A>G:,BRCA1:ENST00000467274:non_coding_transcript_exon:MODIFIER:exon10/10:n.3612A>G:		rs16942	0.3526	0.3490	7768/3592/284	0.3419	-0.3650	T,T,T,T,T,T,T	T	B,B,B,B,B,B	T,T,T,T,T,T	0.01	113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1,604370|Pancreatic cancer,susceptibility to,4,614320];	RCV000034742.3 [benign]; RCV000048229.5 [other]; RCV000112115.5 [benign]; RCV000120278.6 [benign]; RCV000128991.4 [benign]; RCV000157734.1 [benign]; 	CM058359 [CLASS=DP MUT=ALT PHEN="Breast cancer protection against association with" GENE=BRCA1]; 	COSM3755561, COSM148277	422	1572	1	[1] old entry - no details available			BRCA1 (inh=AD pLI=0.00)
chr17	41244435	41244435	T	C	het	pred_pathogenic	QUAL=10833;DP=980;AF=0.49;MQM=60	BRCA1	missense,3'UTR,intron,non_coding_transcript_exon	BRCA1:ENST00000471181:missense:MODERATE:exon10/24:c.3113A>G:p.Glu1038Gly,BRCA1:ENST00000357654:missense:MODERATE:exon10/23:c.3113A>G:p.Glu1038Gly,BRCA1:ENST00000309486:missense:MODERATE:exon9/22:c.2225A>G:p.Glu742Gly,BRCA1:ENST00000346315:missense:MODERATE:exon10/19:c.3113A>G:p.Glu1038Gly,BRCA1:ENST00000354071:missense:MODERATE:exon10/18:c.3113A>G:p.Glu1038Gly,BRCA1:ENST00000493795:missense:MODERATE:exon9/22:c.2972A>G:p.Glu991Gly,BRCA1:ENST00000461221:3'UTR:MODIFIER:exon10/23:c.*2896A>G:,BRCA1:ENST00000351666:intron:MODIFIER:exon6/18:c.548-1386A>G:,BRCA1:ENST00000352993:intron:MODIFIER:exon9/21:c.671-1386A>G:,BRCA1:ENST00000468300:intron:MODIFIER:exon10/21:c.788-1386A>G:,BRCA1:ENST00000586385:intron:MODIFIER:exon1/7:c.5-28467A>G:,BRCA1:ENST00000591534:intron:MODIFIER:exon1/10:c.-43-17897A>G:,BRCA1:ENST00000591849:intron:MODIFIER:exon1/4:c.-99+32853A>G:,BRCA1:ENST00000491747:intron:MODIFIER:exon10/22:c.788-1386A>G:,BRCA1:ENST00000484087:intron:MODIFIER:exon4/11:c.410-1386A>G:,BRCA1:ENST00000478531:intron:MODIFIER:exon10/17:c.785-1386A>G:,BRCA1:ENST00000493919:intron:MODIFIER:exon9/16:c.647-1386A>G:,BRCA1:ENST00000487825:intron:MODIFIER:exon4/6:c.413-1386A>G:,BRCA1:ENST00000467274:non_coding_transcript_exon:MODIFIER:exon10/10:n.3177A>G:		rs16941	0.3357	0.3429	7641/3610/156	0.3259	-0.4800	D,D,D,D,D,D,D	T	B,B,B,B,P,B	T,T,T,T,T,T	22.20	113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1,604370|Pancreatic cancer,susceptibility to,4,614320];	RCV000034738.3 [benign]; RCV000112006.5 [benign]; RCV000114987.2 [benign]; RCV000120276.7 [benign]; RCV000128978.3 [benign]; RCV000353897.1 [likely benign]; RCV000233884.1 [uncertain significance]; 	CM032861 [CLASS=DP MUT=ALT PHEN="Endometriosis association with" GENE=BRCA1]; 	COSM3755563, COSM3755562	420	1569	1	[1] old entry - no details available			BRCA1 (inh=AD pLI=0.00)
chr17	41244936	41244936	G	A	het	pred_pathogenic	QUAL=2131;DP=132;AF=0.58;MQM=60	BRCA1	missense,3'UTR,intron,non_coding_transcript_exon	BRCA1:ENST00000471181:missense:MODERATE:exon10/24:c.2612C>T:p.Pro871Leu,BRCA1:ENST00000357654:missense:MODERATE:exon10/23:c.2612C>T:p.Pro871Leu,BRCA1:ENST00000309486:missense:MODERATE:exon9/22:c.1724C>T:p.Pro575Leu,BRCA1:ENST00000346315:missense:MODERATE:exon10/19:c.2612C>T:p.Pro871Leu,BRCA1:ENST00000354071:missense:MODERATE:exon10/18:c.2612C>T:p.Pro871Leu,BRCA1:ENST00000493795:missense:MODERATE:exon9/22:c.2471C>T:p.Pro824Leu,BRCA1:ENST00000461221:3'UTR:MODIFIER:exon10/23:c.*2395C>T:,BRCA1:ENST00000351666:intron:MODIFIER:exon6/18:c.548-1887C>T:,BRCA1:ENST00000352993:intron:MODIFIER:exon9/21:c.671-1887C>T:,BRCA1:ENST00000468300:intron:MODIFIER:exon10/21:c.787+1825C>T:,BRCA1:ENST00000586385:intron:MODIFIER:exon1/7:c.5-28968C>T:,BRCA1:ENST00000591534:intron:MODIFIER:exon1/10:c.-43-18398C>T:,BRCA1:ENST00000591849:intron:MODIFIER:exon1/4:c.-99+32352C>T:,BRCA1:ENST00000491747:intron:MODIFIER:exon10/22:c.787+1825C>T:,BRCA1:ENST00000484087:intron:MODIFIER:exon4/11:c.409+1825C>T:,BRCA1:ENST00000478531:intron:MODIFIER:exon10/17:c.784+1825C>T:,BRCA1:ENST00000493919:intron:MODIFIER:exon9/16:c.646+1825C>T:,BRCA1:ENST00000487825:intron:MODIFIER:exon4/6:c.412+1825C>T:,BRCA1:ENST00000467274:non_coding_transcript_exon:MODIFIER:exon10/10:n.2676C>T:		rs799917	0.5439	0.4100	11586/3799/3500	0.4022	4.2460	T,T,T,T,T,T,T	T	B,B,B,B,B,B	T,T,T,T,T,T	14.03	113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1,604370|Pancreatic cancer,susceptibility to,4,614320];	RCV000034735.3 [benign]; RCV000111903.5 [benign]; RCV000114986.2 [benign]; RCV000120285.6 [benign]; RCV000132149.4 [benign]; RCV000261383.1 [likely benign]; RCV000077111.2 [likely benign]; RCV000221093.1 [uncertain significance]; RCV000047899.2 [not provided]; RCV000111902.1 [uncertain significance]; 	CM096315 [CLASS=DFP MUT=ALT PHEN="Cervical cancer decreased risk association with" GENE=BRCA1]; 	COSM148278, COSM3755564	471	1592	1	[1] Christopher Schroeder 27.04.2015			BRCA1 (inh=AD pLI=0.00)
chr17	41245237	41245237	A	G	het		QUAL=1538;DP=127;AF=0.46;MQM=60	BRCA1	synonymous,3'UTR,intron,non_coding_transcript_exon	BRCA1:ENST00000471181:synonymous:LOW:exon10/24:c.2311T>C:p.Leu771Leu,BRCA1:ENST00000357654:synonymous:LOW:exon10/23:c.2311T>C:p.Leu771Leu,BRCA1:ENST00000309486:synonymous:LOW:exon9/22:c.1423T>C:p.Leu475Leu,BRCA1:ENST00000346315:synonymous:LOW:exon10/19:c.2311T>C:p.Leu771Leu,BRCA1:ENST00000354071:synonymous:LOW:exon10/18:c.2311T>C:p.Leu771Leu,BRCA1:ENST00000493795:synonymous:LOW:exon9/22:c.2170T>C:p.Leu724Leu,BRCA1:ENST00000461221:3'UTR:MODIFIER:exon10/23:c.*2094T>C:,BRCA1:ENST00000351666:intron:MODIFIER:exon6/18:c.548-2188T>C:,BRCA1:ENST00000352993:intron:MODIFIER:exon9/21:c.671-2188T>C:,BRCA1:ENST00000468300:intron:MODIFIER:exon10/21:c.787+1524T>C:,BRCA1:ENST00000586385:intron:MODIFIER:exon1/7:c.5-29269T>C:,BRCA1:ENST00000591534:intron:MODIFIER:exon1/10:c.-43-18699T>C:,BRCA1:ENST00000591849:intron:MODIFIER:exon1/4:c.-99+32051T>C:,BRCA1:ENST00000491747:intron:MODIFIER:exon10/22:c.787+1524T>C:,BRCA1:ENST00000484087:intron:MODIFIER:exon4/11:c.409+1524T>C:,BRCA1:ENST00000478531:intron:MODIFIER:exon10/17:c.784+1524T>C:,BRCA1:ENST00000493919:intron:MODIFIER:exon9/16:c.646+1524T>C:,BRCA1:ENST00000487825:intron:MODIFIER:exon4/6:c.412+1524T>C:,BRCA1:ENST00000467274:non_coding_transcript_exon:MODIFIER:exon10/10:n.2375T>C:		rs16940	0.3353	0.3420	7603/3578/154	0.3276							113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1,604370|Pancreatic cancer,susceptibility to,4,614320];	RCV000111822.5 [benign]; RCV000114985.2 [benign]; RCV000128982.2 [benign]; RCV000152867.5 [benign]; RCV000264575.1 [likely benign]; 		COSM3755566, COSM3755565	416	1568	1	[1] Ulrike Faust 13.06.2015			BRCA1 (inh=AD pLI=0.00)
chr17	41245466	41245466	G	A	het		QUAL=460;DP=62;AF=0.44;MQM=60	BRCA1	sequence_feature,synonymous,3'UTR,intron,non_coding_transcript_exon	BRCA1:ENST00000471181:sequence_feature:MODERATE:exon10/24:c.2082C>T:,BRCA1:ENST00000471181:sequence_feature:MODERATE:exon10/24:c.2082C>T:,BRCA1:ENST00000357654:sequence_feature:MODERATE:exon10/23:c.2082C>T:,BRCA1:ENST00000357654:sequence_feature:MODERATE:exon10/23:c.2082C>T:,BRCA1:ENST00000493795:sequence_feature:MODERATE:exon9/22:c.1941C>T:,BRCA1:ENST00000493795:sequence_feature:MODERATE:exon9/22:c.1941C>T:,BRCA1:ENST00000471181:synonymous:LOW:exon10/24:c.2082C>T:p.Ser694Ser,BRCA1:ENST00000357654:synonymous:LOW:exon10/23:c.2082C>T:p.Ser694Ser,BRCA1:ENST00000309486:synonymous:LOW:exon9/22:c.1194C>T:p.Ser398Ser,BRCA1:ENST00000346315:synonymous:LOW:exon10/19:c.2082C>T:p.Ser694Ser,BRCA1:ENST00000354071:synonymous:LOW:exon10/18:c.2082C>T:p.Ser694Ser,BRCA1:ENST00000493795:synonymous:LOW:exon9/22:c.1941C>T:p.Ser647Ser,BRCA1:ENST00000461221:3'UTR:MODIFIER:exon10/23:c.*1865C>T:,BRCA1:ENST00000351666:intron:MODIFIER:exon6/18:c.548-2417C>T:,BRCA1:ENST00000352993:intron:MODIFIER:exon9/21:c.670+2397C>T:,BRCA1:ENST00000468300:intron:MODIFIER:exon10/21:c.787+1295C>T:,BRCA1:ENST00000586385:intron:MODIFIER:exon1/7:c.5-29498C>T:,BRCA1:ENST00000591534:intron:MODIFIER:exon1/10:c.-43-18928C>T:,BRCA1:ENST00000591849:intron:MODIFIER:exon1/4:c.-99+31822C>T:,BRCA1:ENST00000491747:intron:MODIFIER:exon10/22:c.787+1295C>T:,BRCA1:ENST00000484087:intron:MODIFIER:exon4/11:c.409+1295C>T:,BRCA1:ENST00000478531:intron:MODIFIER:exon10/17:c.784+1295C>T:,BRCA1:ENST00000493919:intron:MODIFIER:exon9/16:c.646+1295C>T:,BRCA1:ENST00000487825:intron:MODIFIER:exon4/6:c.412+1295C>T:,BRCA1:ENST00000467274:non_coding_transcript_exon:MODIFIER:exon10/10:n.2146C>T:		rs1799949	0.3365	0.3483	7796/3607/286	0.3388							113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1,604370|Pancreatic cancer,susceptibility to,4,614320];	RCV000111763.4 [benign]; RCV000114984.2 [benign]; RCV000128966.3 [benign]; RCV000152868.6 [benign]; RCV000322007.1 [likely benign]; 		COSM148280, COSM3755567	421	1571	1	[1] Ulrike Faust 13.06.2015			BRCA1 (inh=AD pLI=0.00)
chr17	41249364	41249364	A	-	het	off-target	QUAL=594;DP=70;AF=0.39;MQM=60	BRCA1	intron	BRCA1:ENST00000471181:intron:MODIFIER:exon7/23:c.548-58delT:,BRCA1:ENST00000357654:intron:MODIFIER:exon7/22:c.548-58delT:,BRCA1:ENST00000351666:intron:MODIFIER:exon6/18:c.547+2428delT:,BRCA1:ENST00000309486:intron:MODIFIER:exon6/21:c.-341-58delT:,BRCA1:ENST00000346315:intron:MODIFIER:exon7/18:c.548-58delT:,BRCA1:ENST00000352993:intron:MODIFIER:exon7/21:c.548-58delT:,BRCA1:ENST00000354071:intron:MODIFIER:exon7/17:c.548-58delT:,BRCA1:ENST00000468300:intron:MODIFIER:exon7/21:c.548-58delT:,BRCA1:ENST00000586385:intron:MODIFIER:exon1/7:c.4+27835delT:,BRCA1:ENST00000591534:intron:MODIFIER:exon1/10:c.-43-22826delT:,BRCA1:ENST00000591849:intron:MODIFIER:exon1/4:c.-99+27924delT:,BRCA1:ENST00000493795:intron:MODIFIER:exon6/21:c.407-58delT:,BRCA1:ENST00000461221:intron:MODIFIER:exon7/22:c.*331-58delT:,BRCA1:ENST00000491747:intron:MODIFIER:exon7/22:c.548-58delT:,BRCA1:ENST00000484087:intron:MODIFIER:exon3/11:c.292+2428delT:,BRCA1:ENST00000478531:intron:MODIFIER:exon7/17:c.545-58delT:,BRCA1:ENST00000493919:intron:MODIFIER:exon6/16:c.407-58delT:,BRCA1:ENST00000487825:intron:MODIFIER:exon3/6:c.295+2428delT:,BRCA1:ENST00000467274:intron:MODIFIER:exon7/9:n.612-58delT:,BRCA1:ENST00000470026:intron:MODIFIER:exon7/9:c.548-58delT:,BRCA1:ENST00000477152:intron:MODIFIER:exon6/8:c.470-58delT:,BRCA1:ENST00000492859:intron:MODIFIER:exon8/10:c.*484-58delT:,BRCA1:ENST00000497488:intron:MODIFIER:exon1/1:c.-218-2487delT:,BRCA1:ENST00000494123:intron:MODIFIER:exon7/9:c.548-58delT:,BRCA1:ENST00000473961:intron:MODIFIER:exon3/3:c.265+2428delT:,BRCA1:ENST00000476777:intron:MODIFIER:exon7/8:c.545-58delT:		rs273902772	0.3349	0.0000	0/0/0	0.3013							113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1,604370|Pancreatic cancer,susceptibility to,4,614320];	RCV000112738.3,RCV000112738.3 [benign,benign]; 			144	488					BRCA1 (inh=AD pLI=0.00)
chr17	41256101	41256103	AAG	-	het	off-target;low_QUAL;low_DP	QUAL=7;DP=11;AF=0.27;MQM=60	BRCA1	intron	BRCA1:ENST00000471181:intron:MODIFIER:exon6/23:c.441+36_441+38delCTT:,BRCA1:ENST00000357654:intron:MODIFIER:exon6/22:c.441+36_441+38delCTT:,BRCA1:ENST00000351666:intron:MODIFIER:exon5/18:c.441+36_441+38delCTT:,BRCA1:ENST00000309486:intron:MODIFIER:exon5/21:c.-448+36_-448+38delCTT:,BRCA1:ENST00000346315:intron:MODIFIER:exon6/18:c.441+36_441+38delCTT:,BRCA1:ENST00000352993:intron:MODIFIER:exon6/21:c.441+36_441+38delCTT:,BRCA1:ENST00000354071:intron:MODIFIER:exon6/17:c.441+36_441+38delCTT:,BRCA1:ENST00000468300:intron:MODIFIER:exon6/21:c.441+36_441+38delCTT:,BRCA1:ENST00000586385:intron:MODIFIER:exon1/7:c.4+21096_4+21098delCTT:,BRCA1:ENST00000591534:intron:MODIFIER:exon1/10:c.-44+21185_-44+21187delCTT:,BRCA1:ENST00000591849:intron:MODIFIER:exon1/4:c.-99+21185_-99+21187delCTT:,BRCA1:ENST00000493795:intron:MODIFIER:exon5/21:c.300+36_300+38delCTT:,BRCA1:ENST00000461221:intron:MODIFIER:exon6/22:c.*227+36_*227+38delCTT:,BRCA1:ENST00000491747:intron:MODIFIER:exon6/22:c.441+36_441+38delCTT:,BRCA1:ENST00000484087:intron:MODIFIER:exon2/11:c.189+36_189+38delCTT:,BRCA1:ENST00000478531:intron:MODIFIER:exon6/17:c.441+36_441+38delCTT:,BRCA1:ENST00000493919:intron:MODIFIER:exon5/16:c.300+36_300+38delCTT:,BRCA1:ENST00000487825:intron:MODIFIER:exon2/6:c.189+36_189+38delCTT:,BRCA1:ENST00000467274:intron:MODIFIER:exon6/9:n.505+36_505+38delCTT:,BRCA1:ENST00000470026:intron:MODIFIER:exon6/9:c.441+36_441+38delCTT:,BRCA1:ENST00000477152:intron:MODIFIER:exon5/8:c.363+36_363+38delCTT:,BRCA1:ENST00000492859:intron:MODIFIER:exon7/10:c.*377+36_*377+38delCTT:,BRCA1:ENST00000497488:intron:MODIFIER:exon1/1:c.-218-9226_-218-9224delCTT:,BRCA1:ENST00000494123:intron:MODIFIER:exon6/9:c.441+36_441+38delCTT:,BRCA1:ENST00000473961:intron:MODIFIER:exon2/3:c.162+36_162+38delCTT:,BRCA1:ENST00000476777:intron:MODIFIER:exon6/8:c.441+36_441+38delCTT:,BRCA1:ENST00000461798:intron:MODIFIER:exon6/6:c.*227+36_*227+38delCTT:	(AAG)n	rs147856441;rs730881450	0.3948	0.0074	11/7/0	0.0276							113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1,604370|Pancreatic cancer,susceptibility to,4,614320];	RCV000159863.1 [benign]; RCV000210985.1,RCV000159863.1 [benign,benign]; RCV000210985.1 [benign]; 			143	498					BRCA1 (inh=AD pLI=0.00)
chr17	56769979	56769979	C	T	het	off-target	QUAL=11259;DP=987;AF=0.46;MQM=60	RAD51C	5'UTR,non_coding_transcript_exon	RAD51C:ENST00000337432:5'UTR:MODIFIER:exon1/9:c.-26C>T:,RAD51C:ENST00000461271:5'UTR:MODIFIER:exon1/5:c.-274C>T:,RAD51C:ENST00000583539:5'UTR:MODIFIER:exon1/8:c.-26C>T:,RAD51C:ENST00000475762:5'UTR:MODIFIER:exon1/8:c.-26C>T:,RAD51C:ENST00000486827:5'UTR:MODIFIER:exon1/2:c.-26C>T:,RAD51C:ENST00000487525:5'UTR:MODIFIER:exon1/9:c.-26C>T:,RAD51C:ENST00000482007:5'UTR:MODIFIER:exon1/8:c.-26C>T:,RAD51C:ENST00000487921:non_coding_transcript_exon:MODIFIER:exon1/5:n.43C>T:,RAD51C:ENST00000476741:non_coding_transcript_exon:MODIFIER:exon1/2:n.17C>T:		rs12946397	0.1583	0.1797	2089/1377/92	0.1795							602774 [RAD51C (provisional) Fanconi anemia,complementation group O,613390|Breast-ovarian cancer,familial,susceptibility to,3,613399];	RCV000269140.1 [likely benign]; RCV000381874.1 [likely benign]; 			47	316					RAD51C (inh=AR+AD pLI=0.00)
chr17	56798207	56798207	T	C	het	off-target	QUAL=203;DP=27;AF=0.44;MQM=60	RAD51C	intron	RAD51C:ENST00000337432:intron:MODIFIER:exon6/8:c.904+34T>C:,RAD51C:ENST00000583539:intron:MODIFIER:exon6/7:c.904+34T>C:,RAD51C:ENST00000475762:intron:MODIFIER:exon5/7:c.*1541-3194T>C:,RAD51C:ENST00000487525:intron:MODIFIER:exon6/8:c.*477+34T>C:,RAD51C:ENST00000482007:intron:MODIFIER:exon5/7:c.*332+34T>C:,RAD51C:ENST00000584617:intron:MODIFIER:exon5/6:c.*483+34T>C:,RAD51C:ENST00000413590:intron:MODIFIER:exon5/7:c.541+34T>C:,RAD51C:ENST00000581221:intron:MODIFIER:exon2/4:n.419+34T>C:,RAD51C:ENST00000578151:intron:MODIFIER:exon2/2:n.239+34T>C:,RAD51C:ENST00000584804:intron:MODIFIER:exon2/3:c.199+34T>C:		rs28363318	0.2053	0.2800	5250/3988/381	0.2674							602774 [RAD51C (provisional) Fanconi anemia,complementation group O,613390|Breast-ovarian cancer,familial,susceptibility to,3,613399];				117	458					RAD51C (inh=AR+AD pLI=0.00)
chr17	59760996	59760996	A	G	hom		QUAL=7621;DP=310;AF=1.00;MQM=60	BRIP1	synonymous	BRIP1:ENST00000259008:synonymous:LOW:exon20/20:c.3411T>C:p.Tyr1137Tyr		rs4986763	0.6208	0.5941	22043/11338/2201	0.5943							605882 [BRIP1 (confirmed) Breast cancer,early-onset,114480|Fanconi anemia,complementation group J,609054];	RCV000162378.1 [benign]; RCV000251677.1 [benign]; RCV000283962.1 [likely benign]; RCV000341269.1 [likely benign]; RCV000410144.1 [benign]; RCV000411217.1 [benign]; 			1229	1685	1	[1] Ilnaz Sepahi 29-03-2016 batch import			BRIP1 (inh=AR+AD pLI=0.00)
chr17	59763347	59763347	A	G	hom	low_DP	QUAL=369;DP=12;AF=1.00;MQM=60	BRIP1	missense	BRIP1:ENST00000259008:missense:MODERATE:exon19/20:c.2755T>C:p.Ser919Pro,BRIP1:ENST00000577598:missense:MODERATE:exon18/18:c.2755T>C:p.Ser919Pro		rs4986764	0.6278	0.5972	22365/11454/2344	0.5828	0.1360	T	T	B	T	0.20	605882 [BRIP1 (confirmed) Breast cancer,early-onset,114480|Fanconi anemia,complementation group J,609054];	RCV000120400.2 [benign]; RCV000132148.2 [benign]; RCV000286073.1 [likely benign]; RCV000377937.1 [likely benign]; RCV000410195.1 [benign]; RCV000412161.1 [benign]; 	CM046104 [CLASS=DP MUT=REF PHEN="Breast cancer association with" GENE=BRIP1]; 		1234	1686	1	[1] Ilnaz Sepahi 29-03-2016 batch import			BRIP1 (inh=AR+AD pLI=0.00)
chr17	59763465	59763465	T	C	hom		QUAL=3671;DP=114;AF=1.00;MQM=60	BRIP1	synonymous	BRIP1:ENST00000259008:synonymous:LOW:exon19/20:c.2637A>G:p.Glu879Glu,BRIP1:ENST00000577598:synonymous:LOW:exon18/18:c.2637A>G:p.Glu879Glu		rs4986765	0.8151	0.7188	32088/14734/4248	0.7134							605882 [BRIP1 (confirmed) Breast cancer,early-onset,114480|Fanconi anemia,complementation group J,609054];	RCV000162379.1 [benign]; RCV000242120.1 [benign]; RCV000290016.1 [likely benign]; RCV000347348.1 [likely benign]; RCV000410880.1 [benign]; RCV000412411.1 [benign]; 		COSM437064, COSM1479821	1670	1518	1	[1] Ilnaz Sepahi 29-03-2016 batch import			BRIP1 (inh=AR+AD pLI=0.00)
chr17	59857600	59857600	A	-	het	off-target;low_QUAL	QUAL=14;DP=28;AF=0.21;MQM=60	BRIP1	intron	BRIP1:ENST00000259008:intron:MODIFIER:exon13/19:c.1935+22delT:,BRIP1:ENST00000577598:intron:MODIFIER:exon12/17:c.1935+22delT:,BRIP1:ENST00000583837:intron:MODIFIER:exon1/2:n.17+22delT:,BRIP1:ENST00000579028:intron:MODIFIER:exon5/5:c.*374+22delT:		rs763913233	0.0000	0.0160	0/0/0	0.0126							605882 [BRIP1 (confirmed) Breast cancer,early-onset,114480|Fanconi anemia,complementation group J,609054];				0	0					BRIP1 (inh=AR+AD pLI=0.00)
chr17	59857809	59857809	C	G	het	off-target;low_DP	QUAL=183;DP=14;AF=0.64;MQM=60	BRIP1	intron	BRIP1:ENST00000259008:intron:MODIFIER:exon12/19:c.1795-47G>C:,BRIP1:ENST00000577598:intron:MODIFIER:exon11/17:c.1795-47G>C:,BRIP1:ENST00000579028:intron:MODIFIER:exon4/5:c.*234-47G>C:	AluJb	rs4988351	0.7897	0.7476	33638/18248/3568	0.7172							605882 [BRIP1 (confirmed) Breast cancer,early-onset,114480|Fanconi anemia,complementation group J,609054];	RCV000250336.1 [benign]; 		COSN165483	621	330					BRIP1 (inh=AR+AD pLI=0.00)
chr18	19995753	19995753	T	C	hom	low_DP	QUAL=461;DP=19;AF=1.00;MQM=60	CTAGE1	synonymous	CTAGE1:ENST00000391403:synonymous:LOW:exon1/1:c.2022A>G:p.Pro674Pro		rs9946145	0.6855	0.8453	44643/28030/667	0.8003											1349	302					CTAGE1 (inh=n/a pLI=0.00)
chr18	19996011	19996011	G	A	het		QUAL=1512;DP=133;AF=0.46;MQM=60	CTAGE1	synonymous	CTAGE1:ENST00000391403:synonymous:LOW:exon1/1:c.1764C>T:p.Leu588Leu		rs7227477	0.4942	0.4999	15457/8071/1094	0.4627											433	850					CTAGE1 (inh=n/a pLI=0.00)
chr18	20555219	20555219	T	C	hom	off-target	QUAL=2177;DP=70;AF=1.00;MQM=60	RBBP8	intron	RBBP8:ENST00000360790:intron:MODIFIER:exon6/18:c.428+37T>C:,RBBP8:ENST00000582354:intron:MODIFIER:exon8/9:c.428+37T>C:,RBBP8:ENST00000327155:intron:MODIFIER:exon6/18:c.428+37T>C:,RBBP8:ENST00000399722:intron:MODIFIER:exon6/18:c.428+37T>C:,RBBP8:ENST00000399725:intron:MODIFIER:exon6/17:c.428+37T>C:,RBBP8:ENST00000399721:intron:MODIFIER:exon6/10:c.428+37T>C:,RBBP8:ENST00000577445:intron:MODIFIER:exon2/5:c.143+37T>C:,RBBP8:ENST00000585177:intron:MODIFIER:exon1/5:c.38+37T>C:		rs2336916	0.9157	0.9626	54138/30894/3453	0.9110							604124 [RBBP8 (provisional) Pancreatic carcinoma,somatic|Seckel syndrome 2,606744|Jawad syndrome,251255];				1074	67					RBBP8 (inh=AR pLI=0.00)
chr18	20564801	20564803	TCA	-	het	off-target	QUAL=362;DP=32;AF=0.47;MQM=60	RBBP8	intron	RBBP8:ENST00000360790:intron:MODIFIER:exon7/18:c.605-41_605-39delCAT:,RBBP8:ENST00000582354:intron:MODIFIER:exon9/9:c.605-41_605-39delCAT:,RBBP8:ENST00000327155:intron:MODIFIER:exon7/18:c.605-41_605-39delCAT:,RBBP8:ENST00000399722:intron:MODIFIER:exon7/18:c.605-41_605-39delCAT:,RBBP8:ENST00000399725:intron:MODIFIER:exon7/17:c.605-41_605-39delCAT:,RBBP8:ENST00000399721:intron:MODIFIER:exon7/10:c.605-41_605-39delCAT:,RBBP8:ENST00000577445:intron:MODIFIER:exon3/5:c.320-41_320-39delCAT:,RBBP8:ENST00000585177:intron:MODIFIER:exon3/5:c.*178-41_*178-39delCAT:		rs34354995	0.4517	0.5698	18103/12215/199	0.5118							604124 [RBBP8 (provisional) Pancreatic carcinoma,somatic|Seckel syndrome 2,606744|Jawad syndrome,251255];				394	419					RBBP8 (inh=AR pLI=0.00)
chr18	48584855	48584855	-	TT	het	off-target	QUAL=2462;DP=234;AF=0.41;MQM=59	SMAD4	intron	SMAD4:ENST00000342988:intron:MODIFIER:exon7/11:c.904+44_904+45dupTT:,SMAD4:ENST00000398417:intron:MODIFIER:exon7/11:c.904+44_904+45dupTT:,SMAD4:ENST00000588745:intron:MODIFIER:exon4/7:c.667+3507_667+3508dupTT:,SMAD4:ENST00000592186:intron:MODIFIER:exon6/8:c.904+44_904+45dupTT:,SMAD4:ENST00000591126:intron:MODIFIER:exon3/7:n.2905+44_2905+45dupTT:		rs397686427;rs57847829;rs760402978	0.0118	0.1541	617/388/11	0.1198							600993 [SMAD4 (confirmed) Pancreatic cancer,somatic,260350|Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome,175050|Myhre syndrome,139210|Polyposis,juvenile intestinal,174900];				4	127					SMAD4 (inh=AD pLI=0.97)
chr18	48584855	48584855	-	T	het	off-target	QUAL=2462;DP=234;AF=0.16;MQM=60	SMAD4	intron	SMAD4:ENST00000342988:intron:MODIFIER:exon7/11:c.904+45dupT:,SMAD4:ENST00000398417:intron:MODIFIER:exon7/11:c.904+45dupT:,SMAD4:ENST00000588745:intron:MODIFIER:exon4/7:c.667+3508dupT:,SMAD4:ENST00000592186:intron:MODIFIER:exon6/8:c.904+45dupT:,SMAD4:ENST00000591126:intron:MODIFIER:exon3/7:n.2905+45dupT:		rs57847829;rs760402978	0.0066	0.1914	355/191/19	0.1280							600993 [SMAD4 (confirmed) Pancreatic cancer,somatic,260350|Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome,175050|Myhre syndrome,139210|Polyposis,juvenile intestinal,174900];				2	65					SMAD4 (inh=AD pLI=0.97)
chr19	17379558	17379558	C	T	het	off-target	QUAL=1316;DP=109;AF=0.48;MQM=60	BABAM1,CTD-2278I10.6,USHBP1	splice_region&intron,5'UTR,intron	BABAM1:ENST00000359435:splice_region&intron:LOW:exon1/8:c.-51-7C>T:,BABAM1:ENST00000599474:splice_region&intron:LOW:exon1/6:c.-51-7C>T:,BABAM1:ENST00000595632:splice_region&intron:LOW:exon1/5:c.-51-7C>T:,BABAM1:ENST00000601938:splice_region&intron:LOW:exon1/6:c.37-7C>T:,BABAM1:ENST00000602066:5'UTR:MODIFIER:exon1/6:c.-58C>T:,CTD-2278I10.6:ENST00000596542:intron:MODIFIER:exon1/9:c.-188-45C>T:,USHBP1:ENST00000598309:intron:MODIFIER:exon2/3:c.-48-4402G>A:,BABAM1:ENST00000598188:intron:MODIFIER:exon1/8:c.-13-45C>T:,BABAM1:ENST00000594247:intron:MODIFIER:exon1/8:c.-13-45C>T:,BABAM1:ENST00000599057:intron:MODIFIER:exon1/4:c.-5-53C>T:,BABAM1:ENST00000595393:intron:MODIFIER:exon1/3:n.86-45C>T:,BABAM1:ENST00000447614:intron:MODIFIER:exon1/8:c.-13-45C>T:,BABAM1:ENST00000601043:intron:MODIFIER:exon1/8:c.-13-45C>T:,BABAM1:ENST00000601171:intron:MODIFIER:exon1/5:c.-13-45C>T:,BABAM1:ENST00000596335:intron:MODIFIER:exon1/6:c.-13-45C>T:,BABAM1:ENST00000601436:intron:MODIFIER:exon1/5:c.-13-45C>T:,BABAM1:ENST00000448635:intron:MODIFIER:exon1/4:n.51-45C>T:		rs10424178	0.1727	0.3600	1239/714/323	0.1515											23	312					BABAM1 (inh=n/a pLI=0.73), CTD-2278I10.6 (inh=n/a pLI=n/a), USHBP1 (inh=n/a pLI=0.00)
chr19	17382505	17382505	A	T	het	off-target	QUAL=331;DP=49;AF=0.37;MQM=60	BABAM1,CTD-2278I10.6,USHBP1	intron	BABAM1:ENST00000359435:intron:MODIFIER:exon3/8:c.344+41A>T:,CTD-2278I10.6:ENST00000596542:intron:MODIFIER:exon2/9:c.111-2208A>T:,USHBP1:ENST00000598309:intron:MODIFIER:exon2/3:c.-49+2717T>A:,BABAM1:ENST00000598188:intron:MODIFIER:exon3/8:c.344+41A>T:,BABAM1:ENST00000594247:intron:MODIFIER:exon2/8:c.286-2208A>T:,BABAM1:ENST00000599474:intron:MODIFIER:exon3/6:c.344+41A>T:,BABAM1:ENST00000599057:intron:MODIFIER:exon3/4:c.344+41A>T:,BABAM1:ENST00000595393:intron:MODIFIER:exon3/3:n.442+41A>T:,BABAM1:ENST00000447614:intron:MODIFIER:exon3/8:c.344+41A>T:,BABAM1:ENST00000601043:intron:MODIFIER:exon3/8:c.344+41A>T:,BABAM1:ENST00000601171:intron:MODIFIER:exon4/5:c.*58+41A>T:,BABAM1:ENST00000596335:intron:MODIFIER:exon3/6:c.344+41A>T:,BABAM1:ENST00000601436:intron:MODIFIER:exon3/5:c.344+41A>T:,BABAM1:ENST00000448635:intron:MODIFIER:exon3/4:n.407+41A>T:,BABAM1:ENST00000595632:intron:MODIFIER:exon3/5:c.344+41A>T:,BABAM1:ENST00000601938:intron:MODIFIER:exon3/6:c.431+41A>T:,BABAM1:ENST00000602066:intron:MODIFIER:exon2/5:c.344+41A>T:,BABAM1:ENST00000598567:intron:MODIFIER:exon2/3:c.152+41A>T:		rs10420922	0.4631	0.4367	10978/5948/2038	0.4150											175	494					BABAM1 (inh=n/a pLI=0.73), CTD-2278I10.6 (inh=n/a pLI=n/a), USHBP1 (inh=n/a pLI=0.00)
chr19	17387254	17387254	G	A	het	off-target	QUAL=1375;DP=102;AF=0.52;MQM=60	BABAM1,CTD-2278I10.6,USHBP1	intron,non_coding_transcript_exon	BABAM1:ENST00000359435:intron:MODIFIER:exon6/8:c.570-50G>A:,CTD-2278I10.6:ENST00000596542:intron:MODIFIER:exon5/9:c.336-50G>A:,USHBP1:ENST00000598309:intron:MODIFIER:exon1/3:c.-200-1881C>T:,BABAM1:ENST00000598188:intron:MODIFIER:exon6/8:c.570-50G>A:,BABAM1:ENST00000594247:intron:MODIFIER:exon5/8:c.*184-50G>A:,BABAM1:ENST00000599474:intron:MODIFIER:exon6/6:c.570-50G>A:,BABAM1:ENST00000595393:intron:MODIFIER:exon3/3:n.443-50G>A:,BABAM1:ENST00000447614:intron:MODIFIER:exon6/8:c.569+37G>A:,BABAM1:ENST00000601043:intron:MODIFIER:exon6/8:c.570-50G>A:,BABAM1:ENST00000596335:intron:MODIFIER:exon6/6:c.594-50G>A:,BABAM1:ENST00000448635:intron:MODIFIER:exon4/4:n.529-50G>A:,BABAM1:ENST00000595632:intron:MODIFIER:exon3/5:c.345-50G>A:,BABAM1:ENST00000601938:intron:MODIFIER:exon6/6:c.657-50G>A:,BABAM1:ENST00000602066:intron:MODIFIER:exon5/5:c.570-50G>A:,BABAM1:ENST00000598567:intron:MODIFIER:exon3/3:c.229+2465G>A:,BABAM1:ENST00000598382:non_coding_transcript_exon:MODIFIER:exon1/3:n.18G>A:		rs61634114	0.0990	0.2372	483/299/39	0.1056											19	307					BABAM1 (inh=n/a pLI=0.73), CTD-2278I10.6 (inh=n/a pLI=n/a), USHBP1 (inh=n/a pLI=0.00)
chr19	17389648	17389648	C	T	het		QUAL=1229;DP=109;AF=0.47;MQM=60	BABAM1,CTD-2278I10.6,USHBP1	splice_region&intron,intron	BABAM1:ENST00000359435:splice_region&intron:LOW:exon8/8:c.787-6C>T:,BABAM1:ENST00000598188:splice_region&intron:LOW:exon8/8:c.787-6C>T:,BABAM1:ENST00000447614:splice_region&intron:LOW:exon8/8:c.787-6C>T:,BABAM1:ENST00000601043:splice_region&intron:LOW:exon8/8:c.787-6C>T:,BABAM1:ENST00000595632:splice_region&intron:LOW:exon5/5:c.562-6C>T:,BABAM1:ENST00000598382:splice_region&intron:LOW:exon2/2:n.285-6C>T:,BABAM1:ENST00000601232:splice_region&intron:LOW:exon2/2:c.*94-6C>T:,CTD-2278I10.6:ENST00000596542:intron:MODIFIER:exon7/9:c.552+1930C>T:,USHBP1:ENST00000598309:intron:MODIFIER:exon1/3:c.-201+3697G>A:,BABAM1:ENST00000594247:intron:MODIFIER:exon8/8:c.*498+1495C>T:,BABAM1:ENST00000598567:intron:MODIFIER:exon3/3:c.230-198C>T:		rs10406920	0.1118	0.1798	1404/941/140	0.1450											65	726	1	[1] Ilnaz Sepahi 29-03-2016 batch import			BABAM1 (inh=n/a pLI=0.73), CTD-2278I10.6 (inh=n/a pLI=n/a), USHBP1 (inh=n/a pLI=0.00)
chr19	17389704	17389704	G	A	het		QUAL=6312;DP=539;AF=0.47;MQM=60	BABAM1,CTD-2278I10.6,USHBP1	synonymous,3'UTR,intron,non_coding_transcript_exon	BABAM1:ENST00000359435:synonymous:LOW:exon9/9:c.837G>A:p.Lys279Lys,BABAM1:ENST00000598188:synonymous:LOW:exon9/9:c.837G>A:p.Lys279Lys,BABAM1:ENST00000447614:synonymous:LOW:exon9/9:c.837G>A:p.Lys279Lys,BABAM1:ENST00000601043:synonymous:LOW:exon9/9:c.837G>A:p.Lys279Lys,BABAM1:ENST00000595632:synonymous:LOW:exon6/6:c.612G>A:p.Lys204Lys,BABAM1:ENST00000601232:3'UTR:MODIFIER:exon3/3:c.*144G>A:,CTD-2278I10.6:ENST00000596542:intron:MODIFIER:exon7/9:c.552+1986G>A:,USHBP1:ENST00000598309:intron:MODIFIER:exon1/3:c.-201+3641C>T:,BABAM1:ENST00000594247:intron:MODIFIER:exon8/8:c.*498+1551G>A:,BABAM1:ENST00000598567:intron:MODIFIER:exon3/3:c.230-142G>A:,BABAM1:ENST00000598382:non_coding_transcript_exon:MODIFIER:exon3/3:n.335G>A:		rs8170	0.1124	0.1568	1581/1048/168	0.1486									CM1010189 [CLASS=DP MUT=ALT PHEN="Ovarian cancer susceptibility to" GENE=BABAM1]; 	COSM438891, COSM438892	65	727	1	[1] Ilnaz Sepahi 29-03-2016 batch import			BABAM1 (inh=n/a pLI=0.73), CTD-2278I10.6 (inh=n/a pLI=n/a), USHBP1 (inh=n/a pLI=0.00)
chr20	14167283	14167283	A	G	hom		QUAL=905;DP=31;AF=1.00;MQM=60	MACROD2	intron	MACROD2:ENST00000310348:intron:MODIFIER:exon3/17:c.271+100909A>G:,MACROD2:ENST00000217246:intron:MODIFIER:exon3/16:c.271+100909A>G:,MACROD2:ENST00000477147:intron:MODIFIER:exon3/3:n.540+100909A>G:,MACROD2:ENST00000494602:intron:MODIFIER:exon3/4:n.298+100909A>G:,MACROD2:ENST00000490428:intron:MODIFIER:exon3/4:n.262+100909A>G:	L1PA16	rs6074704	0.4792	0.0000	0/0/0	0.5723											324	399					MACROD2 (inh=n/a pLI=0.01)
chr20	48301146	48301146	G	A	hom		QUAL=39629;DP=1210;AF=1.00;MQM=60	B4GALT5	intron	B4GALT5:ENST00000371711:intron:MODIFIER:exon1/8:c.116-27907C>T:		rs6512586	0.4681	0.5201	15518/8865/587	0.4853											484	791					B4GALT5 (inh=n/a pLI=0.99)
